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Abstract
Three essential issues concerning the development of optimized blood pumps are investigated
in this Thesis: 1) hemolysis models, needed to describe blood damage; 2) a proper approach
for numerical simulation of hemodynamics in blood-transporting equipments using Compu-
tational Fluid Dynamics (CFD); and 3) CFD-based optimization (CFD-O) of blood pumps.
Hemolysis induced by shear stress is the primary and immediate damage of Red Blood
Cells (RBC) and is found in most blood-transporting equipment. A numerical hemolysis
prediction based on CFD is needed to support the initial design process and to later reduce
the cost of prototype tests. The current state of the art concerning numerical models for
hemolysis prediction is reviewed. Existing mathematical models and numerical solutions are
discussed are compared concerning their applicability for integration as an objective function
for CFD-O. New Eulerian formulations of existing models are introduced and first valida-
tions by comparison with experimental data are attempted. A general perspective for future
development concerning hemolysis model is finally proposed.
In a second step, the blood flow in a nozzle involving a sudden expansion and an uncon-
ventional blood pump are investigated numerically. Both are current benchmarks proposed
by the US american Food and Drug Administration (FDA) as part as the assessment program
”Critical Path Initiative”: based on the results, it will be decided if CFD can be officially
involved in later certification steps. The numerical results obtained in our group for the blood
nozzle have been already compared with experimental data, showing good agreement. Com-
parisons for the blood pump will be presented as soon as corresponding experimental data
have been released by the FDA (which is unfortunately not yet the case when submitting this
Thesis).
A general, CFD-based design optimization method for axial-flow rotary pumps has fi-
nally been developed, involving both efficiency and hemolysis as concurrent objectives. This
method is first suitable for screw-type, axial-flow rotary pumps with guide-vanes. It has
been implemented by coupling the optimization tool ESTECOr modeFRONTIER with the
CFD package ANSYSr 14. Concerning the optimization algorithm, a new approach named
”design-theory-based CFD-O” is introduced in the present work, which is a combination of
design theory and CFD-O. The main purpose of design-theory-based CFD-O is to use pump
design theory to reduce the huge computational cost usually associated to CFD-O. Normal
optimization based on CFD requires the numerical simulation of hundreds or even thousands
of designs, which is and will remain in the near future a major restriction preventing a broad
usage of CFD-O. This computational load is tremendously reduced in the current work by 1)
reducing the number of geometrical variables through relationships between geometrical/in-
put variables, and by 2) avoiding evaluation of too unconventional designs.
Since it is unclear yet if a screw-type, axial-flow pump is the best technical solution,
a different alternative, the Tesla pump, has been finally investigated. It features a mostly
laminar flow within the rotor, which is constructed from a group of parallel flat plates. The
shear stress in a Tesla-rotor is observed to be fairly low, compared with a standard rotor
design. This feature makes the Tesla-pump a good candidate for blood pumps, since low
shear stress leads to low hemolysis. However, the major disadvantage of a Tesla pump is its
very low efficiency, which will generate high level of thermal heating in blood. In an effort to
mitigate this issue, the efficiency of a Tesla pump has been optimized by relying again on a
computational model supported by design theory.
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Zusammenfassung
Drei wesentliche Fragen fu¨r die Optimierung von Blutpumpen werden in dieser Dissertation
untersucht: 1) Ha¨molysen-Modelle werden beno¨tigt, um Blutscha¨digungen zu beschreiben,
2) eine richtigen Ansatz fu¨r die numerische Simulation der Ha¨modynamik wird auf Basis
der Computational Fluid Dynamics (CFD) entwickelt, 3) daraus kann eine CFD-basierte
Optimierung (CFD-O) von Blutpumpen durchgefu¨hrt werden.
Ha¨molyse, die durch Schubspannung induziert wird, ist die prima¨re und unmittelbare
Bescha¨digung der roten Blutko¨rperchen (Red Blood Cells: RBC) und wird in den meisten
Gera¨ten, die Blut fo¨rdern, beobachtet. Eine numerische Vorhersage der Ha¨molyse basierend
auf CFD wird beno¨tigt, um den Design-Prozess zu unterstu¨tzen und spa¨ter die Kosten
fu¨r die Prototypentests zu reduzieren. Der aktuelle Stand der Technik in Bezug auf nu-
merische Modelle zur Vorhersage der Ha¨molyse wird beschrieben. Bestehende mathematis-
che Modelle und numerische Lo¨sungen werden hinsichtlich ihrer Eignung fu¨r die Integra-
tion als Zielfunktion fu¨r die CFD-O verglichen. Neue Eulersche Formulierungen bestehender
Modelle werden vorgestellt und es werden erste Validierungen durch Vergleiche mit experi-
mentellen Daten durchgefu¨hrt. Eine allgemeine Perspektive fu¨r die ku¨nftige Entwicklung der
Ha¨molysenmodelle wird schließlich gezeigt.
Im zweiten Schritt wird die Durchstro¨mung einer Du¨se mit einer plo¨tzlichen Expansion und
eine unkonventionelle Blutpumpe numerisch untersucht. Beide wurden als aktuelle Bench-
marks von der US-amerikanischen Food and Drug Administration (FDA) als Teil eines Be-
wertungsprogramm (”Critical Path Initiative”) vorgeschlagen: auf Basis dieser Ergebnisse
wird entschieden, ob CFD offiziell in spa¨teren Zertifizierungschritten einbezogen werden kann.
Die in unserer Gruppe fu¨r die Blutdu¨se erhaltenen numerischen Ergebnisse wurden bereits
mit experimentellen Daten verglichen und zeigen eine gute U¨bereinstimmung. Der Vergle-
ich der Blutpumpen wird so bald die entsprechenden experimentellen Daten von der FDA
vero¨ffentlicht wurden, vorgestellt (leider ist dies noch nicht der Fall bei Fertigstellung der
Dissertation).
Ein CFD-basiertes Optimierungsverfahren fu¨r Axial-Rotationspumpen wurde dann en-
twickelt, mit Effizienz und Ha¨molyse als konkurrierende Ziele. Diese Methode wird zuna¨chst
fu¨r Schraub-Axial-Rotationspumpen mit Leitra¨dern verwendet. Hierfu¨r wurde die Kopplung
des Optimierungs-Tools ESTECO Modefrontier und dem CFD-Paket ANSYS 14 vorgenom-
men. In Bezug auf den Optimierungsalgorithmus, wird ein neuer Ansatz mit dem Na-
men ”Design-Theorie-basierten CFD-O” in der vorliegenden Arbeit vorgestellt. Dies besteht
aus einer Kombination der Designtheorie mit CFD-O. Der Hauptzweck der Design-Theorie-
basierten CFD-O ist es, die Pumpe mit der Designtheorie grob zu gestalten, um den großen
Rechenaufwand der CFD-O zu reduzieren. Eine normale Optimierung basierend auf CFD er-
fordert die numerische Simulation von Hunderten oder sogar Tausenden von Designs, was
jetzt und in naher Zukunft eine wesentliche Einschra¨nkung darstellt; so kann keine um-
fassende Nutzung der CFD-O erfolgen. Diese Rechenlast wird dank Design-Theorie enorm
bei den laufenden Arbeiten reduziert, indem 1) die Anzahl der geometrischen Variablen durch
Beziehungen zwischen geometrischen Eingangsgro¨ßen reduziert wird, und da 2) zu unkonven-
tioneller Designs gar nicht betrachtet werden.
Da nicht klar ist, ob eine Schraub-Axialpumpe die beste technische Lo¨sung ist, wurde
schließlich eine andere Alternative, die Tesla-Pumpe, untersucht. Diese verfu¨gt u¨ber eine
u¨berwiegend laminare Stro¨mung innerhalb des Rotors, der aus einer Gruppe von parallelen
flachen Platten besteht. Die Schubspannung in einer Tesla-Rotor ist ziemlich gering, ver-
glichen mit einem Standard-Rotor. Diese Eigenschaft der Tesla-Pumpe ist fu¨r Blutpumpen
gut geeignet, da eine geringe Schubspannung zu einer niedrigen Ha¨molyse fu¨hrt. Ein großer
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Nachteil der Tesla-Pumpe ist jedoch ihr sehr niedriger Wirkungsgrad, sodass eine hohe ther-
mische Erwa¨rmung im Blut erzeugt wird. Es wurde versucht, dieses Problem zu mindern,
indem die Effizienz einer Tesla-Pumpe, erneut dank einer Kombination aus Rechenmodell
und Design-Theorie, optimiert wurde.
Schlu¨sselwo¨rter
Computational Fluid Dynamics (CFD), Optimierung des Pumpendesigns, Axial-Blutpumpe,
numerische Ha¨molyse-Vorhersage, Tesla-Pumpe, FDA ”Critical Path Initiative”
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Nomenclature
Roman symbols
B Length of one of the two shorter axis of a deformed RBC, (m)
c0 Absolute velocity for infinitely long blade (m·s−1)
c()() Absolute velocity, (m·s−1)
cA() Axial component of absolute velocity, (m·s−1)
D Blade radial external diameter (m)
Db Blood damage index
d Shaft diameter (m)
E Young’s modulus, (Pa)
EI Red blood cell elongation index
F Force, (N)
G Elastic modulus, (Pa)
g Gravity acceleration, (m·s−2)
H Pressure head, in water volume height, (m)
Hb Hemoglobin in red blood cell
4Hb/Hb Hemolysis as fraction of leaked hemoglobin versus initial total hemoglobin
Hc Hematocrit (volume concentration of red blood cells)
HL Local hemolysis
Ht Time-step for hemolysis computation
Hth Theoretical pressure head, in water volume height, (m)
h Thickness of the RBC membrane, (m)
K() Attack angle coefficient
L Length of the longer axis of a deformed RBC, (m)
l Impeller axial length, (m)
li Inlet guide vane axial length, (m)
lo Outlet guide vane axial length, (m)
4li Distance between inlet guide vane and impeller, (m)
4lo Distance between impeller and outlet guide vane, (m)
n Rotating speed, (rotation per second)
Nq Specific speed (same as n)
4p Pressure increase or pump pressure head, (Pa)
Q Flow rate, (m3·s−1)
R Radius of an undeformed capsule, (m)
S 3×3 Shape/deformation tensor
s Membrane strain, (s−1)
t Time, (s)
tc RBC membrane relaxation time, (s)
u()() Circumferential velocity at impeller inlet, (m·s−1)
v Velocity, (m·s−1)
V
V Domain volume, (m3)
w()() Relative velocity, (m·s−1)
X Position, (m)
x Distance, (m)
Y Potential energy, Y = gH, (m2·s−2)
Yth Theoretical potential energy, Y∞ = gH∞, (m2·s−2)
z Number of blades of impeller
zi Number of blades of inlet guide vane
zo Number of blades of outlet guide vane
Greek symbols
α()() Velocity angle, (
◦)
β()() Blade angle, (
◦)
γ˙ Shear rate, (s−1)
δ Blade thickness, (m)
 Velocity gradient (or deformation) tensor, (s−1)
η Efficiency, (s−1)
ηi Input efficiency for optimization
λ Relaxation time, (s)
µ Dynamic viscosity, (Pa·s)
µ0 Dynamic viscosity at zero shear rate, (Pa·s)
µin Dynamic viscosity inner RBC, (Pa·s)
µ∞ Dynamic viscosity at infinity shear rate, (Pa·s)
µmb Dynamic viscosity of RBC membrane, (Pa·s)
ξ Blade top clearance (non-dimensional)
τ Shear stress, (Pa)
τ¯ Mean comparative shear stress, (Pa)
τs Threshold of shear stress, beyond which hemolysis occurs, (Pa)
τst Steady shear stress, (Pa)
τy Yield stress, (Pa)
Ω Velocity gradient tensor, (s−1)
ψ()() Squeeze coefficient
Indices for positions within pump
()()n at shaft
()()m at blade middle
()()x at blade top
()−2() at inlet guide inlet
()−1() at inlet guide outlet
()1() at impeller inlet
()2() at impeller outlet
()4() at outlet guide inlet
()5() at outlet guide outlet
Eulerian specification: all flow quantities are depicted as a function of position x and
time t, for instance for velocity
v(x, t).
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Figure 1: Index convention showing the positions within a screw-type axial-flow pump
Lagrangian specification: individual fluid parcels are followed through time. The fluid
parcels are labeled by some (time-independent) vector field a, for instance the initial position
of the fluid parcel. All flow properties are then described as a function of position of the
parcel labeled a and time t:
X(a, t).
The relation between Lagrangian specification and Eulerian specification is:
v(X(a, t), t) =
∂X
∂t
(a, t).
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Chapter 1
Introduction and Basic Concepts
1.1 Ventricular Assist Device
A ventricular assist device (VAD) is a mechanical support, attached to the native heart
and vessels in order to assist the cardiac function of patients with heart failure (Fig. 1.1).
VADs include left ventricular assist devices (LVAD, the most common solution in practice),
right ventricular assist devices (RVAD), bi-ventricular assist devices (bi-VAD) and external
ventricular assist devices. A blood pump (for bi-VAD, there can be more than one) plays the
key role in all VAD systems.
1.1.1 Present Market Situation
In developed countries, around 2% of adults suffer from heart failure. Today, 60% of heart
transplantations are urgent cases, for which donor hearts are difficult to find. VADs are used
in such situations as a bridge to transplantation and/or during patient transport. The yearly
number of patients receiving long-term VAD implantation is about 1700 in the United States
and 430 in Europe (statistics from year 2010) [1]. In year 2009, for all the implantations
with FDA-approved devices, around half of those involved pulsatile devices, the other half
continuous flow devices (rotary blood pumps) as considered in the present work [2]. The total
market for VADs was roughly $500 million in year 2010, and is expected to double until year
2017 [3].
Figure 1.1: Number of heart transplants per year [1].
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Figure 1.2: LVAD contribution in 2010 [3].
1.1.2 Types of Blood Pumps for LVADs
Different types of VADs have been developed and a large amount of research has been devoted
to improve the material, structure and control strategy of these devices.
Based on the blood flow produced by the assist devices, ventricular assist devices can be
classified as pulsatile assist devices and nonpulsatile assist devices. Since the flow pumped
by a natural heart is pulsatile, it was first assumed that pulsatile assistance is preferred.
However, clinical evidences are not conclusive at all. Long-term nonpulsatile bi-ventricular
bypass is reported to produce no harmful physiological effects in animals, and nonpulsatile
assist devices can function as well as pulsatile assist devices, even if 20% higher blood flow
rates are pumped [4]. There is also evidence that pulsatile cardiopulmonary bypass procedure
has no significant advantage compared to nonpulsatile procedures in terms of hemolysis and
deformation of RBCs [5]. Even if prolonged nonpulsatile left ventricular bypass may impact
arterial wall structure and vasoconstrictive function [6], nonpulsatile systems are still broadly
used up to now and become even increasingly popular (Fig. 1.2).
One main reason is that, structurally, devices needed to produce a proper pulsatile flow
are relatively large in size and have large contact surfaces to blood. Nonpulsatile ventricular
assist devices are usually rotary blood pumps, which are smaller and simpler, and have less
contact surface. Since a quite constant shear stress is produced in rotary blood pumps, a
lower hemolysis level may be achieved for appropriate designs. This is the reason why this
Thesis concentrates on nonpulsatile (rotary) blood pumps.
1.1.3 Surgery Issues
Typically, a pulsatile LVAD is large, and is placed outside of the body. It is connected to left
atrium and left ventricle by pipes through the belly skin (as in Fig. 1.3, left). Some smaller
systems can now be implanted inside the abdomen, but there is no approved commercial
system available for in-chest implantation.
On the other hand, available nonpulsatile LVADs can be implanted inside the chest (as
in Fig. 1.3, middle), or even inside the left atrium (as in Fig. 1.3, right), if its size is small
enough. Until 2011, all existing VAD models on the market were implanted through me-
dian sternotomy, for which a vertical inline incision is made along the sternum, after which
the sternum itself is divided. Future, even smaller VADs could possibly be implanted by
minimally-invasive surgery, hugely reducing the complexity of the intervention.
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Figure 1.3: Left: Extracorporeal implantation (Berlin HeartrExcor); Center: In-chest im-
plantation (Berlin HeartrIncor); Right: In-heart implantation: Jarvikr2000.
1.1.4 Working Condition for Rotary Blood Pumps
Corresponding to physiological constraints, most rotary blood pumps operate at a flow rate
around 5 L/min, against a pressure of around 100 mmHg, with a rotating speed from 2 000
to 20 000 rpm. The hydraulic efficiency of such pump varies strongly depending on the
employed design. The maximal hydraulic efficiency claimed in the literature exceeds 80%,
but other systems have been associated with efficiencies below 50%. These values must be
considered with caution, since independent studies are the exception, most figures being
directly or indirectly provided by the company selling the corresponding pump. Obviously,
a lower efficiency implies that more heat will be generated due to power loss, which could
lead to negative effects concerning in-body implantation and blood damage. In that sense,
the efficiency should – as usual – be maximized, but without forgetting that hemolysis is of
paramount importance: increasing the efficiency by 2% makes no sense if the hemolysis is
simultaneously doubled.
1.1.5 Rotary Blood Pump with Magnetic Levitation System
The third generation of rotary blood pumps is characterized by its magnetic levitation system.
In such a pump, the rotor of the driving electric motor is integrated into the impeller of the
pump, and the stator is integrated into the pump shell. In that way, the pump and the driving
electric motor are constructed in the same block. Permanent magnet elements are assembled
inside the impeller, the coils of the stator of the electric motor are assembled either in the
pump shell or in the shaft of the guide blade (as in Fig. 1.4).
In a blood pump with magnetic levitation system, the impeller floats in blood. It is
not driven by a transmission rod, and has no physical connection or contact with the fixed
parts; thus, no bearing is needed. Mechanical friction and friction-induced efficiency losses
are therefore minimized. Since mechanical friction regions are typically of major importance
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for hemolysis, removing such regions helps to minimize the total hemolysis. Current magnet-
levitated blood pumps include two groups of magnetic coupling, for instance for the Berlin
Heart Incor, Fig. 1.4. One group is inside the shafts of the guide vanes and at the front and
back side of the impeller; it is used to levitate the impeller in the middle position of the pump.
The other group is the stator and the rotor magnet; it serves to rotate the impeller by the
magnetic flux between the two components of the group.
Figure 1.4: Berlin HeartrIncor [7].
Figure 1.5: Levitation system with
single magnetic coupling [7].
The magnetic coupling for levitation and the magnetic coupling for driving can also be
integrated together, in order to further simplify the mechanical structure of the pump. Fig-
ure 1.5 is an example of such a solution.
1.1.6 Tesla Pump as Blood Pump
A Tesla pump is a very unconventional design [8]. There, the rotor is composed of parallel
co-rotating disks. These disks are flat, thin and smooth and are spaced along the shaft with
tiny gaps. The distance between disks can be determined approximately by calculating the
thickness of the boundary layer of the fluid, normal to the disk surface. Friction forces between
disks and liquid and within the liquid are the transportation driving force.
Compared with typical pumps involving rotor and blades, a Tesla pump shows a very low
average flow-induced shear stress, which is the main cause of hemolysis. Therefore, using a
Tesla pump as blood transport equipment could greatly reduce occurrence of hemolysis. This
is why some scientific publications and patents exist concerning the practical usage of Tesla
pumps for blood flows [9].
On the other hand, a typical Tesla pump has a very low efficiency (usually less than 20
%), which would generate massive heat transfer to the blood, which might be a problem for
blood damage and patient health.
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Figure 1.6: A typical Tesla pump [8]
Due to its possible practical relevance, and considering that our research group is very
experienced concerning the optimization of hydraulic efficiency for turbomachines, a specific
subproject has been considered during this Thesis. The suitability of a Tesla pump as a blood
pump is discussed in Chapter 6. A CFD-based design optimization for the rotating disks of
a Tesla-pump is discussed, and currently considered in more details in [10].
1.2 Numerical Hemolysis Prediction
Hemolysis and Thrombosis are the two major complications associated with blood pump
applications. Hemolysis is the damage of red blood cells (RBCs) and the release of their
content (hemoglobin) into the surrounding fluid (blood plasma). Reducing the hemolysis
would result in a lower need of potentially harmful anti-hemolysis agents. It would open the
door for the development of new generation VAD devices [11]. At the difference of thrombosis,
hemolysis does not lead to accumulated substance on the wall of the arteries. It does not lead
to a change in geometry and is thus easier to be considered in a CFD approach. Additionally,
the time-scale of damages induced by hemolysis is much shorter than for thrombosis. This is
why only hemolysis is considered in the present work; it is already a considerable challenge,
as will be discussed later.
A simple relation between hemolysis, magnitude of shear stress and exposure time was
first introduced by [12] in 1990:
4Hb/Hb = 3.63 107τ 2.416t0.785 (1.1)
with 4Hb/Hb referring to released hemoglobin in percentage, τ referring to shear stress and t
referring to exposure time. This relationship was worked out by curve fitting, and is based on
experimental data with constant shear stress. It was later interpreted in different numerical
ways, coded in different CFD tools, and is still widely used. However, in real flows found
in blood transportation equipments, the precision of this model can be very poor, results
being one or two orders of magnitude different from measured values [13]. . . The success of
this model is mostly due to its simplicity of coding, and partly due to shortcomings of other
alternatives.
More complex mathematical models are also available. Some do deliver a better precision
for certain applications [13], but usually only with limited generality. The difficulty for
identifying new mathematical models lies in the overwhelming complexity and versatility
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of the hemolysis process. All existing hemolysis models are based on macroscopic blood
properties; the equations are designed based upon strong assumptions, and the parameter
values are fitted to experiments results. Modeling and simulation of individual RBCs would
lead to unacceptable computational costs and cannot therefore be included for industrial
CFD-based equipment design yet.
There are two major approaches for the numerical implementation of hemolysis models, for
instance Eq.(1.1): the particle tracking (Lagrangian) approach (during post-processing), and
the in-solver, additional transport equation (Eulerian approach). The former has a broad
applicability, but the precision is usually limited by the imprecision in particle track and
averaging, especially when there are large recirculation regions in the flow domain. The latter
is only valid for a certain type of hemolysis models, but is faster and in principle more accurate
[11]. It is easier to integrate into an automatic design optimization process.
A detailed discussion of numerical hemolysis prediction methods is given in Chapter 2.
1.3 CFD-Based Pump Design Optimization
1.3.1 About CFD-O
Instead of the trial-and-error manual method aiming at regional improvement, CFD-O (Op-
timization relying on evaluations obtained by Computational Fluid Dynamics, or CFD-based
Optimization [14, 15]), means a mathematical optimization: an automatic process, revealing
the relationship among all important parameters affecting the performance of a design.
A fully automatic optimization employs a shell program for the generation of design vari-
ables’ value, the flow-path control, and the evaluation of the performance of the designs.
In the flow-path, geometry and mesh generators, CFD solver, and pre- and post-processing
tools are integrated. The integrated CFD-tools are executed in sequence based on journal
(also called replay) scripts, and thus the optimization procedure is automatic without need
for further human interference. The shell program repeats this sequence running in a loop,
determines the value(s) of the objective(s), and ranks each design based on these objective
values (Fig. 1.7).
The iterations within the optimizer loop are sorted into groups (or ”generations”). Evo-
lutionary algorithms (EA) are typically used for the production of variable values for genera-
tions, producing and evaluating one generation at a time. The newer generation is designed
by evaluating the outcomes (objective values) of the earlier generations.
Genetic algorithm is the most popular type of EA (Fig. 1.8). With such an algorithm,
the initial population is a set of quasi-random configurations in the domain defined by the
limits imposed on the parameters. The creation of a new generation from the present one
is performed by applying genetic operators to the individuals of the present generation. At
each generation, the individuals are classified as a function of their corresponding objective
values, leading to a rank within the population and finally to a fitness. The probability
for an individual to participate in the reproduction process is determined by a probability
based on its fitness value. Individuals associated with a higher fitness value have a better
chance to survive and to take part in the reproduction process. In this way, better and
better generations are generated step by step. The advantages of GA are a remarkable
robustness, a good potential to explore the whole space and to avoid getting trapped in local
optima. GA can iterate further even if some evaluations fail, and that is often the case for
pump optimization, since many designs will fail to produce a certain pressure head. The
disadvantage of GA lies in its large computational cost [15].
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Figure 1.7: A sample optimization loop [16].
Figure 1.8: Flowchart of a genetic
algorithm [16].
1.3.2 CFD-O of Axial-flow Blood Pump
The design objectives of a blood pump usually include the following aspects:
1. Higher efficiency.
2. Smaller size.
3. Lower hemolysis.
4. Lower coagulation (thrombosis).
Efficiency is typically considered as the basic and primary objective of pump optimization;
a pump system with higher hydraulic efficiency consumes less power, has usually less total
weight, and will lead to reduced heat fluxes. Pump size is a critical consideration for selecting
the surgery method; pump size could be easily included as a secondary objective in CFD-O,
since no extra computational cost has to be added; the corresponding objective is directly
an arithmetic result of some of the geometrical variables. Nevertheless, it is not done in
the present, purely theoretical project, since surgery is not considered. On the other hand,
hemolysis, being of central importance, can be added as a secondary objective during the
optimization. Thrombosis is not included in the current work, for the reasons discussed
previously.
The main difficulty associated to the direct optimization of a 3-dimensional complex ge-
ometry with an unsteady flow lies in the vast computational cost associated to this problem.
This has never been done previously in our group: either a 3-dimensional optimization prob-
lem was simplified into a 2-dimensional problem, such as for the wind turbines in [16]; or
only steady flow conditions where considered. However, the current problem can neither be
simplified to 2D nor to steady conditions.
The total time of an optimization equals in principle the evaluation time for one design
times the total number of designs to be evaluated. The vast computational cost for a 3D
pump optimization partly lies on the long duration for each CFD simulation of one pump
design. A typical hexahedral mesh for an axial-flow pump with front and back guide-vanes
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possesses half a million cells, using periodical interfaces to reduce the mesh size by omitting
duplicate parts (axial-symmetry). A CFD simulation for such a mesh takes typically 5 hours
on a good desktop machine with an Intelrcore-i5 quad-core processor. Additionally, the
simulation needs to be repeated with different rotating speeds, in order to find out the right
rotating speed to reach the target pressure head.
The vast computational cost lies also partly on the large number of designs to be evaluated.
The number of total designs in an optimization increases with the number of design (input)
variables. And the geometrical parameterization of an axial-flow blood pump requires a very
large number of geometrical variables.
In Chapter 4, an innovative method with the name of ”design-theory-based CFD-O”
(DTB-CFD-O) is introduced for the first time. It combines the advantages of pump design
theory and CFD-O, and is able to significantly reduce the total number of designs to be
evaluated, compared with standard CFD-O. Design theory is used to reveal the relationship
between geometrical variables; when the values of geometrical variables change in a correlated
manner, the variables’ variation domain can be reduced. If some geometrical variables can be
expressed by a definite mathematical expression as function of other variables, the number of
input variables can be immediately reduced, In this way, the total computational cost of the
optimization can be significantly reduced. In our optimization, the geometrical variables are
divided into two groups: the controlling group and the derived group. Only values for the
first group are decided by the optimizer, the values of the derived group being determined
by the pump design theory; thus, a full geometrical description is realized by using only a
limited number of input variables.
1.4 Structure of the Thesis
This dissertation begins with a general review of current knowledge concerning blood, followed
by a detailed review of the current state of the art for numerical hemolysis prediction methods.
Different approaches for hemolysis prediction are compared and validated by comparison with
the (unfortunately very limited) experimental data available. These models are then used for
the numerical hemolysis prediction in the rest of this work.
The second part of the dissertation is a typical ”passive” CFD, used as a validation of the
developed computational chain. It involves the numerical simulation of the blood flow in two
existing equipments: a nozzle with sudden expansion and a centrifugal pump, both considered
in the FDA’s ”Critical Path Initiative” project. These test cases were selected to find out how
accurately can CFD predict the blood flow in medical equipments with complex geometries,
and to test the possibility of numerical hemolysis prediction. Our numerical results for the
first test case have been successfully validated by comparison with experimental data. In
particular, the impact of the turbulence models has been compared. The numerical results
for the second test case are obtained with an hexahedral mesh involving around 10 million
cells. Unfortunately, reference experimental data are not available yet for comparison.
The dissertation turns in the third part to an ”active” usage of CFD: CFD-aided design.
A design method for turbomachinery combining the merits of traditional pump design theory
and modern computer-aided design process with CFD is introduced. A Matlab-based solu-
tion of the equations is integrated into the automatic CFD-O loop. A detailed theoretical
derivation and practical numerical tools are described in this part.
In the fourth part, an alternative design for blood pump, a Tesla pump, is discussed.
The main objective here is to increase the efficiency of the Tesla pump. First results are
encouraging, but further investigations are required concerning this point.
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Numerical Hemolysis Prediction
2.1 Literature Review on Blood and RBC Properties
Human blood is a suspension of red blood cells (RBCs), white blood cells (WBCs) and
platelets in plasma. Blood shows a complex behavior, including shear-thinning viscosity and
cell damage. These phenomena are due to the intricate biological nature and physiological
function of blood.
2.1.1 RBC
RBCs (Fig. 2.1) constitute 40% (women) or 45% (men) of blood by volume. The inner content
of RBCs (90% is hemoglobin) is a Newtonian fluid with a viscosity of 6.5 10−3 Pa·s [17]. Some
key features of human RBCs are [13]:
• A RBC has 40% excess surface compared to a sphere of the same volume. This is
attributed to its biconcave-disk shape (Fig. 2.2). This excess surface area allows the
RBC to undergo area- and volume-preserving deformations, and increases the surface
area available for the gases to diffuse across the semipermeable membrane;
• The viscoelastic membrane of a RBC can accommodate a maximal stretching of 6%
[17]. The membrane starts to rupture beyond this limit. Hemolysis starts after the
protruded surface (see later Figs. 2.17 to 2.19) occupies about 29% of the total surface
area, i.e., a lesion area of 27±6 µm2, based on an initial total surface of 140 µm2 [18];
• The natural half-lifetime of RBCs is 120 days. When submitted to shear, young RBCs
have a relaxation time of about 100 ms, old RBCs have a relaxation time tending to
300 ms.
Figure 2.1: Natural shape of
RBC for zero shear
Figure 2.2: Typical dimensions of
RBC [13]
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2.1.2 Blood Viscosity
Blood is a shear-thinning (or viscoelastic) non-Newtonian fluid. The suspending medium
(plasma) is a Newtonian fluid (viscosity of 1.1 10−3 to 1.3 10−3 Pa·s) [19]; its viscosity is
independent from the rate of strain in the flow. The viscoelastic behavior of blood is due to
the complex mechanical response of blood cells in interaction with the plasma. At zero or
very low shear, RBCs aggregate into coin-stack structures; as shear increases, this coin-stack
structure breaks; and at higher shear, RBCs start to deform and their orientation change.
This stage-by-stage modifications of RBCs lead to the shear-thinning behavior of blood; i.e.,
the viscosity of blood decreases as the rate of strain in the flow increases [13]. Among many
others, Thurston has introduced an equation for the relationship between shear stress and
velocity gradient in blood [20]. For low velocity gradients, a constant viscosity is used:
τ
1/2
st = τ
1/2
y +
(
µ
∂v
∂x
)1/2
(2.1)
where τst is the flow shear stress, ∂v/∂x is the corresponding value of the velocity gradient, µ
is dynamic viscosity and τy is the yield stress. This equation shows that blood can sustain a
static stress without flowing, as long as it is below the yield stress. However, reported values
of τy are quite low. This first relationship between stress and velocity gradient is only valid for
small velocity gradients, as long as RBCs are unperturbed and remain in the fully aggregated
state. With increasing velocity gradients the structures become disrupted, at which level
shear-thinning appears [20].
Measured shear-dependent viscosity data for a human blood sampled with 45% hematocrit
is shown in Table 2.1 [21]:
Shear rate (s−1) 0.01 0.06 0.12 0.53 5.99 58.1 11.4 118 230
Viscosity (mPa·s) 158 99.7 74.3 36.2 11.2 8.62 5.44 4.61 4.04
Table 2.1: Measured shear-dependent viscosity of human blood [21]
Leuprecht and Perktold used the Carreau-Yasuda model (Eq. 2.2) to model blood behavior
in a stenosed artery [22]:
µ(γ˙) = µ∞ +
µ0 − µ∞
(1 + (λγ˙)b)a
(2.2)
where µ0 = 1.6 10
−1 Pa·s, µ∞ = 3.5 mPa·s, a = 1.23, b = 0.64, λ = 8.2 s.
The hematocrit level, the volume fraction of RBCs in blood, influences the viscosity of
blood. Oldroyd considered the suspension behavior of spherical drops that are surrounded by
a film with viscoelastic behavior, and gave the relationship between hematocrit and viscosity
as [23, 24]:
µsusp
µ0
= 1 +KHc
(µi + µm)/µ0 + 0.4
(µi + µm)/µ0 + 0.6
(2.3)
where µ0 is the viscosity of the continuous phase, µi is the viscosity of the dispersed phase, µm
is a function of the rheological properties of the membrane and Hc is the volume concentration
of the spherical drops.
However, as done in almost all published CFD studies concerning blood pumps, a constant
viscosity (Newtonian model) will be employed in the rest of this Thesis. For this specific
application, only small differences are expected when using a more realistic, non-Newtonian
description.
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2.1.3 RBCs’ Elongation, Tank-treading and Tumbling
The behavior of RBCs in a shear flow is characterized by elongation, tank-treading and
tumbling. When blood is at rest, the RBCs aggregate into coin-stack-shaped structures (also
called rouleaux); these structures break as the shear stress in blood increases, and RBCs
become individually dispersed. In the flow the RBCs behave as neutrally buoyant droplets
with high deformability but small areal stretchability [25, 26]. Schmid-Schoenbein and Wells
found that the dispersed RBCs preserve their biconcave shape and tumble in a flow for a
shear stress below 0.1 Pa [25]. The tumbling gradually reduces and the cells begin to align
with the flow around 0.2 Pa (Fig. 2.3). The RBCs deform into ellipsoidal shape, orient with
the flow and show tank-treading of membrane at shear stress larger than 1 Pa. Tank-treading
is a phenomenon in which the cell membrane rotates around the encapsulated fluid [13].
Figure 2.3: Qualitative RBC behavior as shear increases [13]
2.1.3.1 Steady-state Investigations on Elongation
The Elongation Index EI is used to measure the elongation of a microcapsule or a RBC:
EI =
L−B
L+B
(2.4)
where L is the longer axis of the RBC and B is one shorter axis of the (ellipsoidal) RBC. The
elongation of an initially spherical microcapsule in linear shear flow can be described by the
ratio of deforming and restoring forces, as in Eq.(2.5) [27]:
EI ≈ 25µγ˙R
4Eh
(2.5)
where µ is the viscous resistance of the solvent phase, γ˙ is the applied shear rate, R is the
radius of the undeformed capsule, E is the bulk Young’s modulus and h is the thickness of
the membrane.
Bronkhorst studied experimentally the relation between RBC rheology and the various
stages of the deformation curve with blood flow in a stationary cylinder. His results are
shown in Fig. 2.4 [28].
The Lineweaver-Burke method gives a relation between shear stress τ and EI [29]:
1
EI
=
τ1/2
EImax
1
τ
+
1
EImax
(2.6)
where τ1/2 is the shear stress that causes half-maximal RBC deformation EImax/2. In this
method 1/EI is first plotted against 1/τ . Then, the relationship is described with a linear
regression (as in Fig. 2.5). However, this reciprocal plot deviates from a straight line. The
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Figure 2.4: RBC deformation in shear flow [28]
least squares method used for regression minimizes the absolute difference between the mea-
surement points and the fitted line. The difference causes merely a small relative difference
at high 1/τ and high 1/EI, but causes a huge relative difference at low values of 1/τ and
1/EI [30].
Figure 2.5: Lineweaver-Burke transformation
showing 1/EI vs. 1/τ [31]
Figure 2.6: Streekstra-Bronkhorst
transformation showing τ vs. EI [28]
The Streekstra-Bronkhorst model (Eq. 2.7), on the other hand, is based on a S-shaped
curve. For this purpose, the shear stress in plotted on a logarithmic scale (see Fig. 2.4) [28],
EI = (EImax − EImin)
(
τ
τ1/2
)m
(
τ
τ1/2
)m
+ 1
+ EImin (2.7)
where, m is a constant. In order to remove the variable EImin in Eq. (2.7), an approximate
form has been proposed in [32]:
EI = EImax
(
τ
τ1/2
)m
(
τ
τ1/2
)m
+ 1
(2.8)
Ookawara measured the influence of temperature on plasma viscosity (Fig. 2.7) and RBCs’
EI (Fig. 2.8) [33]. Result shows that the kinetic heating in artificial blood devices – somewhat
surprisingly – tends to reduce hemolysis. This partly explains why many numerical hemolysis
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models over-predict hemolysis in commercial blood pumps. However, it is still unclear why
this phenomenon is observed; to what extent kinetic heating impacts hemolysis prediction
still has to be clarified.
Figure 2.7: Dependence of plasma
viscosity on temperature [33]
Figure 2.8: Dependence of
RBCs’ EI on temperature [33]
2.1.3.2 Transient Investigations on Elongation
The investigations on the relation between τ and EI in Section 2.1.3.1 are all based on
measurements with time-constant shear stress. However, the deformation of RBCs is a time-
dependent process; a time delay exists between a rise in shear stress and the time at which
RBCs reach steady-state of EI .
Watanabe measured the deformation of RBCs under oscillation of shear stress. The first
experiment is at a frequency of 3 Hz and a peak shear stress of 220 Pa (Fig. 2.9) [34]. The
second experiment is at a frequency of 2 Hz, a peak of shear stress of 128 Pa, and with shear
stress pre-loading of 64 Pa (Fig. 2.10) [35]. A clear time delay between the minimum value
of shear stress and the minimum value of deformation is observed. However, a time delay
between the peak value of shear stress and the peak value of deformation is not obvious.
Maffettone and Minale used a tensor-based ellipsoidal drop model to portray the behavior
of RBC under transient shear stress. Equation (2.9) is the original formation for a simple
deformable ellipsoidal drop [36]:
dS
dt
− a[Ω · S + S · Ω] = −f1[S − g(S)I] + af2[ · S + S · ] (2.9)
Arora later modified this equation with additional consideration for membrane tank-treading
effect, dsee etails in Section 2.3.3.1.
Hochmuth introduced an exponential function for the relaxation of RBC after cessation
of stress [37]:
EI(1 + EI2max)
(1 + EI2)EImax
= exp
(
− t
tc
)
(2.10)
where tc is the characteristic time of relaxation.
In addition, Yoon’s measurements for single RBC under stretching force shows a power-law
decay of the stress in time (Eq. 2.11) [38]:
F (t)/4L(t) = k(t) = k∞ +4k0(t/t0)−α (2.11)
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Figure 2.9: L/B of porcine blood under oscil-
lation of shear stress [34]
Figure 2.10: L/B under uniform shear stress
of 64 Pa amplitude for varying exposure time
[35]
where F is force, L is length, k is stiffness, t is time, α is a constant.
2.1.3.3 Tank-treading
The notion of ”Tank-treading”, first mentioned by Fischer et al. in [39], refers to the fact
that the membrane is driven into a motion around the RBC, generating a shear flow in
the cytoplasm. This phenomenon occurs when the RBC is in a suspension and encounters
a shear rate above a certain threshold, and is consequently oriented and elongated. The
angle and tank-treading frequency generally decrease with increasing elongation of RBC. The
range of the predicted angles and tank-treading frequencies and their behavior with increasing
elongation are in agreement with experimental observations on human RBC [40].
This issue has been broadly discussed. Many former investigations [40–44] were focused
on kinetic models, while [45] focused on membrane energy dissipation; recent investigations
[46–52] try to find general flow conditions for tumbling and tank-treading, and the trigger for
the change of state between both.
According to Noguchi’s mathematical model, besides tumbling and tank-treading, there
exists another state for RBC, the swinging state. A tank-treading mode occurs with a constant
inclination angle θ at low viscosity of the internal fluid µin or low membrane viscosity µmb; a
tumbling mode occurs at high µin or µmb with low shear rate γ˙; and a swinging motion occurs
at middle µin or µmb with high γ˙ [51].
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Although much progress was already achieved in modeling tank-treading and tumbling
behavior, the existing mathematical models are not really helpful for CFD-based hemolysis
prediction, since they are very complex but of limited generality. Each model is usually
dedicated to one single aspect, such as membrane kinetics in steady state, deformation or
transient state. There is at present no general model able to describe at the same time
membrane tension (generation of mini-holes), deformation and change of state.
2.1.4 RBC Membrane and Shear-induced RBC Alteration
The deformation of a RBC is dominated by the membrane rather than by cytoplasmic prop-
erties (internal viscosity) [18]. Hence, a deeper understanding of the RBCs’ deformation and
hemolysis requires the knowledge of the properties of RBC membrane.
Rand introduced a transient relation between shear stress and strain in RBC membrane
[53]:
s = τ
[
1
G2
+
1
G1
(1− e−(G1/µ1)t) + 1
µ2
t
]
(2.12)
where s is membrane strain, G is elastic modulus and µ is viscosity. This equation is used in
the hemolysis model discussed in Section 2.3.3.2.
Arwatz and Smits [54] modified Rand’s model into:
s = τ
[
1
G1
(1− e−(G1/µ1)t) + 1
G2
(1− e−(G2/µ2)t) + 1
µ3
t
]
(2.13)
where µ1/G1 = 0.1 s and µ2/G2 = 20 s. Both Rand’s model and Arwatz’s model can be used
directly for hemolysis prediction using 4Hb/Hb = Cs [54], where C is a constant. These two
models, like the models discussed in Section 2.1.3.3, are based on the following assumptions:
1) the elastic constant of the RBC membrane is more than four orders of magnitude larger
than the shear rigidity modulus of the cell; 2) the membrane can be treated as a simple,
homogeneous substance built from a two-dimensional, incompressible material (i.e., with a
fixed area); 3) the maximum fractional area expansion required to produce hemolysis is around
3%, when uniformly distributed [55].
Watanabe et al. numerically simulated the deformation of RBC under oscillation of shear
stress, with a membrane stretch-based model. In a cyclically reversing unsteady flow at 5 Hz,
the simulation results of L/B were consistent with experimental results of [34], as shown in
Fig. 2.11. In a steady flow, the maximum principal strain is well correlated with the fluid
shear stress, as demonstrated in Fig. 2.12. In a more complex, unsteady flow, the relation
between shear stress and maximum of area-averaged strain (and thus hemolysis) became
chaotic (Fig. 2.13 ), since the shape of a RBC was then determined not only by the fluid force
acting on it at that moment but also by its deformation history [56].
The RBC membrane shows complex mechanical properties. The decreasing deformability
of RBC, as a result of membrane hardening, is under certain conditions irreversible. Mem-
brane hardening, being one aspect associated to RBC damage, can be induced by a long-time
exposure to low or medium level of shear-rate, and can happen before, after or simultaneously
to hemolysis. It can also influence the occurrence and level of hemolysis. However, a clear
picture connecting membrane hardening and hemolysis is missing yet.
The deformability of a RBC is often measured by the shearing ratio:
(EIun − EIpre)/EIun × 100% (2.14)
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Figure 2.11: L/B under oscillation of shear stress [56]
Figure 2.12: First principle
strain vs. shear stress [56]
Figure 2.13: Maximal area-
averaged strain vs. shear
stress [56]
which is used a standardized measure to quantify the effect of shear, and is a difference of EI
values between unsheared (EIun) and pre-sheared (EIpre) cells.
Mizuno’s experiment shows that there are at least two different processes underlying
structural changes of the RBC membrane under shear stress loading. One is caused by intense
stress, with RBCs being promptly destroyed without noticeable alteration in the membrane
skeleton; the other is caused by lower stress levels (in the experiment, shear rate of 420 s−1)
acting over a longer time and leading to strong alteration in the RBC membrane skeleton
[57].
Kameneva’s measurement showed that the RBC Deformation Index (DI),
DI =
RBC suspension viscosity
Suspension medium viscosity
(2.15)
decreases after exposure to mechanical stress [58].
Lee’s measurement shows that the threshold shear stress leading to RBC damage is ap-
proximately 30 Pa (after 120 s of pre-shearing), as shown in Fig. 2.14 [59]. Unfortunately, the
RBC damage depends on both the magnitude and duration of shearing. The characteristic
time of RBC relaxation is also influenced by pre-shear, as demonstrated in Fig. 2.15 [60].
Yokoyama’s experiment shows a correlation between the fragility of RBCs, which is quan-
tified by hemoglobin in plasma Hb, and deformability measured by L/B (the ratio of the
RBC’s long axis divided by its short axis), as shown in Fig. 2.16. The fragility of RBCs is
showed to be as expected in a negative correlation with L/B [61].
Zeitz did more fundamental investigations concerning the irreversible alteration of the
microscopic structure of RBC. The transient polymerization of protein fibers inside the cell,
as found in sickle cell anemia, or a transient external force can trigger the formation of a
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Figure 2.14: Shear effect as
a function of pre-sheared stress
[59]
Figure 2.15: Characteristic
time of RBC with and with-
out pre-shear [60]
Figure 2.16: Relation between L/B and fragility of RBCs [61]
cytoskeleton-free membrane protrusion of µm dimensions. The complex relaxation kinetics
of the cell shape is responsible for selecting the final state once the perturbation is removed,
thereby controlling the reversibility (or not) of the deformation. In some cases, tubular
protrusions are found to relax via an unusual ”pearling instability” [62].
Figure 2.17 shows three possible final states of a RBC with protrusion after removing the
perturbation. The strongly deformed RBC shows a long, cytoskeleton-free membrane tube
filled with hemoglobin, created by an internal or external force. Upon force removal, the cell
may relax to its initial shape if the tube completely retracts (a), or to a different state where
some membrane area remains outside the cell body and forms a spherical bulge (b). In (c),
the tube might exhibit pearling during relaxation [62].
Figure 2.18 shows the region where a (meta)stable protrusion can exist, in the parameter
space determined by Kc/σ (elastic ratio) and 0 (the cytoskeleton pre-stress). Figure 2.19
is the critical initial protrusion volume beyond which a transient protrusion always fails to
retract inside the cell body. Case (a) is for a protrusion created by an external force, which is
a function of ratio of the volume to area exchange times (here for Kc/σ = 10 and 0 = 0.25),
while Case (b) is for a protrusion created by a bundle of protein fibers (4 nm in size) [62].
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Figure 2.17: Three possible evolu-
tions of a protrusion after removal of
perturbation [62]
Figure 2.18: Condition for the exis-
tence of a protrusion as function of
Kc/σ and 0 [62]
Figure 2.19: Limit conditions leading to complete retraction of a protrusion [62]
2.1.5 RBC Diffusion
Srivastav et al. studied the diffusion coefficient of a RBC suspension by injecting a jet of RBCs
in a microfluidic channel. Results show that the diffusion coefficient of a RBC suspension is
comparable to that of a suspension of drops, since RBCs are usually in tumbling motion and
can thus be considered as symmetric when averaging over one rotation period, as long as no
deformation occurs. On average, there should therefore be no diffusion, as for spheres. Since
the cells meet each other over a time interval shorter than one rotation period and encounter
deformation, averaging does not rule out all asymmetries and some diffusion is expected.
However, it should still be lower than the diffusion of drops that are elongated and flow with
their main axis constantly inclined with a given non-zero angle relatively to the flow direction
[63].
Tan et al. studied numerically the hydrodynamic diffusion coefficients of a suspension of
elastic capsules of viscosity ratio unity and volume fraction up to 20%, and found that the
coefficient does not increase monotonously with elastic capillary number. Instead, it drops
when the capsules become sufficiently soft [64].
RBC diffusion is one possible reason for the over-prediction often encountered when using
numerical hemolysis methods, since the highest shear stress usually occur near walls. However,
due to RBC diffusion and to the resulting inhomogeneous concentrations, RBCs are less often
found near walls than in the main stream. Till now, no numerical hemolysis method has been
proposed to take into account this effect in CFD.
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Figure 2.20: Lower RBC concentration near walls, as induced by diffusion [65]
2.1.6 Other Factors Influencing Hemolysis
Leverett’s measurement shows that an air-blood interface may be responsible for hemolysis,
but that RBC-RBC interactions are not an important mechanism for erythrocyte destruction.
A temperature exceeding 49◦C causes significant hemolysis and fragmentation [66].
Hashimoto carried out complex experimental measurements concerning hemolysis under
periodically fluctuating shear stress [67]. One particularly interesting result is that hemolysis
increases linearly with shear stress fluctuation frequency. This effect cannot be reproduced
by any of the current hemolysis models discussed in Section 2.2.
2.1.7 Direct Microscopic RBC Simulations
Direct RBC simulations lead to extremely high computational requirements. Pozrikidis sim-
ulated a single RBC with a surface grid of 512 quadratic elements for 4000 time steps on a
single-core 2.4GHz CPU. The simulation lasted 1 week [68].
Dupin simulated 200 RBCs, each with a surface grid of 800 tetrahedral elements, under
a shear rate of 10 s−1 for 4000 time steps. The volume fraction of RBCs was 30%. The total
simulation time was 150 hours using 15 AMD-Opteron CPUs. The simulation considered RBC
deformation, relaxation, tank-treading and tumbling, but did not account for any interaction
between neighboring RBCs [69].
Liu carried out a simulation with a finer surface grid of 4567 tetrahedral elements, but a
smaller number of RBCs. The simulation considered RBC-RBC interaction and RBC-wall
interaction [70].
As already discussed in Section 2.1.3.3, such simulations are very interesting to investigate
some particular aspect, but do not cover all important processes and cannot be coupled with
a full CFD model within the next years.
2.1.8 Intermediate Conclusion
Since a comprehensive mathematical model describing RBC behavior from microscopic obser-
vations is not available yet, it is not possible to derive a proper macroscopic model describing
cell damage and hemolysis. For this reason, all hemolysis prediction models currently em-
ployed in CFD try to connect hemolysis directly or indirectly to macroscopic flow properties
(stress or strain), without considering any microscopic effects.
2.2 Literature Review on Numerical Hemolysis Predic-
tion
When considering hemolysis in a CFD simulation, blood is usually simulated as a homoge-
neous non-Newtonian fluid instead of being treated as multiphase suspension, in order to
reduce the computational cost, as explained in the previous sections.
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Most existing hemolysis codes are typically in a one-way coupling with the CFD-solver.
Flow-induced shear stress functions as the exchange quantity between flow simulation and
RBC behavior. One-way coupling means that the variables describing RBC deformation
and hemolysis only exist in the hemolysis code, but not in the main flow simulation; the
velocity gradient influences the deformation of RBC and thus hemolysis, but the RBCs and
their deformation have no influence whatsoever on the velocity/pressure/turbulence equations
solved by CFD.
2.3 Computing strain and stress
One difficulty common to all models discussed in this section is how to transform in an
appropriate manner a tensor τ (involving 9 components, but, due to symmetry, only 6 free
parameters) into a single scalar value τ . This is not so straightforward, since the components
of τ are associated to different directions in space but also to different effects (shear stress or
normal stress, corresponding to two very different forces acting on the RBC). For instance, in
order to compute the scalar shear stress τ appearing later in Eq. (2.22), [71–73] use following
equation:
τ =
[
1
6
∑
i,j
(τii − τjj)2 +
∑
i,j
τ 2ij
] 1
2
(2.16)
with
τij = µ
∂vi
∂xj
(2.17)
where vi refers to the velocity component in i direction.
However, alternative definitions for τ are also found in other publications. For instance,
extremal values are used in [74]:
τ =
1
2
max [|1 − 2|, |2 − 3|, |1 − 3|] (2.18)
as well as in [75] (where i refers to the principal stress):
τ =
1
2
{
max
[
(1 − 2)2, (2 − 3)2, (1 − 3)2
]} 1
2 (2.19)
In [13], all terms of the tensor are taken into account:
τ =
[
1
3
(τ 211 + τ
2
22 + τ
2
33)−
1
3
(τ11τ22
+τ11τ33 + τ33τ22) +
1
3
(τ 212 + τ
2
13 + τ
2
23)
] 1
2
(2.20)
To our knowledge, no study has been published concerning the possible impact of these
different definitions on the hemolysis prediction. This is why, in the rest of this Thesis, we
will always follow the original method proposed in the literature for a corresponding model.
2.3.1 Stress-based Model (Power-law Equation)
If local hemolysis is assumed in a direct ratio (especially in a power-law relationship) to local
shear stress, the model is named a stress-based model (Fig. 2.21).
20
Chapter 2: Numerical Hemolysis Prediction
Figure 2.21: (Shear) stress-based model
The reference model in this category reads
4Hb/Hb = 3.63 10−7τ 2.416t0.785 (2.21)
and was already given as Eq. (1.1). This model and the obtained parameters have been
obtained from fitting measurement data discussed in [76, 77]. The underlying experiments
correspond to submitting RBC to a shear stress constant in time, with values of τ up to 255
Pa and an exposure time t up to 700 ms. The power values are obtained by curve fitting.
Equation (2.21) has been later implemented following different numerical approaches. The
formulation seems adequate for predicting hemolysis at constant shear stress with interme-
diate values of τ and of exposure time t. This configuration is, however, not found in many
practical applications. When considering varying shear stress in a higher range (300 to 1500
Pa) but with a shorter exposure time (10 to 100 ms), it has been observed that the hemol-
ysis rate predicted by Eq. (2.21) overestimates hemolysis by at least an order of magnitude
[13, 78, 79]. Unfortunately, these parameters are typical of those found in blood pumps and
most blood supply equipments. Therefore, and in spite of its very attractive simplicity, this
model does not appear suitable for our purpose (optimizing blood pumps). However, it is still
a very good alternative as long as the considered applications fulfill the underlying hypotheses
(constant and not too high value of τ , intermediate exposure time). It is also still widely used
outside of such conditions, though, mostly due to the shortcomings of alternative models, as
discussed in what follows.
Another group of power values for Eq. (2.21) is found in [71]:
4Hb/Hb = 3.63× 10−6τ 1.991t0.765 (2.22)
Note that the factor 10 difference in the pre-factor term in Eq. (2.22)compared to Eq. (2.21)
is not a typing mistake, but appears as such in [71].
2.3.1.1 Considering a threshold in shear stress
Experiments with RBC discussed in the first part of this chapter have shown that, below
a certain level for τ , no hemolysis is observed at all. In order to take into account this
observation, a shear-stress threshold τs below which hemolysis is inactive was introduced in
later versions of the power-law model and of all further models. Combined for instance with
the power-law equation, this leads to Eq. (2.23):
4Hb/Hb = 3.63 10−7τ 2.416t0.785 (for τ > τs)
4Hb/Hb = 0 (for τ ≤ τs)
(2.23)
One obvious shortcoming of this straightforward threshold approach is that, when reaching
the threshold τs, the hemolysis will jump for Eq. (2.23) in a discontinuous way from 0 to
3.63 10−7τ 2.416s t
0.785. To avoid this problem, a ramp function could be built into the model,
for instance based on an hyperbolic tangent. However, such an approach has apparently never
been published.
Different values for τs are found in the literature, varying between 100 and 250 Pa [80].
Looking back at the experiments [76, 77] leading to Eq. (2.21), it is somewhat disturbing to
21
Chapter 2: Numerical Hemolysis Prediction
see that the maximal shear stress imposed in these experiments (255 Pa) is for some other
authors nearly identical to the threshold below which no hemolysis at all is observed (τs = 250
Pa). This contradiction is a first indication that it is extremely complex to design suitable
experiments for a proper estimation of hemolysis in RBC, and this is due to four main reasons:
1. Deformation and shearing of RBC involve a tensor τ , while all models rely at the end
on a single scalar τ ;
2. RBC do not react identically to different flow solicitations. For instance, shearing and
elongation are known to lead to completely different behaviors for animal cells [81, 82];
3. RBC are not inert particles, but react to the perturbation induced by the flow with their
own time-scale. As a consequence, the experiment attempts to measure a quantity that
is changing due to the experiment itself;
4. The level of shear stress and the exposure time (or frequency) are not independent
quantities for the RBC, explaining why different experimental procedures might lead to
contradictory conclusions.
From these observations, it is clear that the experiments needed to develop suitable hemolysis
models are extremely challenging, sometimes even impossible. It is nevertheless useful to
further compare the results obtained with different published hemolysis models, as done in
the rest of this chapter.
In an attempt to take into account the fourth observation listed previously, several authors
have introduced the threshold in shear stress as a function of the exposure time. For instance,
Nerem introduced the time-dependent threshold equation [83]:
τs = 88.905 t
−0.3372 (2.24)
as the condition for hemolysis to occur.
Sharp and Mohammad introduced another formulation for a shear-stress threshold func-
tion of the exposure time [84]:
t(τs/1500− 1)2 = 0.01 (2.25)
An underlying assumption for all models is that the hemolysis process starts with a healthy
RBC (100% hemoglobin content) without any previous hemolysis history. From this simple
fact and looking back at the power-law models (Eqs. (2.21) and (2.22)), it is possible to draw
an important conclusion: when submitted to a constant shear stress exceeding the threshold,
the relative hemolysis potential of a RBC is decreasing with time, since the power for time t
in the models (time being now directly equivalent to the exposure duration) is around 0.77,
noticeably smaller than 1. This means that, when submitted to a constant shear stress τ ≥ τs,
and considering the same lapse of time 4t, the lysis potential starting from time t (t > 0) is
lower than at the beginning of the process t = 0. Considering for instance Eq. (2.21), this is
obvious, since:
(4t)0.785 > (t+4t)0.785 − t0.785 (2.26)
This observation is directly a consequence of the third observation listed previously. Bio-
logical reasons can be proposed to explain this fact:
• Former hemoglobin leakage reduces the hemoglobin quantity within the RBC, thus
reducing its volume and lowering membrane tension;
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• Irreversible changes in RBC membrane (membrane hardening) when submitted to stress,
reduces the potential of mini-holes formation and thus reduces hemoglobin leakage [55,
57, 58, 60–62].
In order to obtain correct predictions, a numerical hemolysis model should take into account
this effect. However, the fact that time appears with a non-unity exponent leads to difficul-
ties during the numerical integration. This important fact must be taken into account for
hemolysis modeling. Suitable approaches have been developed to solve this problem and are
discussed in what follows.
2.3.2 Practical Solution Methods for Stress-based Model
2.3.2.1 Method A
In order to implement the power law method into a CFD solver, a derived formulation is far
more practical. The process begins by rewriting the original Eq. (2.21) (the same treatment
is obviously possible as well for Eq. (2.22)) into the following form [80, 85–87] :
4Hb/Hb =
[
(3.63 10−7)(1/0.785)τ (2.416/0.785)t
]0.785
(2.27)
Then, the part within the square brackets is linear in time, and can be recast as a complete
differential form:
dHL
dt
= (3.63 10−7)(1/0.785)τ (2.416/0.785) (2.28)
where HL refers to the local hemolysis taking place within a CFD grid cell. Equation (2.28)
is then rewritten as a standard transport equation, as found in any common CFD-solver:
∂HL
∂t
+ v.∇HL =
δ(3.63 10−7)(1/0.785)τ (2.416/0.785)(1−HL)
(2.29)
with
δ =
{
0 if τ < τs
1 if τ ≥ τs (2.30)
Multiplying the right-hand side with (1−HL) has been done to assure that the hemolysis
rate measured by HL reduces with time at constant shear stress, as discussed previously. The
hemolysis value corresponding to the whole CFD domain is finally collected along domain
outlet by computing a mass-flow-average. The obtained value for each pathline (or streamline
for steady simulations) is finally transformed back to real time thanks to a power of 0.785:
4Hb
Hb
=
∑
outlet cellsHL
0.785m˙cell∑
outlet cells m˙cell
(2.31)
2.3.2.2 Method B
Though it looks partly quite similar to the power-law method in its structure, Method B is a
purely empirical, macroscopic formula, originally developed for blood pumps [73]:
4Hb/Hb = 3.8τ−1.9t1.5V 0.25(4p)1.4 (2.32)
It is based on a regression analysis from experimental data, as discussed in [73]. The variable
V refers to volume and 4p refers to pressure head of blood pump.
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2.3.2.3 Method C
In this alternative method the blood damage index Db is computed as a function of the lysis
induced in each grid cell [72, 88, 89]:
Db = τ
b/a t (2.33)
For each integration step the cumulative mechanical dose contributes to a damage incre-
ment, yielding finally the discrete formulation along each streamline (corresponding to a total
residence time ti between inflow and outflow of the CFD domain):
4Hb(ti)/Hb =
outlet∑
inlet
a c
[
i∑
j=1
τ(ti)
b/a4tj +Db(t0)
]a−1
τ(ti)
b/a4ti
(2.34)
where Db(t0) is the mechanical dose already accumulated by the cell at the integration
start time and a, b, c are empirical parameters. The term in the square brackets represents
the whole mechanical dose acting on the cell moving along the pathline from the starting
observation time until the ith instant, whereas τ(ti)
b/a4ti is the elementary mechanical dose
received by the RBC in the ith interval [72]. The parameter values finally proposed by [89]
read:
(a1, b1, c1) = (0.77, 3.075, 3.31 10
−6) (2.35)
Another group of values are given by [90]:
(a2, b2, c2) = (1.3198, 0.6256, 10
−5) (2.36)
These two widely different parameter sets highlight again the difficulty of obtaining proper
validation data from experiments, and are an indication of a poor generality.
Following [11], it is possible to reformulate Eq. (2.34) as a transport equation, see Eq. (2.37).
However, this equation unfortunately cannot be directly coded into any major CFD solver
due to its structure:
d(4Hb/Hb)
dt
+∇.(v(4Hb/Hb))−∇.(Db∇(4Hb/Hb))
= a c
(
dt+
(4Hb/Hb
Cτ b
)1/a)a−1
τ b
(2.37)
Compared with Method A, this method C appears to be more sensitive to the employed
discretization in space and time.
2.3.2.4 Method D
As another alternative, Gu and Smith propose following equation [91]:
4Hb/Hb =
(
ti,j
t
)∑
j
∑
i
1.8 10−6τ 1.991i,j (ti+1,j
− ti,j)0.765
(
t
ti,j
)0.71 (2.38)
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where t is the total time for traveling along a pathline, i is pathline number, j is timestep
number.
This is a purely arithmetic modification of Eq.(2.22). The obtained hemolysis result
depends again on the discretization, due to the non-unity exponent in time.
2.3.3 Strain-based Models
If local hemolysis is not a direct result of local shear stress, but is instead associated to an
intermediate variable (such as the membrane surface extension, or RBC deformation), the
model is typically named a strain-based model (Fig. 2.22).
Figure 2.22: Strain-based model
2.3.3.1 Method E: a Strain-tensor-based Lagrangian Model
In this model, the deformation of RBCs is due to accumulation of shear stress in the past
history, and hemolysis is due to instantaneous deformation [13, 78].
A red blood cell is modeled as a deformable droplet in a flow. Its shape and orientation are
represented by a symmetric, positive-definite 3rd-order morphology tensor S. The evolution
of S occurs subject to four effects:
1. resistance to deformation and rotation: −(S − g(S)I);
2. shear-induced deformation: ε˜.S + S.ε˜;
3. shear-induced rotation: W˜ .S + S.W˜ ;
4. rotation of the surrounding frame: Ω.S + S.Ω.
Combining all four items together with factors f1, f2, f3 for the first three terms, the
equation for deformation is obtained:
dS
dt
=
∂S
∂t
+ v.∇S
=− f1[S − g(S)I] + f2[ε˜.S + S.ε˜]
+ f3[W˜ .S + S.W˜ ] + [Ω.S + S.Ω]
(2.39)
where, ε˜ = (1/2)(∇v +∇vT ) is the (symmetric) strain tensor of the flow; W = (1/2)(∇v −
∇vT ) is the (antisymmetric) vorticity tensor of the flow. Then,
W˜ = W − Ω (2.40)
is the vorticity really encountered by the droplet in its own frame of reference. Finally, g(S)
is given by:
g(S) = 3 III/II (2.41)
with III = (tr(S))2 − tr(S2), II = det(S), the invariants of tensor S. The rotation rate of
the frame of reference Ω is given by:
Ω = e˜i
(
∂e˜i
∂t
+ v.∇e˜i
)
(2.42)
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where (ei) refers to the eigenvectors of S. Finally, hemolysis is calculated by:
4Hb
Hb
= 3.63 10−7
(
µ
√
f 21ϕ
2
(1− ϕ2)f 22
)2.416
t0.785 (2.43)
where ϕ = (L− B)/(L+ B) is the instantaneous aspect ratio of the droplet, denoting L the
longer length contained within the droplet ellipsoid, and B its shorter length.
Equations (2.39) and (2.42) are discretized in a Lagrangian manner with a first-order
explicit approximation:
dSn+1
dt
=
Sn+1 − Sn
4t (2.44)
Ωn = (ei)n
∂(ei)n
∂t
= (ei)n
(ei)n − (ei)n−1
4t (2.45)
Inserting these last two equations into Eq. (2.39), it comes:
Sn+1 − Sn
4t = −f1[Sn − g(Sn)I]
+ f2[ε˜n.Sn + Sn.ε˜n] + f3[W˜n.Sn + Sn.W˜n]
+
[
(ei)n
(ei)n − (ei)n−1
4t
]
.Sn + Sn.
[
(ei)n
(ei)n − (ei)n−1
4t
] (2.46)
Then, inserting Eqs. (2.40) and (2.41) into Eq. (2.46), Sn+1 at the next step is calculated
explicitly based on the former two time steps:
Sn+1 =Sn +
(
−f1
[
Sn − 0.5((tr(Sn))
2 − tr(S2n))
det(Sn)
I
]
+ f2[ε˜n.Sn + Sn.ε˜n]
+ f3
[
(Wn − (eigv(Sn))eigv(Sn)− eigv(Sn−1)4t ).Sn
+Sn.(Wn − (eigv(Sn))eigv(Sn)− eigv(Sn−1)4t )
]
+
[
(eigv(Sn))
eigv(Sn)− eigv(Sn−1)
4t
]
.Sn
+Sn.
[
(eigv(Sn))
eigv(Sn)− eigv(Sn−1)
4t
])
4t
(2.47)
where eigv() solves for all eigenvectors.
Such a backward discretization is numerically unstable. The resulting numerical diffusion
depends on the total number of points on each pathline, and on the interpolation between
pathline points. Once again, the result of this method depends on the underlying discretiza-
tion, since the term involving t is not linear in Eq. (2.43).
2.3.3.2 Method F: a Strain-scalar-based Lagrangian Model
As shown in Fig. 2.23, this model introduces a scalar s for the area-averaged strain of the
RBC membrane and sc = 0.064 1/s as the critical strain for membrane failure. From the
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Figure 2.23: Strain-scalar-based model.
strain, a membrane deformation can be computed, and finally hemolysis can be deduced.
Equation (2.48) is the relation between s, shear stress and exposure time [92, 93]:
s
sc
=
4a b
5
(τ − τe)[C0 + C1(1− e−C2t) + C3t] (2.48)
where τe = 150 Pa is the stress required to elongate the cell to an iso-area ellipsoid, t is
the exposure time, a = 39.01 is an empirical constant, b = 1.7 µm is the minimum radius
of a deformed RBC, C0 = 35 m/N and C1 = 39 m/N are related to the Young’s moduli
of the membrane, while C2 = 8 s
−1 and C3 = 0.15 m/N were obtained by curve fitting of
experimental data.
Equation (2.48) can be rewritten in a total differential form:(
s
sc
)
i
=
m∑
j=0
{
4 a b
5
[
C0 + C1(1− e−C2ti,j)
+C3ti,j] (τsi,j − τsi,j−1)
+
4 a b
5
(τsi,j − τe)
[
C1C2e
−C2ti,j + C3
]
(ti,j − ti,j−1)
} (2.49)
where i refers to the number of a pathline, j refers to the steps along this pathline. At any j, if
(τsi,j−τsi,e) < 0, it is reset to (τsi,j−τsi,e) = 0, inactivating the last term in Eq. (2.49). On the
left-hand side of this equation, (s/sc)i is the normalized strain value along pathline i. If along
a particular pathline (s/sc)i > 1, then the RBCs traveling along this pathline are predicted
to rupture, leading to 100% hemolysis. As long as (s/sc)i ≤ 1, the corresponding value is
used to determine the hemolysis ratio (Fig. 2.23). Unfortunately, the detailed equations used
to compute hemolysis are not given in [92, 93]. . . The only useable information is that the
aspect ratio of RBC is calculated from s by:
V =
4
3
piLB2 (2.50)
A = 2pi
[
B2 +
L2B√
L2 −B2 arcsin
√
1− B
2
L2
]
(2.51)
A
A0
= 1 + s (2.52)
where A refers to surface area, V refers to cell volume, L and B are long axis and short axis
of RBC.
Finally, let us note that this model does not consider the recovery of the membrane strain
when the shear is released.
27
Chapter 2: Numerical Hemolysis Prediction
2.4 Choosing an Hemolysis Model for Blood Pump Op-
timization
2.4.1 Lagrangian vs. Eulerian Methods
In Lagrangian methods, hemolysis is calculated along pathlines (flow trajectories). Obviously,
a given pathline depends on its origin in space and time. When steady CFD computations are
involved, time is not an issue any more; in that case, pathlines are identical with streamlines.
The starting points retained for the pathlines are typically chosen at the inlet (inflow boundary
condition) of the CFD domain. This is sufficient for simple flow topologies without noticeable
recirculation regions. However, in more complex geometries (indeed often found in practice),
recirculation regions and large stable vortical structures are often encountered in certain
regions of the flow. Since such structures appear stable in a steady simulation, pathlines
released from the inlet may not cover the whole flow domain, impacting hemolysis prediction
in an unacceptable manner. For steady CFD simulations, coding a Lagrangian-type hemolysis
model can be done in a post-processing step, after completing the CFD simulation, resulting
in a completely separate, and hence quite flexible and simple, hemolysis prediction. In this
sense, Lagrangian models can save memory. However, they often lead to a lower accuracy and,
as explained previously, they depend on (sometimes arbitrary) user-defined choices concerning
the pathlines. They are far less attractive when unsteady flows are involved, as is the case for
our target application. Additionally, many commercial software are unable to track pathlines
through moving grid interfaces, as often needed for practical pump simulations. In such a
case, Lagrangian methods cannot be used at all. Since particles used to track pathlines should
only be released after the flow is fully developed in the domain, Lagrangian methods usually
involve one flow-through time more compared to an Eulerian approach. Finally, depending
on the software, continuous particle release might be needed to determine pathlines, implying
at the end a huge amount of pathlines.
An Eulerian method uses additional transport equations within the CFD solver to describe
hemolysis and, if needed, intermediate and related variables. The hemolysis calculation is
then typically carried out simultaneously while solving continuity, Navier-Stokes and (possi-
bly) turbulence equations. No additional post-processing step is needed. Eulerian methods
are better for blood pump CFD-O than Lagrangian method, since they lead to far lower com-
putational costs. The numerical procedure is simplified by avoiding any extra post-processing
step.
Table 2.2 is a first classification of the families of hemolysis models that have been and will
be discussed in this chapter. The absence of any strain-based Eulerian method is mostly due
to the inherent difficulties associated to this approach, as discussed later: first, the employed
equations usually do not allow any temporal variable in the source term; additionally, consid-
ering existing commercial and open-source CFD codes, it is either impossible to code a tensor
as the transported variable (ANSYS, STAR-CCM+) or it is impossible to code dot or eigen-
vector operations acting on the transported tensor (OpenFOAM). Though these difficulties
can in principle be solved, and in spite of the interest of a strain-based Eulerian approach,
this has prevented any such development yet. At the end of this chapter, the equations
corresponding to such a model are introduced as a preparatory step for future projects.
Before discussing the details of the involved comparisons, a first summary of the advan-
tages and disadvantages associated to all hemolysis models is proposed in Table 2.3.
A strain-based model is a priori better than a stress-based model, since the former can
take into account more complex steps and physical properties of RBC. However, it does not
mean that strain-based models automatically lead to a more accurate prediction.
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Lagrangian Method Eulerian Method
Stress-based
Section 2.3.2.3 Section 2.3.2.1
Section 2.3.2.4
Strain-based
Section 2.3.3.1
Section 2.3.3.2
Table 2.2: Classification of reviewed and generally applicable hemolysis models
Model in
Section
Advantage Disadvantage
2.3.2.1
Fully Eulerian,
source term includes no t,
accounts for hemolysis history
Physically too simple
2.3.2.2 Easy coding
Empirical formula,
only for blood pumps
2.3.2.3
Accounts for shear history,
partially ”strain-based”
Fundamentally
still ”stress-based”
2.3.2.4 Quite easy coding
Physically too simple,
no simple transport equation
2.3.3.1
Account for deformation history
and relaxation
tensor-based
with dot and eig() operations,
no simple transport equation
2.3.3.2 Accounts for deformation history
No simple transport equation,
no treatment of τ < τe
Table 2.3: First comparison of hemolysis models
All existing stress-based models have been derived from the basic power-law equation,
Eq. (2.21), even if the obtained results may differ by orders of magnitude depending on the
employed parameter sets.
The model in Section 2.3.3.1 is the only one fully accounting for a relaxation of the
deformation, through the term −(S − g(S)I).
The model in Section 2.3.3.2 partly accounts for RBC relaxation to its original shape.
However, the proposed treatment for τ < τe is not satisfactory.
2.4.2 A Simple 1D Validation
First, a simple one-dimensional configuration is considered to discuss the hemolysis level pre-
dicted by different models. Numerical results are compared with experimental data presented
in [67]. In the experiment, a heparinized sample of beagle blood is filled between a stationary
convex circular cone and a rotating concave circular cone (rheometer). The rotor-convex is
driven to rotate with sinusoidal speed, thus generating a sinus-oscillating shear rate in the
blood. The maximum shear rate value is set to 250, 600 and 1000 s−1 respectively, while the
oscillation frequency is fixed to 0.5 Hz, with a total exposure duration of 7200 s.
A Matlab code has been written to deliver the results corresponding to the different
numerical models. Blood viscosity is taken constant at 0.0035 Pa.s. Method A (see Section
2.3.2.1) is implemented without shear stress threshold (τs = 0). Method B (see Section
29
Chapter 2: Numerical Hemolysis Prediction
2.3.2.2) is not included in this comparison, since it has been especially developed for blood
pumps; in the present experiment, there is no pressure build-up and thus no value for 4p.
Method C (see Section 2.3.2.3) has been coded using the first group of constants, Eq. (2.35).
The second group of constants for method C (Eq. (2.36)) leads to values of 4Hb/Hb larger
than 1 for all 3 values of shear rate. For this reason, the results are not depicted in Fig. 2.24,
in which the comparison between all models is presented
Figure 2.24: Numerically predicted relative hemolysis 4Hb/Hb as a function of maximum
shear rate. Blue triangles: experiments; symbols with lines: models, see legend. All results
are shown for an exposure duration of 7200 s.
Methods A and D (see Section 2.3.2.4 for the latter) strongly under-estimate the measured
hemolysis value, increasingly so for higher shear rate. A possible reason is that the power-law
equation has been derived from experimental data with much shorter exposure time. Anyway,
both methods do not predict correctly the experimental observations, with almost an order
of magnitude difference for a peak shear rate of 1000 s−1.
Results of Method C with constants from Eq. (2.35) lie clearly below the experimental
data. However, the discrepancy is typically only a factor 2, and the slope of the curve follows
closely the experimental curve. From all models tested, Method C is clearly the winner for
this comparison. Taking for the constant c a value of 7 10−6 instead of 3.31 10−6, an almost
perfect agreement with those measurements could be achieved.
Method E (see Section 2.3.3.1) is by far the most complicated one. It shows a curve slope
second close to the experimental data, and lies only slightly below the results of Method
C. However, in addition to its numerical complexity, method E leads also to a high level
of numerical diffusion, in particular due to the underlying first-order discretization. When
taking into account complexity and numerical cost in addition to the accuracy of the results,
Method C is clearly to be preferred over Method E for this simple test-case.
Method F (see Section 2.3.3.2) is also relatively complex, but shows only a very weak
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dependence of hemolysis as function of the shear rate, in direct contradiction with the ex-
periments. The overall order of magnitude is acceptable, and the prediction of Method F
happens even to be the best of all for a shear rate of 600 s−1, falling exactly on top of the
measured value. However, the poor trend demonstrates that Method F will not perform well
in general.
These first tests show that published models lead to considerably different predictions con-
cerning hemolysis. At the lowest shear rate (250 s−1), there is a factor of almost 20 between
the lowest and the highest prediction. No model falls directly on top of the experimental
points. Nevertheless, two of them show the right slope and are relatively close to the ex-
perimental measurements (underpredicting the results by a factor of 2 to 3, which should
be considered as very good for such a complex process). The best model in this case is a
relatively simple power-law model, Method C with the constants from Eq. (2.35). Very close
to it lies a much more complex model, Method E. This first test is obviously not sufficient to
generalize, and further comparisons are needed before choosing an optimal model category
and model formulation. In particular, it is unclear yet how much physical complexity must
be included in the model in order to obtain a good accuracy for a variety of different relevant
conditions.
For practical CFD computations, and in particular when considering unsteady flows, Eu-
lerian hemolysis models would be much easier to integrate into the flow solver, since all major
flow solvers rely on an Eulerian description of the flow equations. However, as can be seen in
Table 2.2, there is only one single published Eulerian model, Method A. As shown previously,
Method A performed very poorly in the first test. This is why we decided to concentrate on
an Eulerian version of the two best models, Method C and Method E, in what follows.
2.4.3 Open Questions
The first open question on the path toward an highly accurate model is the real relation be-
tween membrane strain and hemolysis, which could not be uniquely answered in the scientific
literature up to now. As sketched in Fig. 2.25, Relations A/B/C/D are currently available in
the scientific literature, but an essential link is missing, shown as ?, for which no publication
can be found. An alternative solution for relation ”?” might be to derive it indirectly from
C and D. However, this might induce large uncertainties.
Figure 2.25: Clear and unclear relationships between shear and hemolysis in the published
scientific literature
When trying to progress toward a better model, more and more questions are found on the
way. Can strain be assumed to be distributed equally distributed over the RBC membrane? If
not, is it possible to average, or should a statistical approach (Probability Density Function)
be included? What is the exact influence of membrane harding on hemolysis? Are lung and
body circulation of RBC sufficient to relax membrane hardening before rejoining again the
pump? What is the impact of RBC diffusion, leading to non-homogeneous concentrations,
and thus to RBC depletion in high-shear regions? What are the proper diffusion coefficients
for real human blood (all existing results in the literature are based on diluted blood and/or
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the solvent is not real plasma)? The impact of heat transfer on hemolysis should also be
quantified. For this, the cooling potential of blood in the human body needs to be determined.
Finally, when developing improved hemolysis models, it must be kept in mind that those
models should be compatible with CFD (or they will be useless for this project). And the
largest problem is certainly the missing reference experiments, with a proper description of
process parameters and boundary conditions, deeply needed to validate such models.
2.4.4 Toward a Strain-based Eulerian Model
As explained previously, Eulerian hemolysis models are much more suitable for coupling with
CFD, in particular when considering unsteady flows as found in a real rotary blood pump.
Additionally, strain-based models are more complex but also open the door for a more accurate
and general description of hemolysis in realistic flows. Therefore, an Eulerian strain-based
model would combine both advantages, but has unfortunately never been published in the
scientific literature yet (Table 2.2). Such a model should if possible include following features:
1. Account for membrane hardening: In the 120-day life circle of a RBC, each cell will pass
the blood pump for 200 000 times. If the average residence time in the blood pump is
assumed to be 0.05 s, then the total residence time in the blood pump during life cycle
is more than 2 hours. For such a duration, it is well possible that membrane hardening
plays a noticeable role;
2. Account for accumulation of strain in the membrane;
3. Account for relaxation of membrane strain if shear stress is reduced from a former high
value.
Ideally, further improvements would be:
1. Account also for shear-induced RBC diffusion: the non-homogeneous concentration of
RBC due to diffusion may greatly impact hemolysis. This might explain the over-
prediction of most existing hemolysis models in commercial blood pumps;
2. Account for hemolysis induced by heating: the heat generation in a blood pump with
an hydraulic efficiency of 60% is about 70 W, which might have a non-negligible impact
on hemolysis.
The Lagrangian strain-based hemolysis model from Arora (see Section 2.3.3.1) has the
potential to be modified into an Eulerian strain-based model. Being derived from Method E,
the new model would be called EE in what follows.
When Eq. (2.39) is transformed into an Eulerian formulation, the corresponding equation
to Eq. (2.46) becomes:
∂Sn
∂t
+ (v.∇)S = −f1
[
Sn − 0.5((tr(Sn))
2 − tr(S2n))
det(Sn)
I
]
+ f2[ε˜.Sn + Sn.ε˜] + f3[W˜ .Sn + Sn.W˜ ]
+
[
(eigv(Sn))
∂(eigv(Sn))
∂t
+ (v.∇)eigv(Sn)
]
.Sn
+ Sn.
[
(v.∇)eigv(Sn) + (eigv(Sn))∂(eigv(Sn))
∂t
]
(2.53)
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Inserting Eq. (2.40) into Eq. (2.53):
∂Sn
∂t
+ (v.∇)S = −f1
[
Sn − 0.5((tr(Sn))
2 − tr(S2n))
det(Sn)
I
]
+ f2[ε˜.Sn + Sn.ε˜]
+ f3
[
(W − (eigv(Sn))∂(eigv(Sn))
∂t
+ (v.∇)eigv(Sn)).Sn
+Sn.(W − (eigv(Sn))∂(eigv(Sn))
∂t
+ (v.∇)eigv(Sn))
]
+
[
(eigv(Sn))
∂(eigv(Sn))
∂t
+ (v.∇)eigv(Sn)
]
.Sn
+ Sn.
[
(v.∇)eigv(Sn) + (eigv(Sn))∂(eigv(Sn))
∂t
]
(2.54)
This last equation can be then recast into its final form:
∂Sn
∂t
+ (1− f3)eigv(Sn).∂(eigv(Sn))
∂t
.Sn
+ (1− f3)Sn.eigv(Sn).∂(eigv(Sn))
∂t
+ (v.∇)Sn + (1− f3)eigv(Sn).(v.∇)eigv(Sn).Sn
+ (1− f3)Sn.eigv(Sn).(v.∇)eigv(Sn)
= f1
[
Sn − 0.5((tr(Sn))
2 − tr(S2n))
det(Sn)
I
]
+ f2 [ε(v).Sn + Sn.ε(v)] + f3 [W (v).Sn + Sn.W (v)]
(2.55)
Equation (2.55) includes the inner-product of three transported tensor-related items eigv(S),
∂(eigv(S))/∂t and S in the time-derivative, diffusion and convection terms. By these opera-
tions, the nine elements of the deformation tensor S are no longer formulated in a segregated
manner. Unfortunately, such an element-coupled tensor transport equation cannot be im-
plemented in any commercial flow solver. It is also not supported in the currently available
versions of the open-source CFD code OpenFOAM, even if OpenFOAM appears as the best
candidate for coding this equation in a future version.
In order to be compatible with the current requirements for OpenFOAM, one possible sim-
plification would be to approximate in an explicit manner the time derivative term, releasing
the condition on the inner product:
∂(eigv(Sn))
∂t
=
eigv(Sn−1)− eigv(Sn−2)
4t (2.56)
However, this would obviously strongly impact the stability and accuracy of the estimation.
Therefore, the only acceptable solution seems to be a very deep-level implementation of model
EE in OpenFOAM. This could not be achieved before end of this Thesis, and is left for future
projects.
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2.4.5 An Eulerian Formulation of Model C
As a practical alternative, an Eulerian formulation of Model C has been derived in this project.
Depending on the original version, it might be very complex or even impossible in practice
to develop an Eulerian formulation based on an originally Lagrangian model. Fortunately,
this is not the case for Method C, which can be relatively simply rewritten in an Eulerian
framework. For this purpose, Eqs. (2.33) and (2.34) are directly rewritten in an Eulerian
form:
∂Db
∂t
+ (v.∇)Db = τ b/a (2.57)
∂HL
∂t
+ (v.∇)HL = a cDa−1b τ b/a (2.58)
The obtained model, being directly derived from Method C, is denoted CE in what follows.
The resulting transport equations are similar to any flow conservation equation and can
be immediately coded in any standard CFD solver. For the following comparisons, theses
equations have been implemented in Ansysr Fluent using User-Defined Functions (UDF).
Equation (2.16) has been retained to compute τ .
Experimental measurements involving three cannulas with different inner tube diameters
(Fig.2.26, [79]) are now used for comparing further the two only available Eulerian models,
Method A and CE. This is a much more complex validation step since it involves now
a realistic flow configuration, relevant for practical purposes. All flow simulations in this
section rely on Ansysr Fluent, using an axis-symmetrical setup. The boundary conditions
for CFD are set following [80]. The three different cannulas are simulated with the same inlet
flow rate, outlet (right boundary) flow rate, and inner tube reversed flow rate.
Note that this configuration is particularly challenging, since CFD reveals that Case 13G
has the lowest peak value for τ , but the highest average value; while the opposite is observed
for Case 16G, with the highest peak but the lowest mean value for τ .
The numerical prediction of hemolysis obtained with Method A and Method CE are
compared in Table 2.4 with the experimental measurements from [79].
Figure 2.26: Geometrical configuration considered for the second validation step
Method A gives hemolysis values not too far from the experimental values concerning
order of magnitude, but fails completely to predict the trend: while the hemolysis increases
steadily from Case 13G to 14G to 16G, Method A predict a slightly decreasing level.
Method CE can successfully predict the trend, but gives values much larger than the
experimental values. . . By changing the value of constant c, Method CE would be in principle
able to give a much better fit to the experimental values. However, considering that fitting
model parameters by comparison with a single experiment would be too limited, the default
set of model parameters has been kept in the rest of this Thesis.
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Case A B
4Hb/Hb
Method A
4Hb/Hb
Method CE
4Hb/Hb
Experimental
13G 1.105 mm 0.8 mm 7.06e-7 1.04e-5 7.35e-8
14G 0.955 mm 0.65 mm 5.13e-7 1.34e-5 2.55e-7
16G 0.725 mm 0.6 mm 5.10e-7 1.86e-5 4.35e-7
Table 2.4: Comparison of predicted and measured 4Hb/Hb for the three cannulas (experi-
mental measurements from [79])
2.5 Conclusions
As a whole, seven different hemolysis models from the literature and two derived formulations
have been discussed and compared in this work, with the final objective of coupling one of
those models with CFD computations of rotary blood pumps. All these models show specific
advantages and drawbacks, and there is unfortunately no clear guidelines concerning appli-
cability or limitation. An even worse problem is the lack of well-documented experimental
data suitable for a final check of those models under realistic conditions.
Based on a first validation for a simple configuration, a Lagrangian power-law model
(Method C) performs best, followed closely by a much more complex Lagrangian strain-based
model (Method E). Considering that Eulerian models are more suitable for coupling with
CFD simulations, corresponding formulations have been derived, leading to Methods CE
and EE. Unfortunately, the model with the highest potential in principle, model EE cannot
be implemented easily into any existing CFD solver, due to the structure of the resulting
equations. The results obtained with method CE show the right trend, but not the correct
order of magnitude. This demonstrates that much more work is needed before obtaining
an accurate, generally-applicable hemolysis model compatible with CFD: this will be left to
future projects.
Concerning perspectives, the implementation of Method EE into the open-source soft-
ware OpenFOAM should be pursued. Most important, the need for further experiments
concerning hemolysis under well-defined, reproducible and well-documented con-
ditions is again highlighted. This will be ultimately the only possibility to develop and
validate models with a high level of generality and accuracy. Those experiments will hopefully
also cast light on further open issues, in particular:
• importance of membrane hardening under shear stress;
• process leading to the release of membrane deformation when reducing shear stress;
• importance – or not – of RBC diffusion; if this is important, what are the proper
diffusion coefficients?
• importance of hemolysis associated to heating, a point particularly important for blood
pumps, which have currently a limited efficiency.
Since we have not been able in this Chapter to obtain a final answer concerning applica-
bility and generality of all hemolysis models (there is no clear winner), the results discussed
in the next chapters involve models A, B, and CE.
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Chapter 3
Numerical Simulation of the FDA’s
Test Cases
This chapter describes numerical investigations of the two test cases recently proposed by
the US Food and Drug Administration (FDA) as part of the so-called “CFD Critical Path
Initiative” project. The final purpose of this project is to determine if and how computational
fluid dynamics can be effectively used to characterize fluid flow and to predict blood damage
in medical devices. In case of a positive outcome of this project, CFD might be used as part
of the official approval procedure by FDA. In any case, these two FDA challenges can be used
as realistic benchmarks to evaluate CFD for hemodynamics and blood pumps.
3.1 FDA Test Case #1 (Hemodynamics): Blood Nozzle
with Sudden Expansion
3.1.1 Introduction
The nozzle proposed by FDA shows an axis-symmetrical geometry and is shown in more
details in Figs. 3.1 and 3.2. All details can be found in [94] and on the Website given in this
article. The nozzle shows characteristics found in many medical devices that have blood flow-
ing through them, including blood tubing, hemodialysis sets, catheters, cannulas, syringes,
and hypodermic needles. It incorporates tubes of two diameters, with a cone connecting the
two tubes on one end, and a sudden change in diameter on the other side. When the flow
is going from left to right in Fig. 3.1 (the reference case), the blood flow thus encounters a
sudden expansion. The configuration retained by FDA will deliver flow pathlines showing
sudden accelerations and strong recirculations, both aspects considered to be very important
in order to model blood damage in medical devices [94].
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Figure 3.1: Blood nozzle: tube with sudden expansion
Figure 3.2: Defined axial positions along the tube
As prescribed by FDA, the CFD simulations are carried out for 5 different flow conditions
with volume flow rates of 5.2 10−6 m3/s, 2.08 10−5 m3/s, 3.64 10−5 m3/s, 5.21 10−5 m3/s,
and 6.77 10−5 m3/s, corresponding to five increasing Reynolds numbers of 500, 2000, 3500,
5000 and 6500 respectively, computed with the diameter of the smallest, central tube. Thus,
depending on the case considered, laminar, transitional or mild turbulent conditions are
expected in the system, which explains the difficulty of this case, as discussed in more details
in [95].
3.1.2 Numerical Study
3.1.2.1 Grid
All quadrangular, 2D axis-symmetrical meshes have been constructed using ANSYSr ICEM-
CFD. After checking mesh independency of the velocity fields, several regions have been locally
refined. Two selected regions of the finally retained mesh are shown in Figs. 3.3 and 3.4. The
final mesh includes altogether 1 159 247 quadrangles. The simulated domain is exactly twice
as long as the given geometry show in Fig. 3.1, in order to minimize the influence of the
boundary conditions employed at inlet and outlet (which are not prescribed further by FDA).
On the inlet side, the extrusion is used to get a fully developed flow field at the entrance of
the domain of interest. On the outlet side, extending the domain is necessary to avoid any
flow reentry through the outlet.
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Figure 3.3: Zoom on the mesh in the
entry region of the central tube (flow
from left to right)
Figure 3.4: Zoom on the
mesh at the end of the cen-
tral tube (sudden expan-
sion)
3.1.2.2 Settings of the Numerical Simulations
All simulations rely on ANSYSr Fluent using a 2D axis-symmetrical geometry. For all RANS
(Reynolds-averaged Navier-Stokes) and RSM (Reynolds Stress model) turbulence models,
steady flow conditions are prescribed. The further settings are listed in Table 3.1.
Density 1035 kg/m3
Viscosity 0.0035 Pa.s
Inlet velocity profile Vmax
√
0.006− x[1] (y-direction)
Inlet turbulence intensity 0
Pressure-velocity coupling SIMPLE
Outlet Outflow
Table 3.1: Settings employed in Fluent
The impact of different turbulence models has been tested for the flow conditions cor-
responding to Re=5000. The velocities obtained at selected positions along the central line
of the system are compared with experimental data given in [96], as discussed in the next
section. The turbulence model leading to the best agreement with the experimental data is
then employed for all further simulations.
Two hemolysis models discussed in the previous chapter have been coded into Fluent using
User-Defined Functions (UDF). The corresponding lines of code can be found in Appendix
D. The obtained results will be discussed as well in what follows.
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3.1.3 Results
3.1.3.1 Impact of Turbulence Model
The comparison of velocity magnitude along the central axis of the device for Re=5000 is
shown in Fig. 3.5. Two different, independently obtained sets of experimental measurements
have been proposed by FDA, as discussed in [96]. From Fig. 3.5, it appears that the standard
Reynolds-Stress Model (RSM) of Fluent with quadratic pressure-strain relation delivers the
best overall agreement with the experimental data. A small region of the central tube around
x = −0.02 is the only one for which noticeable differences are found between RSM and
measurements, the rest of the prediction being in very good agreement with the experiments.
Figure 3.5: Velocity magnitude along central axis for Re=5000 as function of the turbulence
model, compared to experimental data from [96]
Therefore, the further flow conditions corresponding to Re=500, 2000, 3500, 6500 have
been simulated as well with the RSM model using a quadratic pressure-strain relation. The
corresponding comparisons between our numerical results and the experimental data pub-
lished by FDA are shown in Figs. 3.6 to 3.9. The agreement obtained for Re=2000 and
Re=3500 is almost perfect. At the highest Reynolds number (Re=6500), the agreement is
still very good, in spite of a slight underprediction of the peak velocity in the inner tube. For
the laminar conditions (Re=500), the agreement is quite good until the sudden expansion;
there, the two RSM versions (quadratic pressure-strain relation or stress-ω relation) lead to
two widely different predictions that surround the measurements. Obviously, the recirculation
zone and the reattachment region are difficult to predict using RSM for the laminar case.
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Figure 3.6: Velocity magnitude along cen-
tral axis for Re=500 compared to experi-
mental data from [96]
Figure 3.7: Velocity magnitude along cen-
tral axis for Re=2000 compared to exper-
imental data from [96]
Figure 3.8: Velocity magnitude along cen-
tral axis for Re=3500 compared to exper-
imental data from [96]
Figure 3.9: Velocity magnitude along cen-
tral axis for Re=6500 compared to exper-
imental data from [96]
3.1.3.2 Hemolysis
As explained in the previous chapter, it has been unfortunately impossible to identify an
accurate, generally applicable hemolysis model compatible with CFD. Therefore, hemolysis is
now calculated using two different models, in order to get an idea of the underlying variability.
Both model A (see Section 2.3.2.1) and our own, Eulerian formulation of model C, called
model CE (see Section 2.4.5) have been employed. The obtained predictions are compared in
Table 3.2.
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Re
4Hb/Hb
Model A
4Hb/Hb
Model CE
500 2.83 10−8 9.52 10−9
2000 4.18 10−8 8.21 10−6
3500 1.40 10−7 3.03 10−5
5000 3.03 10−7 5.63 10−5
6500 5.61 10−7 1.41 10−4
Table 3.2: Prediction of hemolysis 4Hb/Hb in the FDA blood nozzle obtained by models A
and CE at different Reynolds numbers
3.1.4 Final Comments and Discussion Concerning the FDA Blood
Nozzle
Based on the presented results and on many further simulations involving RANS turbulence
models and Large-Eddy Simulations, not shown in the interest of space, first conclusions can
be drawn concerning turbulence modeling:
• The standard Reynolds-stress models implemented in Fluent show the best agreement
with the experimental data. This is particularly true at axial (x) positions larger than
0 m and smaller than −0.04 m (see Fig. 3.2). The worst agreement is always obtained
within and just after the conical section joining the larger tube with the smaller, inner
tube.
• According to theory, the RSM model with quadratic-pressure-strain relation should
show a superior performance for axis-symmetric expansions/contractions [97], explain-
ing why it works particularly well here. In the entry region, all RSM models per-
form equally well. But, after entering the smaller, central tube, the RSM model with
quadratic-pressure-strain relation shows a noticeably better agreement.
• However, for the laminar case (Re=500), the RSM Stress-ω model shows a better perfor-
mance than the RSM quadratic-pressure-strain model just after the sudden expansion.
• Numerical simulations with RSM models are often associated with convergence prob-
lems, far more so than with RANS turbulence models. The only solution is to reduce
the Max Coarsening Levels and to increase the Sweeps (both are numerical options in
Fluent).
• Many tests with a variety of RANS models show that the k––RNG model performs
best for this configuration. The obtained agreement with experimental data is only
slightly worse than for the RSM model with quadratic-pressure-strain relation. It is
even better than the RSM model in the axial region between −0.04 and 0 m.
• In collaboration with Prof. G. Janiga, an extensive study has been carried out for
this case involving Large-Eddy Simulations. The results are documented in [95], and
prove that LES can be used to simulate with a high accuracy – but unfortunately also
with a high computational cost – this configuration. One exemplary result is shown in
Fig. 3.10.
Let us now summarize some preliminary findings concerning hemolysis:
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Figure 3.10: Volume rendering of the instantaneous velocity magnitude obtained by Large-
Eddy Simulation; further details can be found in [95]
• Model CE gives larger differences in hemolysis, 4Hb/Hb, between the different flow
conditions (different values of Re), compared to model A. This confirms the hemolysis
predictions in Section 2.4.5, where4Hb/Hb with model C varies much more considerably
than with model A. Since the actual FDA experiment involves an artificial substitute
instead of real blood, a more detailed validation is – unfortunately – not possible.
• Following FDA’s requirement, a constant viscosity value has been used in the above
simulations. Using in a further test a non-Newtonian Carreau viscosity model (Eq. 3.1)
with constants listed in Table 3.3, noticeable differences are observed in the velocity
field, and, consequently, in the resulting hemolysis values. Since hemolysis models are
very sensitive to large shear stress values, and remembering that a non-Newtonian model
may significantly reduce peak values of shear stress, such differences are not surprising.
η = η∞ + (η0 − η∞)(1 + γ2λ2)(n−1)/2 (3.1)
Time Constant, λ (s) 8.2
Power-Law Index, n 0.21
Zero Shear Viscosity (Pa.s) 0.16
Infinite Shear Viscosity (Pa.s) 0.0035
Table 3.3: Values employed for blood modeled with a Carreau model
Finally, all further fields required by the FDA in order to participate into the contest for
the Blood Nozzle are shown in Appendix A.
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3.2 FDA Test Case #2: Blood Pump
3.2.1 Introduction
The FDA blood pump features a very simple centrifugal type, with straight blades and a
volute of constant diameter, as shown in Fig. 3.11. The rotor itself is half covered by a disk
of large thickness in opposite direction to the inlet. Four very simple straight blades of large
thickness and relatively small chordwise depth constitute the impeller. Both the disk and the
blades are polished along edges and corners. Finally, the setup involves unusually long inlet
and outlet pipes.
According to FDA, this blood pump model is highly relevant for several blood pump
designs currently being developed as part of the NIH Pediatric Circulatory Support initiative.
This is the reason why this unusual geometry has been retained for the case study.
Six different flow conditions must be numerically investigated, as a combination of four
different flow rates and two rotating speeds. The transport media is to be considered as a
liquid with constant density (1035 kg/m3) and constant dynamic viscosity 0.0035 Pa.s (3.5
cP).
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Figure 3.11: Selected details of the geometry of the FDA blood pump, see also
https://fdacfd.nci.nih.gov/
3.2.2 Numerical Study
3.2.2.1 Grid
After a grid-independence study concerning the obtained velocity fields, a fully hexahedral
mesh with 10 086 367 elements has been generated thanks to Ansysr IcemCFD. It involves
nine segments (see Fig. 3.12) with nonidentical surface meshes along the connecting interfaces.
The number of elements in the different segments is listed in Table 3.13. The interface between
the rotating part and the stationary part is placed at the arithmetical middle in diametrical
distance between the volute shell and the span-end of the rotor.
Figure 3.12: Mesh segments
Region Mesh Size
1 60 345
2 671 814
3 38 817
4 2 028 860(×4)
5 959 886
6 240 065
Figure 3.13: Mesh size of
the different regions
Figures 3.14 to 3.17 show zooms on selected regions of the mesh.
3.2.2.2 Numerical Simulation
The approach called GGI (General Grid Interface) is used in AnsysrCFX to connect the
different grid parts, between rotating and stationary zone.
A desktop PC with 32 GB memory and Intelr Core i7-4930K processor (6-core, 3.4 GHz,
12 MB-cache) is used to carry out the numerical simulation. The CFD solver CFX runs with
single precision (in order to get a higher speed-up), and the memory allocation factor is set
to 1.2. The total system memory consumption is around 23 GB, with approximately 2 GB
occupied by the Windows 7 (x64) operating system.
The reference flow condition with a flow rate of 6 L/min and a rotation speed of 3500
rpm is first computed. It is initiated with a laminar flow model for the first two rotations.
Then, the resulting solution is mapped to the RNG k– turbulence model with scalable wall
function, found to be best of all RANS models in the previous section. The settings employed
in the CFD simulation relying on CFX are listed in Table 5.2.
The simulation is finally stopped after computing a total of 12 rotations; at this point,
a fully periodic steady state is observed concerning pump pressure head. The employed
timestep size is 1/200 of one rotation, and the residual target is set to 0.0005 (RMS). For
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Figure 3.14: Mesh at beginning of
blade
Figure 3.15: Mesh at end of blade
Figure 3.16: Mesh at rotor inlet Figure 3.17: Mesh at cut water
other flow conditions, this converged solution is used to start the corresponding simulation.
Then, 5 to 10 rotations are needed to obtain a periodically repeating pressure head, and the
time step size is set to 1/100 of one full rotation.
Density 1035 kg/m3
Viscosity 0.0035 Pa.s
Turbulence Model RNG k–
Inlet velocity profile Vmax(1− (r/Rmax))1/n, n=3 @ 2.5, 4 @ 4.5, 5 @ 6&7 L/min
Inlet turbulence Intensity 4% to 7%, as prescribed by FDA for each case
Convergence Criteria RMS 0.00005
Outlet Open
Min. Coeff. Loops 1
Max. Coeff. Loops 10
Timestep size (s) 1.71 10−4 (@3500rpm), 2.4 10−4 (@2500rpm)
Table 3.4: Settings of CFX for the CFD simulation of the FDA pump
3.2.3 Results
3.2.3.1 Flow Field
Figure 3.18 is a plot of pressure head versus time for the reference flow condition (6 L/min
at 3500 rpm). An almost periodic pattern is observed already after 8 rotations. However, a
truly periodic repetition (less than 5% difference) is first observed after 12 rotations, which
is perhaps a consequence of turbulence.
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Figure 3.18: Instantaneous pump pressure head vs. time
Table 3.5 summarizes the most important parameters and the results asked for by FDA
for the simulation of the six different flow conditions as prescribed by FDA.
Flow rate (L/min) 2.5 2.5 4.5 6.0 6.0 7.0
Pump speed (rpm) 2500 3500 3500 2500 3500 3500
Timestep size (s) 2.40 10−4 1.71 10−4 1.71 10−4 2.40 10−4 8.57 10−5 1.71 10−4
Pressure Head (Pa),
averaged over
last full rotation
21 920 53 160 49 732 8 740 44 481 41 261
Time-averaged
maximum wall
shear stress (Pa)
over the housing rim,
averaged over last
full rotation
1.38 102 1.99 102 1.78 102 1.08 102 1.15 102 1.31 102
Time-averaged maximum
wall shear stress
magnitude (Pa)
over the entire outlet fillet,
averaged over last
full rotation
1.42 102 2.88 102 1.83 102 2.65 102 2.55 102 3.84 102
Time-averaged shaft torque
(Nm), averaged over
last full rotation
1.01 10−2 1.63 10−2 2.30 10−2 1.86 10−2 2.80 10−2 3.16 10−2
Hemolysis rate 4Hb/Hb
obtained from model CE
0.0073 0.0085 0.0034 0.00062 0.0025 0.0014
Table 3.5: Detailed CFD settings and main results for the six different conditions prescribed
by FDA
3.2.3.2 Hemolysis
The hemolysis rate predicted by the simulation using model CE (see Section 2.4.5) is given
as well in Table 3.5. The FDA has communicated that experimental data will be published
concerning the really observed hemolysis in this configuration. Unfortunately, at the time
when this Thesis has been submitted (early January 2015), such data sets are not available
yet. Therefore, a comparison – and hence a validation – is not possible at that time.
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3.2.4 Final Comments and Discussion Concerning the FDA Blood
Pump
Keeping in mind that the FDA will publish experimental results concerning this blood pump,
but that those results are not available yet, first conclusions can only rely on the obtained CFD
results. From the computational results obtained for the six working conditions, following
conclusions can be drawn:
• Considering the four flow conditions with the same rotation speed (3500 rpm), the
pressure head decreases when the flow rate increases, which is logical for the shape of
a typical characteristic pump curve. The same situation is also observed for the two
conditions with a rotation speed of 2500 rpm. This is a first indication that the obtained
results are physically sound.
• Due to the unusual (very simple) design of the impeller, large oscillations in pressure
head are observed, even after many full rotations. A truly stable, periodical evolution
of the pressure head can only be obtained with a much coarser grid (4 million grid cells
and less), associated to a much higher level of numerical diffusion. The values listed in
Table 3.5 are cycle-averaged values.
• For this particular geometry, it was impossible to obtain converged results with the
standard k– and k–ω-models. Only the realizable k–, RNG-k– and SAS-SST models
converged. From the latter models, SAS-SST requires a noticeably longer computational
time, so that RNG-k– was finally retained as a reference.
• All further fields required by the FDA in order to participate into the contest are shown
in Appendix B.
3.3 Conclusion
Even if a proper validation could not be achieved yet due to missing experimental data,
it appears that CFD is able to reproduce with a satisfactory accuracy hemodynamic fields
in practically relevant geometries and configurations. This opens the door for a possible
optimization of practical blood pumps using CFD-O, as will be considered next.
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4.1 Literature Review
4.1.1 Pump
An hydraulic pump is a machine used to move a liquid through a piping system and to
raise the pressure of the liquid. Looking at the rotor outflow direction, a rotary pump can
be classified into three groups: centrifugal pumps (as an example, see Fig. 4.1), axial-flow
pumps (Fig. 4.2); and mixed flow pumps, as a compromise between both designs.
Figure 4.1: Example of a cen-
trifugal pump, from [98]
Figure 4.2: Example of an axial-flow
pump, from [98]
The energy conversion in a pump takes place in the impeller, in which the input energy
is converted into mechanical energy. First, the rotating impeller causes the liquid that has
entered the pump to accelerate, raising the kinetic energy of the liquid. The vanes in a rotary
pump are often curved backward to the direction of rotation. When the liquid leaves the
impeller vane outlet tip, it is at its maximum velocity. Figure 4.3 illustrates typical velocity
and pressure changes in a rotary pump as the liquid moves through the pump. After the liquid
leaves the impeller tip, it enters the outlet region. The outlet region design ensures that the
cross-sectional area of the flow passage increases in direction of liquid movement. Because
of this, a diffusion process occurs, causing the liquid velocity to decrease. In agreement with
the Bernoulli equation, the decreased kinetic energy is transformed into increased pressure
energy.
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Figure 4.3: Typical velocity and pressure
evolution along the flow path in a pump
[99]
Figure 4.4: Typical characteristic curve of
a pump [99]
Figure 4.5: Performance correction chart for
viscosity [99]
A centrifugal pump operating at a given rotation speed and with a given impeller diameter
produces a differential pressure, or differential head. While all terms in the Bernoulli equation
are expressed in specific energy units (J/kg), this equation is in practice very often converted
to height units (m) by dividing the whole equation by gravity acceleration g. Then, the
resulting head is finally expressed in meters (or feet in english-speaking countries). The
amount of head produced varies with the flow rate, as illustrated by the characteristic head-
flow rate curve (also called H-Q curve, connecting the head H to the flow rate Q or q˙). Such
H-Q curves are shown in red in Fig. 4.4. As the flow rate increases, the head of the pump
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decreases. Increasing the rotating speed of a pump, will move the H-Q curve towards higher
values, as shown in Fig. 4.4 for three increasing values of the rotating speed (n3 > n2 > n1).
Increasing the rotating speed will also typically move the efficiency curve to the right, as the
orange curves illustrate.
A point on a H-Q curve is called an operation point. It represents a certain combination
of flow rate and pressure head for a certain rotating speed. If different operation points
on different H-Q curves share the same efficiency, they are called similar operation points.
Connecting similar operation points will deliver the equal-efficiency curves shown in blue
in Fig. 4.4. Equal-efficiency curves in the central region correspond to higher efficiencies,
E2 > E1.
The system curve is a graphical representation of the head requirement of the external
system connected to the pump. It usually consists of a combination of static and frictional
components. The static head does not vary with flow velocity, while the frictional head varies
quadratically with flow velocity. The intersection of the system curve and of the pump (H-Q)
curve indicates the real working condition of the pump interacting with the system. This
working condition is stable when and only when the product of the two derivatives of the two
curves is negative at the intersection point, as is the case in Fig. 4.4.
Pressure head and flow rate of two points (for instance, point 1 and point 2 in Fig. 4.4) on
the same equal-efficiency curve follow the so-called Affinity Law described by the relationships
in Eqs. (4.1) and (4.2):
Q2
Q1
=
n2
n1
(4.1)
H2
H1
=
(
n2
n1
)2
(4.2)
If a rotary pump is being considered for pumping a viscous liquid other than water, the
pump performance curve obtained with water must be adjusted to take into account the
impact of a different viscosity. In general, pumping a viscous liquid with viscosity higher
than water causes a corresponding reduction in both head and capacity. Correction factors
for pressure head and flow rate are given in Eqs. (4.3) and (4.4):
CH =
Hvisco
Hwater
(4.3)
CQ =
Qvisco
Qwater
(4.4)
The relation between CH , CQ, H, Q, and viscosity is shown in Fig. 4.5.
4.1.2 Design Theory for Axial-flow Pump
A typical pump design process begins with the Specific Speed, Nq, used by pump designers:
Nq =
nQ1/2
H3/4
(4.5)
In this equation, the flow rate Q is normalized by a reference flow rate of 1 m3/s and the
head is normalized by 1 m. For this reason, the unit of Nq is the same as the unit of n, either
1/s or very commonly 1/min. The first use of Nq is to classify the pump impeller concerning
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type and proportions. Table 4.1 shows empirical data relating pump type and Nq, based on
decades of past experience and leading to a good hydraulic efficiency [100].
Type of Impeller Nq in 1/min Impeller outlet diameter/Inlet diameter
Slow speed radial flow 10-30 3.5-2
Standard speed radial flow 30-50 2-1.5
High speed radial flow 50-80 1.5-1.3
Mixed flow 80-160 1.2-1.1
Axial flow 110-500 1.0
Table 4.1: Typical relation between Nq and impeller shape based on experience [99]
If a specific pump type is decided in advance by the application or due to geometrical
limitations, then n can be estimated knowing Nq, Q and H by inverting Eq. (4.5), as shown
later in Eq. (4.22).
The axial velocity cA is then determined by n and Q when assuming a given inlet blade
angle β (see Eq. 4.23), which will be recalculated and improved in later steps. For an axial-
flow pump, Nq also empirically decides the ratio of d/D, as shown in Table 4.2. Finally, after
cA, n and d/D have been determined, d and D can be calculated separately from Eqs. (4.24),
(4.25) and (4.26).
Nq 140 150 165 220
d/D 0.6 0.55 0.5 0.4
Table 4.2: Optimal relation between Nq and diameter ratio based on experience [101]
The next step is to decide the shape of the impeller blades, especially the outlet angles.
This task is fulfilled by analyzing the velocity triangle at the impeller outlet axial plane.
Figure 4.6 shows the velocity triangles at different axial positions along an axial-flow pump.
First neglecting the thickness of the blades, the axial velocity c0 does not change through the
pump (conservation of flow rate in the steady system). The blade angles at impeller outlet
determine the local absolute velocity of the flow, which is directly related to its kinetic energy.
Equation (4.6) is the basic equation delivering the theoretical pressure head (in m) for
the impeller. The head is composed of the pressure rise (pp∞ − p0)/ρg generated within the
impeller, and of the kinetic energy rise (c22 − c21)/2g, which is to be converted partly into
pressure rise later in the outlet vane/diffuser.
Hth =
pp∞ − p0
ρg
+
c22 − c21
2g
(4.6)
The pressure head equation for the whole pump is thus derived using following steps,
considering now a centrifugal pump as an example (this procedure can obviously be adapted
as well to an axial pump, as done later).
First looking at Fig. 4.7 in region (a), the centrifugal force balance equation reads dfdp =
dfdrρrω2 along the tangential direction and generates a pressure rise of dp = ρω2rdr N/m2,
which can be rewritten as:
dp
ρ
= ω2rdr = dY ′ (4.7)
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Figure 4.6: Velocity triangles for an axial-flow pump
This corresponds to the work needed by centrifugal force to move 1 kg of fluid along a distance
dr. Its integration reads:
Y ′ =
1
ρ
∫ p∞
p0
dp =
p∞ − p0
ρ
= ω2
∫ r2
r1
rdr =
u22 − u21
2
(4.8)
Figure 4.7: Typical pressure variation in im-
peller and outlet guide vane in a centrifugal
pump [102]
Figure 4.8: Velocity tri-
angle just before/just after
blade end taking into ac-
count blade thickness [102]
In region (b) of Fig. 4.7, the dynamic equation for the fluid control volume reads:
dfdp = −dfρwdw = −dfρds
dt
dw = −dfdsρdw
2
dt
(4.9)
Equation (4.9) for the whole channel length is:
Y ′′ =
1
ρ
∫ pp∞
p∞
dp =
pp∞ − p∞
ρ
=
w20 − w22
2
(4.10)
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Thus, the total pressure rise in the impeller is:
pp∞ − p0
ρg
=
u22 − u21 + w20 − w22
2g
(4.11)
In the outlet guide vane (region (c) of Fig. 4.7), part of the kinetic energy is converted
into a pressure rise, and the corresponding equations read:
dfdp = −dfdsρdc
dt
(4.12)
dp
ρ
= −cdc (4.13)
= dY ′′′ (4.14)
Y ′′′ =
p2∞ − pp∞
ρg
(4.15)
=
c22 − c21
2
(4.16)
Finally, the total pressure rise for the whole pump is:
Hth =
pp∞ − p0
ρg
+ Y ′′′ =
1
2g
(u22 − u21 + w20 − w22 + c22 − c21) (4.17)
Since w22 = u
2
2 + c
2
2 − 2u2c2 cosα2 and w20 = u21 + c20 − 2u1c0 cosα1, Equation (4.17) can be
rewritten into:
Hth =
u2c2 cosα2 − u1c1 cosα1
g
(4.18)
Considering an inflow without rotation (β0 = 0), the pressure head equation can be
simplified as:
Hth =
u2c2 cosα2
g
(4.19)
The blade angles at the shaft, at the blade radial top, and at the middle position, are
usually calculated separately, in order to ensure equal or at least similar values of cA along
axial planes.
The blades of the inlet guide vane are designed to reduce useless rotation before the
impeller and to ensure a smooth transition between inlet guide vane and impeller. The
blades of the outlet guide vane are designed to ensure a smooth transition between impeller
and outlet region, and to support a maximal conversion efficiency from kinetic energy to
pressure energy. Detailed equations are given later in Section 4.2.
When considering the real thickness of the blade, the velocity triangles are modified, as
shown at the end of the impeller in Fig. 4.8. However, the overall flow rate c cosα does not
change before and after the blade end, and is used as a bridge between the equations for
impeller and guide vanes.
4.1.3 Past Experience Concerning CFD of Blood Pumps
The computation of the pump will rely on Computational Fluid Dynamics (CFD). Since
blood pumps show very specific properties, it is useful to describe in more details practical
aspects associated with CFD of such pumps.
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CFD is being increasingly used as a promising design tool for the development of VAD
systems. It is employed not only at an early stage (design), but also later (optimization).
Applying CFD for blood pumps shows the following advantages [103]:
• Time and cost-effectiveness, since prototype building and experiments can be reduced;
• Full information concerning the exact flow properties within the device are obtained;
• Easy design modifications become possible.
In the field of turbomachinery, ANSYSr CFX (formally called CFX-TASCflow/CFDS-
FLow3D/CFX-4) is the most widely employed commercial CFD tool, because it comes with a
variety of add-ons developed during decades to support and facilitate corresponding computa-
tions. It uses a hybrid finite volume/finite element methodology, by which the control volumes
are constructed around nodes, while finite elements describe the solution variation within each
element. It is of course also possible to use other commercial solvers, like ANSYSr Fluent
and STAR-CCM+, or Open Source tools like OpenFOAM [104]; all these tools are based on
a pure finite volume methodology.
The total grid size employed to simulate a whole pump varies typically in the scientific
literature and considering our own experience from 0.1 to 5 million cells. CFD simulations
of pumps often require hexahedral meshes with O-grid around the blades, becoming progres-
sively finer in the direction perpendicular to the blade in order to capture the large pressure
gradients. For instance, Taskin’s simulation of the UltraMag centrifugal pump used a hy-
brid mesh of 3.86 million cells, showing that (a) a hybrid mesh may be a good compromise
between the difficulty of meshing complicated geometries with a structured mesh, and the
benefits of having a structured mesh in critical regions, (b) the mesh structure may influence
the calculated flow field in the gap region, since the expected vortices were only observed
when using a hexahedral mesh [105, 106].
Many older numerical simulations of centrifugal and axial-flow blood pumps used as an ap-
proximation CFX’s Frozen Stator-Rotor model (or the equivalent Multiple Reference Frame
model of Fluent). Though such approaches lead to a tremendous reduction in the needed
computational resources, they constitute only an approximation of reality and may lead to no-
ticeable errors, increasingly so for strong interactions between rotating and static parts. Song
et al. investigated the difference between MRF and Sliding Mesh models for the HeartQuest
CF4, showing that the (steady) pressure head predicted by MRF was about 2% higher than
the (average) pressure head predicted by Sliding Mesh [106, 107]. With the continuing in-
crease of computer power, simulations in the future are likely to use in a systematic manner
the far more realistic General Grid Interface model of CFX and OpenFOAM (or the equivalent
Sliding Mesh model of Fluent).
In the scientific literature, the documented hydraulic efficiency of blood pumps covers a
huge range, from 20% to 80%. Predicting the hydraulic performance by CFD is a difficult
task. Part of the error is introduced by the imprecision of the employed turbulence models.
Several comparisons between experimental values and CFD concerning pressure have been
published. For the standard k −  turbulence model, the pressure head was overpredicted by
30− 60 mmHg (25-70%) in the HeartQuest CF3 ; in the Kyoto-NTN, it was underpredicted
by 10 mmHg (8.3%); in the Virginia LEV-VAD, it was overpredicted by 10 mmHg (10%); in
the PVAD22, it was underpredicted by 15 mmHg (13%); in the Impella it was underpredicted
by 24 mmHg (30%). When activating the logarithmic wall function with the k−  model, the
pressure head prediction error was 20 mmHg (18%) for the Virginia LEV-VAD and 10 mmHg
(30%) for the PVAD3. Finally, when using the SST k − ω model, the TinyPump’s pressure
head was underpredicted by 4− 25 mmHg (5-21%) [106].
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Concerning hemolysis, an accurate prediction of shear stress is essential. However, this is
a difficult task for CFD. When simulating by CFD the Kyoto-NTN with the standard k − 
turbulence model at 2500 rpm with a 3 mm gap, the calculated maximal shear stress was 696
Pa on the casing and 203 Pa in the fluid, compared with experimental measurements of 450
Pa on the casing and 180 Pa in the fluid [106]. With a narrower gap of 0.5 mm, the calculated
maximal shear stress was 585 Pa in the fluid, compared with an experimental value of 330
Pa, showing a very large difference (by a factor of 1.8). All these comparisons illustrate the
difficulty of simulating properly blood pumps with CFD.
4.1.4 CFD-based Design Optimization of a Blood Pump
Although the concept of CFD-O is not new, the extremely high computational costs typically
associated to this process still limit its applicability. Figure 4.9 is the flow chart of a typical
CFD-based design process, see also [14, 108] for further details. CFD-O is usually started from
a fairly good design, which is achieved by an experience-based cut-and-try approach. Most
published instances of CFD-O for blood pumps involve only regional optimization, without
parameterizing the geometry of the whole pump. The difference between obtaining (manually)
a so-called “Optimized Design” and an (automatic) Design Optimization, as considered in
the present Thesis, is explained in Table 4.3.
Figure 4.9: A CFD-based design process
Module Options
Evaluate Design Modify Design Modify Geometry
Optimized Design Qualitative Institution & Experience Manual
Design Optimization Quantitative Formal Optimization Automatic
Table 4.3: Optimized Design vs. Design Optimization [108]
One major challenge of CFD-O is the automatic and robust looping, involving all steps
shown in Fig. 4.9 without human interference. In many published works, part of the op-
timization remained a manual process. For instance, the geometry was parameterized and
updated in an automatic manner, but the grid was still generated manually. Using such a
semi-automatic approach, and after choosing two or more values as geometry variables, the
influence of these variable on the objective(s) can be evaluated [109–112].
More recently, a few works describing fully automatic pump optimization have been pub-
lished. Singh et al. developed an automatic remeshing technique based on an elastic spring
analogy for unstructured meshes [113]. This remeshing technique was used to automatically
optimize the outlet stator of a cardiac assist device [114]. The mesh contained about 55 500
tetrahedral elements. Six geometry variables were chosen to regulate the diameter of the
outlet region, while the blade angles were kept fixed for the stator.
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Zhu et al. optimized the diffuser of an axial-flow blood pump with fixed-shape straight-
ener and impeller. The mesh for the fixed parts involved about 500 000 elements. Remeshing
was carried out by re-running an Ansysr ICEM-CFD replay file, ESTECOr modeFRON-
TIER4.0 was used for procedure control, and the NSGA-II algorithm was used for generating
variables’ values. A total of 37 days were needed for the simulation of a total of more than
1 600 designs, on a platform built with 20 CPUs with average frequency of 2.4 GHz. The two
objective functions were pressure head and backflow index. The maximum pressure output
obtained was 93 mmHg [115].
Derakhshan et al. optimized a centrifugal pump considering 6 geometry variables, by using
artificial neural networks (ANNs) and an Artificial Bee Colony algorithm. The mesh involved
about 230 000 nodes. The evaluation of each design consumed half an hour of computing time
on a platform of Intel Core i5 processor 2.4 GHz with 4 GB memory [116].
4.2 Basic Design of a Screw-type Axial-flow Pump
The design method presented in this section is a combination of the approaches presented in
several reference textbooks [99, 101, 102, 117].
The standard working condition of a blood pump is: 1) a flow rate of 8.33 10−5 m3/s (cor-
responding to 5 L/min), and 2) a pressure head equivalent to 1.36 m of water, corresponding
to 100 mmHg. Hence, as an additional challenge, each new design requires more than one
single CFD simulation, in order to ascertain the right rotating speed (variable parameter),
which delivers the right pressure head (prescribed value) for the given flow rate (prescribed
value). It is therefore clear that the computational challenges associated with this problem
are extremely high. A new, more efficient solution procedure is required.
Some further considerations, important for the design of a blood pump, are:
1. Due to limited viscosity differences, and looking back at Fig. 4.5, the correction factors
CQ and CH for blood are very close to 1. Hence, the design method for a water pump
can be directly used for a blood pump.
2. Though inlet guide and outlet guide are not a compulsory requirement for the design
of an axial-flow pump, they are almost always found in existing blood pumps, in par-
ticular to accommodate the fixed part of electronic magnets for the levitation system.
Therefore, both inlet and outlet guide vanes will be considered in what follows.
3. Existing axial-flow blood pumps usually employ a screw-shaped impeller with consid-
erable axial length, in order:
• To achieve a smoother blade angle change from β1 to β2, leading to low shear
stress;
• To achieve a larger blade angle change, β1 − β2, and thus a higher pressure head
at a lower rotating speed.
4. Since β1 − β2 is large, the standard axial-flow pump pressure head equation
Y = ζa
uw2∞l
2cAt
sin(β∞ + λ) (4.20)
leads to a poor accuracy for such a design. Instead, the general pressure head equation
(Eq. 4.19) is preferred in the design process.
57
Chapter 4: Design Optimization Method for Blood Pumps
5. For calculation convenience, a simple geometry is chosen in this first work, involving a
constant diameter for impeller and guide vanes.
6. For the same reason, it is assumed that α−2 = α−1 = α5 = 90◦.
Design Procedure
The first step is to choose the minimal specific speed of an axial-flow pump, Nq = 110 1/min,
which corresponds to the highest H/Q ratio:
Nqy = 3Nq × 10−3 = 3× 110× 10−3 = 0.33 (4.21)
Then use Eq. (4.5) to calculate n:
n = Nqy
Y 3/4
Q1/2
= 0.33
(1.36× 9.8)3/4
(8.33× 10−5)1/2 = 252.21 (rpm) (4.22)
Assuming an average impeller inlet squeeze coefficient ψ1 = 0.8, choose average values
β0 = 20
◦, α−1 = α0 = α1 = 90◦. For Ns = 110 1/min, the empirical best d/D-ratio is 0.7.
Then, calculate the axial velocity by:
cA =

4pi tan2 β0k21−( d
D
)2 k1
Qn2

1/3
=
(
4pi tan2 17◦ × 0.8
0.51× 1 8.33 10
−5 × 252.212
)1/3
= 2.995 (m/s)
(4.23)
where, k = 1 − (d/DA)2 = 0.51 is the contraction factor, and k1 = D1/DA = 1 if the pump
has a fixed diameter (simple design). Additionally, k2 = c0/cA = 0.8 for ψ1 = 0.8.
Then, calculate the equivalent diameter:
D0 =
(
4Q
picA
)1/2
=
(
4× 8.33 10−5
2.136pi
)1/2
= 5.95 10−3 (m) (4.24)
The diameters are then obtained by:
D =
D01−( d
D
)21/2
=
7.05 10−3√
1− 0.72 = 9.92 10
−3 (m) (4.25)
and
d = 0.7D = 7.93 10−3(m) (4.26)
At this point, it is possible to calculate the circumferential velocity, for a simple axial flow
with constant diameters:
u1n = u2n = pind = 7.41 (m/s) (4.27)
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u1x = u2x = pinD = 9.27 (m/s) (4.28)
For an axial-flow pump with screw-type long blades, βn and βx should obey the following
rule, in order to ensure that the blade stays perpendicular to the axis on the span direction:
d tan βn = D tan βx (4.29)
Taking as a first estimate β0 = 20
◦ for the geometrical middle spanwise position of the
blade, it is possible to calculate the blade angles at blade top and bottom separately:
β1x = arctan
tan β0 D√D2 + d2
2
 = 22.02◦ (4.30)
β1n = arctan
tan β0 d√D2 + d2
2
 = 17.93◦ (4.31)
Considering a number of blades z = 2 and a blade thickness δ = 1 mm, it is possible to
calculate the real average squeeze coefficient with a slightly simplified formulation:
1− zδ
sin β0
1
pi
√
D2 + d2
2
= 0.79 (4.32)
If a large difference is found between the assumed squeeze coefficient and the real average
one, then the thickness of blade δ should be modified to reduce the difference. If the thickness
of the blade is fixed due to physical limitations, then the former steps should be repeated
iteratively, until reaching a close fit between the real and the target value.
The next step is to calculate the blade angle at rotor outlet. Assuming first a pump
efficiency ηi = 0.8 as an initial guess, solve Eq. (4.33) using Eqs. (4.34) and (4.35):
Hth
ηi
= u2mc2m cosα2m (4.33)
sinα2m =
c0/φ2m
c2m
(4.34)
φ2m = 1−
zδ
2pi
√
D2 + d2
2
sinα2m
(4.35)
This results into:
(α2m, ψ2m, c2m) = (28.38
◦, 0.85, 5.85 m/s) (4.36)
where α2m refers to the velocity angle at middle spanwise position. Here, the variable values
at spanwise middle position are used as the average values for calculating the pressure head,
in order to simplify the numerical procedure.
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The blade angles at rotor outlet are calculated by:
β2m = arctan
c0/φ2m√
u2x
2 + u2n
2
2
− c2m cosα2m
= 41.03◦ (4.37)
together with
β2x = arctan
tan β2m D√D2 + d2
2
 = 44.04◦ (4.38)
and
β2n = arctan
tan β2m d√D2 + d2
2
 = 37.72◦ (4.39)
Then, it is possible to calculate α4:
α4x = arctan
tanα2m D√D2 + d2
2
 = 43.87◦ (4.40)
and
α4n = arctan
tanα2m d√D2 + d2
2
 = 37.54◦ (4.41)
As a summary, all angles (assumed or obtained from the numerical procedure) are listed
in Table 4.4.
position
-2 -1 1 2 4 5
αx 90
◦ 90◦ - - 43.87◦ 90◦
αn 90
◦ 90◦ - - 37.54◦ 90◦
βx - - 17.93
◦ 37.72◦ - -
βn - - 22.02
◦ 44.04◦ - -
Table 4.4: Blade/velocity angles
4.3 Design-theory-based CFD-O for Axial-flow Pump
As already explained, CFD-O refers to the computer-based optimization relying on evalua-
tions obtained by CFD. Here, optimization means that corresponding algorithms are employed
to converge toward optimal solutions as quantified by (possibly concurrent) objective func-
tions. It is not simply a comparison between a few designs, with a final statement that the
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best of those is the “optimal” one, as often found in the literature. After developing, test-
ing and validating the procedure, the resulting optimization is at the end a fully automatic
process. Concerning CFD-O, our group has gathered a rich experience over the last fifteen
years, from wind turbines to burners, from bioreactors to heat exchangers. The fundamental
description of the approach used for CFD-O in our group is found in [14, 15, 118]. Specific ex-
amples associated to the optimization of turbomachines considered in particular vertical-axis
wind turbines [119], Wells turbines [120] and Pitot-tube pumps [121].
A fully automatic optimization employs a shell program for choosing and generating the
parameter variables, and for controlling the optimization loop. In this automatic optimization
loop, geometry and mesh generators, CFD solver, and all further pre- and post-processing
tools are all integrated. The involved tools are executed based on journal scripts, so that the
optimization proceeds automatically without need for human interference. The shell program
calls all the integrated tools in a pre-defined sequence, and repeats this sequence in a loop,
with embedded tests and controls to avoid any error.
Based on our experience during the last fifteen years, Evolutionary Algorithms (EA) are
very robust for CFD-O and have been used in the vast majority of our projects. This is
done as well for the rotary blood pump now considered. EA involve iterations sorted in
groups, which are called design “generations” in EA terminology. The variable values of later
generations depend on the outcomes (objective values) of earlier generations. After analyzing
each generation, the corresponding objective values are stored in a result file for final analysis.
The main limitation of CFD-O is the vast requirement in terms of computational resources
concerning both hardware (computing time, memory requirements) and software licenses
(when using commercial CFD solvers, as done in the present project). This is particularly
true for standard EA procedures considering multi-objective, concurrent optimization, since a
large number of designs must be simulated in order to identify and populate the set of optimal
solutions (so-called Pareto front). For this reason, most CFD-O analyses documented in the
past considered only two-dimensional or axis-symmetric configurations, or extremely simple
3D geometries, both usually for steady flows. In that case, the numerical cost of a CFD
evaluation is low, and EA can really perform excellent work. However, the blood pump
considered in the present article is an axial-flow pump with inlet and outlet guide vanes. It
is a complex 3D geometry, which can not be simplified and simulated in 2D. Each evaluation
requires unsteady flow simulations with nine complete rotations, in order to reach periodic
steady-state results. As a final difficulty, each new design requires more than one single CFD
simulation, in order to find out the right rotating speed (variable parameter), which delivers
the right pressure head (prescribed value) for the given flow rate (prescribed value). It is
therefore easy to understand that the computational challenges associated to this problem
are extremely high. A new, more efficient solution procedure is needed.
For this purpose, it is useful to look at the currently used procedure for commercial
providers of innovative pump designs. Progress is there very strongly connected to the im-
pressive experience of the involved engineers, supported by well-established scientific and
technical procedures known as pump design theory, building on top of at least one century
of high-quality research. In its current state, pump design theory is a combination of math-
ematical procedures and technical empirical experience. It provides a well-trained engineer
with a close-to-best pump design suitable for further CFD and/or prototype tests. Pump
design theory can readily provide, in addition to relevant geometrical data, indicative values
for rotating speed, expected flow rate and pressure head around the design point.
Therefore, a very promising solution can be obtained by combining the best of the two
approaches. This extended method is called “design-theory-based CFD-O” (DTB-CFD-O) in
what follows. DTB-CFD-O uses pump design theory to reduce the total number of designs
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that must still be evaluated using CFD, by: 1) avoiding the evaluation of completely atypical
designs that are incompatible with the design theory and would thus deliver probably an
extremely poor efficiency; 2) reducing the number of geometrical parameters involved in
CFD-O, since many geometrical variables can be expressed as a function of other variables
thanks to design theory; 3) delivering suitable assumptions for the rotating speed leading to
the targeted pressure head, thus reducing the number of inner iterations within each CFD-O
evaluation.
The function of design theory as a support of a CFD-O can best be illustrated by an
example.
Suppose the geometry of a design can be parameterized by 3 variables: x1, x2 and x3. If
x3 can be expressed as a function of x1 and x2 using Eq. (4.42), derived from design theory,
x3 = f1(x1, x2) (4.42)
then x3 is no longer a free geometrical variable, and therefore the number of geometrical
variable is reduced from 3 to 2.
If, additionally, x1 and x2 can be correlated by design theory through Eq. (4.43),
x2 = cx1 (4.43)
where c is a proportionality variable evolving within a known range (c1, c2), then c can be
involved instead of x2 as design variable. Finally, as illustrated in Fig. 4.10, the design space
considered in the optimization can be tremendously reduced. It shrinks for the first generation
from the square region of [0, x′1] × [0, x′2] to the gray region between line x1c1 and line x2c1;
the two red regions can be completely omitted from the evaluation. Thus, the number of
evaluated designs can be very strongly reduced, leading to a considerable speed up. It is
worth mentioning that, for the second generation of designs, the evaluation regions for x1 and
x2 are reduced to [x
′′
1, x
′′′
1 ] and [x
′′
2, x
′′′
2 ], respectively. Thus, Eq. (4.43) is further on helpful to
reduce the evaluation domain by omitting the two light-green regions. This applies as well
during the whole optimization process.
Figure 4.10: Example showing the design parameter space and how it can be reduced thanks
to design theory
For the special case of a screw-type axial-pump (also sometimes called Archimedes screw
pump), DTB-CFD-O is a key to success by:
1. Establishing a relation between βx and βn at each axial position. Thus, it is possible to
suppress at least one design variable at each axial position, while still ensuring that the
extension line from the blade top to the blade bottom meets the axis.
2. Using Nq to decide d/D and n. This empirical method ensures that the produced design
works close to the optimal working condition on the characteristic curve.
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3. Using an assumed ηo to calculate β2, thus narrowing the range of design variable values
for β2. Although this first assumption for ηo may initially lead to a large inaccuracy, it
is still more robust than assuming β2 directly, as shown by first tests.
4. Using a coefficient to relate β2 with β4 (and also β1 with β−1). This is used to reduce the
size of the domains β4−β2 (and β1−β−1), similarly to the example shown in Fig. 4.10.
Geometry Parameterization
Now, it is time to describe the numerical strategy employed to parametrize the Archimedes
screw pump in the DTB-CFD-O approach. Figure 4.11 shows the derivation logics for the
five design parameters (or geometrical variables) used in the simplest optimization strategy.
Here, Nq, β0, ηo, ξ and K4 are the design variables, and all other pump geometrical variables
are derived from those five variables. Decades of experience by pump practitioners prove
that values of Nq, β0 and, to a lesser extent, ηo are absolutely essential to determine properly
the geometry, and therefore must be kept in the optimization. The variable ξ is particularly
important for an Archimedes screw pump, and must also be kept. First tests have shown
that K4, though less essential in general, should be also involved in the optimization for this
particular system. To summarize and rank the importance of the five design variables:
• Nq and β0: absolutely essential;
• ηo and ξ: important;
• K4: useful.
Figure 4.11: Simple optimization strategy involving 5 geometrical variables
Most equations required for this optimization strategy have been already given in Section
4.2. An attack angle is introduced in connection with β4 by adding a coefficient K4, thus
Eqs. (4.40) and (4.41) are changed to Eq. (4.44) and Eq. (4.45), respectively.
tanα4x = K4 tanα2m
D√
D2 + d2
2
(4.44)
tanα4x = K4 tanα2m
d√
D2 + d2
2
(4.45)
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If a more detailed description of the geometry is needed, the next candidates to be retained
as design variables are:
• If the ratio between shaft diameter and blade axial diameter, d/D, is not kept constant,
it must necessarily be included in the optimization process.
• K−1: The equivalent attack angle coefficient for β−1, β−1x and β−1n is governed by
Eqs. (4.46) and 4.47, respectively.
tanα−1x = K−1 tanα1m
D√
D2 + d2
2
(4.46)
tanα−1n = K−1 tanα1m
d√
D2 + d2
2
(4.47)
Finally, the optimization involving seven design variables is the one that has been retained
in the rest of this Thesis (see next chapter for more information), since it is the only one leading
to acceptable computing times.
However, if an even more precise description of the geometry is required (and if corre-
sponding computational resources are available. . . ), the next candidates as design variables
are:
• l: If the total axial length of the pump is pre-defined, li can be estimated by the minimal
length of the electronic magnets, and then l + lo = lmaxAvailable. Choosing l as input
variable, then lo is a derived variable.
• K1.5: This is the equivalent angle of attack coefficient for β1.5m . For a screw-type
impeller with a long axial length, the optimal changing rate of blade angle, ∂β/∂l, may
not be constant. Then, one or more control point(s) along the axial length should be
used to control the change in blade angle. It is proposed to use first one single additional
point at average blade angle β1.5m as control point, located exactly in the middle of the
rotor axial length, together with Eq. (4.48):
K1.5
Hth
ηo
= u1.5mc1.5 cosα1.5m (4.48)
This equation is then solved together with Eqs. (4.49) and (4.50):
sinα1.5m =
c0/φ1.5
c1.5
(4.49)
and
φ1.5 = 1−
zδ
2pi
√
D2 + d2
2
sinα1.5m
(4.50)
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Afterwards, the blade angles at shaft and shell are calculated respectively by:
β1.5n = arctan
tan β1.5m d√D2 + d2
2
 (4.51)
β1.5x = arctan
tan β1.5m D√D2 + d2
2
 (4.52)
• 4l1, 4l2: The gap between inlet guide vane and rotor, 4l1, and the gap between rotor
and outlet guide vane, 4l2, can be critical to control the turbulence generated at this
level, and could be therefore adopted as additional input variables.
Taking into account all those design variables in an advanced optimization, the flow chart
allowing to derive all needed quantities is shown in Fig. 4.12.
Figure 4.12: Advanced optimization strategy
4.4 Practical Optimization Procedure
4.4.1 General Method
The optimization strategy proposed above has been implemented by coupling the commer-
cial optimization tool ESTECOr modeFRONTIER 4.0 with the commercial CFD package
ANSYSr CFX 14. However, the described approach is generally valid and could obviously
be used for other applications; it could rely on other software.
Pump hydraulic efficiency is adopted as primary optimization objective, while hemolysis
may be also integrated as an additional, concurrent objective, as discussed later on.
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Figure 4.13: System distribution of the employed numerical tools
In order to combine the advantage of parallel computing with convenient real-time moni-
toring and post-processing, a distributed allocation of the employed softwares can be adopted.
The choice of this infrastructure is also conditioned by some limitations concerning the sup-
ported operating systems by the employed numerical tools. The finally used allocation of
all numerical tools is shown in Fig. 4.13. Transfer of information through the network is
performed by ”remote SSH” function in ESTECOr modeFrontier, and the most important
transfered data are the CFX ”.def” file (from desktop to cluster) and the result ”.txt” file
(from cluster to desktop). The main CFD simulation and part of the post-processing are car-
ried out on the Linux cluster, while pre-process, another part of the post-processing, design
evaluation and support by pump design theory are carried out on the Windows desktop.
The data flow path through the different numerical tools is shown in Fig. 4.14. In the
loop, modeFrontier generates all values for the design variables; then, these value are sent to
a Matlab code, which generates all derived values. At that point, modeFrontier gathers back
the complete geometrical information, and sends it together with the rotating speed to the
tools employed to generate the geometry and mesh, ICEM-CFD, BladeGen and TurboGrid.
In order to maximize grid quality while keeping a robust procedure, geometry and grid are
generated in five different parts (see next section for more details). The parts are then sent
to CFX-Pre, which calls a pre-generated journal file and assembles the grids together, and
outputs a CFX ”.def” file. Then, modeFrontier sends this file to the Linux cluster and calls
the CFX-Solver to carry out the CFD simulation. During this simulation, an additional CFX
User-Fortran code is activated to calculate hemolysis. The result file ”.res” is filtered to obtain
values for efficiency and hemolysis by running ”cfx5mondata” on the Linux cluster. As a last
step, a ”.txt” file containing efficiency and hemolysis information is sent back to the Windows
desktop, and modeFrontier evaluates the results, before starting the next iteration loop.
4.4.2 Numerical Tools
4.4.2.1 Preprocessing
As explained previously, the geometry and mesh are generated in five separate parts:
1. inlet pipe and shaft before guide vane,
2. inlet guide vane,
3. impeller,
4. outlet guide vane,
5. shaft after guide vane and outlet pipe.
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Figure 4.14: Flow chart for optimization of an Archimedes screw pump
The geometries and meshes of parts 1 and 5 are generated by ANSYSr ICEM-CFD thanks
to journal files. Typically, many control points are needed along the shell as well as at the
beginning and at the end of the shaft in order to get a smooth geometry. This is obtained by
a recursive procedure coded unter Matlab, starting from only few control points and cutting
iteratively the segments into two equal parts.
The geometries of parts 2, 3 and 4 are generated by ANSYSr BladeGen, which is a
dedicated generator for turbomachines. Automatization is based on a script, in which the
diameters and blade angles at user-chosen axial positions (the corresponding number of po-
sitions is unlimited) are recorded. Compared to ICEM-CFD, BladeGen requires far less
operations and is able to generate corresponding geometries in a far more robust manner.
The grids of parts 2, 3 and 4 are generated by ANSYSr TurboGrid, which is a dedicated
mesh generator associated to BladeGen. Using this tool, it is very convenient to obtain a fully
hexahedral grid for the geometries generated by BladeGen. An example of an hexahedral grid
generated by TurboGrid in this manner is shown in Fig. 4.15.
Figure 4.15: Example of TurboGrid hexahedral meshing
The tools employed to generate each part of the geometry and mesh are summarized again
in Fig. 4.16.
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Figure 4.16: Tools employed to generate each part of the geometry and mesh
In practice, using BladeGen and TurboGrid instead of ICEM-CFD has been a major help
for this project. It was almost impossible to develop a sufficiently robust procedure using
ICEM-CFD. The geometries, and consequently the mesh topologies needed for this project
are very complex, involving H-grid and O-grid hexahedral structures.
However, one problem of BladeGen and TurboGrid is that these tools can only run on a
Microsoftr Windows platform. Therefore, a Windows optimizer tool (like modeFrontier in
this project) is needed.
4.4.2.2 Solver
ANSYSr CFX 14.0 is employed for CFD-solving. Generally, CFX and ANSYSr Fluent
offer very similar CFD functions. CFX shows some advantages over Fluent concerning tur-
bomachine simulation. Additionally, it was observed to be more tolerant concerning complex
mesh structures compared to Fluent.
However, Fluent would certainly also be capable of solving similar problems. In addition,
open-source tools like OpenFOAM, which was tested for turbomachinery optimization in
several master theses in our group [104, 122] could be used as well. Preliminary tests have,
however, shown that OpenFOAM often encounters stability problems when using dynamic
mesh. Additionally, the complex geometries and meshes needed for this project could not be
generated automatically with any available open-source tool, so that a license-free procedure
seems out of reach at present.
The CFX simulation is systematically carried out for transient flows, including a transient
stator-rotor dynamic mesh model. Only one blade section is meshed and simulated for the
impeller and guide vanes in order to save computational time. Therefore, partial GGI (General
Grid Interface) and periodical interfaces are used for all variable values in order to map those
properly between the mesh interfaces.
4.4.2.3 Adjusting Rotating Speed
Although an approximative value of the rotating speed has been provided for n using Eq. (4.22),
it may not generate a pressure head exactly equal to the fixed target value Htarget, due to
the imprecision of the process. A further adjustment of n is hence needed in most cases.
Based on the affinity law discussed previously, an updated value for n is given iteratively
using Eq. (4.53), and a new CFD simulation is carried out with this new value of n, until this
iterative process delivers the requested pressure head within a prescribed tolerance:
ni+1 = ni
√
Htarget
Hi
(4.53)
Figure 4.17 illustrates how this method works in connection with the affinity law.
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Figure 4.17: Iterative procedure to find the suitable rotating speed n
Suppose that the very first simulation (rotating speed n1) leads to working point P1. Then,
the rotating speed is adjusted thanks to Eq. (4.53) to n2, leading to the new working point P2.
In a few steps, the target working point is reached. In practice, an even faster convergence
could be obtained by using the modified equation:
ni+1 = 0.5ni
1 +
√
Htarget
Hi
 (4.54)
In practice, for each design, a maximum of three inner iterations are considered to update
the value of the rotating speed n. If this is not sufficient to reach the targeted pressure head,
this particular design is considered as being unsuitable and is simply discarded from the opti-
mization process. A manual check of such designs at the beginning of the project showed that
a bad convergence typically stems from unsuitable design parameter combinations, leading to
highly unstable flow conditions. For the sake of robustness, such solutions should be removed
from the optimization process.
4.4.2.4 Postprocessing
No special postprocessing tool is needed.
Efficiency and pressure head at each time step can be saved into the ”.res” file, if pre-
defined by CEL expressions written in CFX-Pre:
deltaP areaAve ( Pressure ) @outlet − areaAve ( Pres sure ) @in l e t
E f f i c i e n c y −2∗deltaP ∗ f lowRate /( to rque z ( ) @rotor Defau l t ∗
rotSpeed /1 [ rad ] ) / 1 0 0 0 [ kg mˆ−3]
After completion of the CFD simulation, efficiency at each simulation time step can be
written to a text file by following command line, allowing a direct analysis of the value:
cfx5mondata −r e s xx . r e s −n o c o e f f l o o p s −v a r r u l e
”CATEGORY = USER POINT” −out a . txt
The numerical hemolysis prediction method described in Section 2.4.5 has been coded
in CFX-User’s Fortran. Hemolysis is thus solved simultaneously with the CFD simulation.
Details of the code are given in Appendix E.
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4.4.2.5 Optimizer
ESTECOr modeFrontier has been chosen as the optimizer, among many options available,
due to the following properties:
• Runs both on Windows and Linux environments;
• Easy communication through Windows/Linux platforms by ”remote SSH”;
• Graphical user interface facilitates error debugging and code modifications;
• Extensive built-in graphical analysis of the optimization results.
4.5 Conclusions
Now, all the tools needed for optimizing a blood pump, and more specifically first an Archimedes
screw blood pump, are available, working properly and in an acceptably robust manner.
Therefore, the optimization can be started.
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Optimization of an Archimedes Screw
Blood Pump
The optimization procedure described in the previous chapter has been used to optimize an
Archimedes screw blood pump. The first objective is to check the feasibility of the proposed
optimization strategy, and to test its robustness. The second goal is to gather information
and experience on a screw-type axial-flow blood pump, and to check its possible applicability
in practice. Part of this chapter has been submitted as an article to the journal “Artificial
Organs”.
5.1 Details of the Optimization
5.1.1 General Issues
In order to reduce the overwhelming complexity of the problem, the Archimedes screw blood
pump has been simplified concerning several aspects: 1) along the axial direction, the pump
has constant shaft diameter d and shell diameter, and constant clearance distance ξ; 2) the
head and tail of the shaft are not considered in the optimization process; 3) tan β, the tangent
of the blade angle changes linearly in chordwise direction; 4) the rotor includes two blades,
and the inlet guide and outlet guide each includes four blades. In this design, the flow field is
axial-symmetrical, regardless of the relative position between the rotor and guide vanes. By
applying periodical interfaces in the domain of the CFD solver, only half of the whole volume
of the pump has to be numerically simulated.
A standard Archimedes screw-type axial-flow pump corresponds to a fixed value of the
blade angle. The third hypothesis listed above allows for modifications of the blade angle
corresponding to what is typically found in currently commercialized blood pumps.
Additionally, the considered pump involves only a single stage, which is not really an
assumption, since all existing systems comply with this observation.
Summing up the discussion of the previous chapter, the finally realized optimization in-
volves seven input variables, sufficient to parametrize a large number of different designs and
relevant for process outcome:
1. The blade angle for infinitely long blade, β0;
2. The ratio between shaft diameter and blade axial diameter, d/D;
3. The specific speed, Nq;
4. The efficiency loss in the outlet guide vane, ηo;
5. The blade clearance, ξ;
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6. The equivalent angle of attack between α1m and α−1m, K−1
7. The equivalent angle of attack between α2m and α4m, K4.
In a first step, pump efficiency is the only objective and should be maximized.
Figures 5.1-5.3 show as an example three typical designs evaluated during the optimization,
together with the design parameter values listed in Table 5.1
Figure 5.1: Design A
Figure 5.2: Design B
Figure 5.3: Design C
Design K−1 K4 β0 d/D ηo Nq ξ
A 0.0447 0.7668 19.7 0.817 0.953 95.8 0.0678
B 0.0092 0.926 19.5 0.776 0.950 102 0.0614
C 0.148 0.836 19.2 0.789 0.933 94.4 0.0568
Table 5.1: Variable values corresponding to Figs. 5.1 to 5.3
5.1.2 The Variables
5.1.2.1 Rotating Speed n
As already explained, the target pressure head (this time in pressure unit) is 13 300 Pa
[7]. For each design, a maximum of three inner iterations are considered to update the
value of the rotating speed n. If this is not sufficient to reach the targeted pressure head,
this particular design is considered as being unsuitable and is simply discarded from the
optimization process. A manual check of such designs at the beginning of the project indeed
showed that a bad convergence usually stems from exotic design parameter combinations
leading to highly unstable flow conditions. For the sake of robustness, such solutions should
indeed be removed from the optimization process.
5.1.2.2 Outlet Guide Efficiency, ηo
The variable Hth/η in Eq. (4.33) refers to how much kinetic energy is observed in the fluid,
when it leaves the rotor. It equals the expected pressure head, plus the hydraulic loss in the
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outlet guide and outlet pipe:
LossOutletGuide =
Hth
ηo
−Hth (5.1)
From engineering experience, the typical hydraulic loss within the outlet guide vane should
be less than 10%. Therefore, the efficiency ηo is constrained during the optimization within
a range between 0.91 and 0.97.
5.1.2.3 Input Specific Speed, Nq
Specific speed, Nq, is the variable that decides the shape of a pump. However, the traditional
relationship between Nq and pump shape has been mostly derived only for blades with a short
axial length. To what extent the empirical relationship between Nq and pump shape is valid
for a screw-type axial pump is unclear. For this reason, a broader range of Nq, from 80 to
110 (1/min) is used.
5.1.2.4 Shaft to Shroud Ratio, d/D
A screw-type axial pump has usually a large d/D value, in order to avoid large differences in cA
along cross-sections perpendicular to the flow direction. However, the empirical relationship
between specific speed and shaft-to-shell ratio (d/D) given in Table 4.2 does not cover large
d/D values. It is also unclear to what extent this relationship is valid for a screw-type axial
pump with long chordwise length. Therefore, d/D is taken as an individual variable and
associated to an input range of 0.75 to 0.9.
5.1.2.5 Tip Clearance, ξ
Clearance is given as an individual geometrical variable, which is not correlated with other
variables in the theoretical design process. It is considered as constant throughout the pump
axial length. The input range is between 0.03 to 0.08, as a value rendered non-dimensional
by dividing with the blade spanwise height.
5.1.2.6 Inlet Blade Angle of Rotor, β0
The rotor inlet blade angle β0 is considered as a design variable within the range of 18
◦ to
21◦.
5.1.2.7 Equivalent Attack Angles, K−1 and K4
K−1 has a range of 0 to 0.3, and K4 from 0.7 to 1.0.
5.1.2.8 Other Variables
The axial length of rotor and guide vanes are fixed to 0.02 m.
As discussed in the previous chapter, the distance between rotor and guide vanes (4L1
and 4L2) is expected to have also an influence of the pump behavior, but is not included as a
variable. It is fixed to 0.002 m in this study in order to reduce the complexity of the process.
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5.1.3 Numerical Settings
The automatic optimization is extremely complex and involves a variety of tools that must
be coupled in a safe and efficient manner before getting proper results. This required at the
end many months of work. The shell program employed to control the optimization process
is ESTECOr modeFrontier 4.0. All equations from design theory have been coded in a
script using Mathworksr Matlab 2010. The geometry of guide vanes and rotor is generated
automatically using Ansysr BladeGen thanks to an in-house script. Grid generation and
grid quality control take place thanks to Ansysr TurboGrid 14 by running a journal file.
Note that the help of this intermediate program, TurboGrid, has proven highly valuable in
order to generate high-quality hexahedral grids for a complex rotor in an automatic mode. A
previous attempt relying on Ansysr ICEMCFD 14 for this purpose proved to be too complex
and remained unsuccessful.
Initial pre-processing is done with Ansysr CFX-Pre 14 by running a session in command
line. The CFD simulation relies on the Ansysr CFX solver 14. Finally, post-processing for
pressure head and efficiency is realized by the command line instruction ”cfx5mondata” and
redirected toward Matlab, which calculates the average value in time.
The settings and models employed for evaluation by CFD are summarized in Table 5.2.
Density 1035 kg/m3
Viscosity 0.0035 Pa.s
Turbulence Model RNG k-
Convergence criteria RMS 0.0001
Outlet Open
Min. coeff. loops 3
Max. coeff. loops 6
Table 5.2: Settings used in CFX for the CFD simulation of the pump
Since Ansysr BladeGen is only available on Windows platforms to date, the whole opti-
mization process has been controlled from a Windows PC with one Intelri5-2500 quadcore
processor. A detailed flow chart of the optimization is shown in Fig. 5.4.
5.1.3.1 BladeGen
Ansysr BladeGen uses scripts to actualize the blade geometry data. Such scripts have a
fixed format, independent from the designer’s operation sequence in GUI (Graphical User
Interface), and denoted by the file extension ”.bgi”.
Since the definition of blade angle in BladeGen is the angle between axial direction and
blade direction, all the theoretical β values listed in the previous last chapter have been
changed to their complement angle.
Three BladeGen batch scripts have been prepared for the rotor and guide vanes, respec-
tively. These scripts are set in ”Angle/Thickness” mode, which requires blade angles β being
defined at least at two spanwise positions, and at least at two chordwise positions for each
spanwise position. In the following, an example is presented for defining β using five chordwise
positions:
Begin AngleCurve
Layer = ”Layer1”
HorizDim = Mer id iona l
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Figure 5.4: Detailed flow chart of the optimization involving seven design variables
VertDim = Degree
Def in i t ionType = Beta Curve
LE Theta = 0.0000000000
Begin Segment
CurveType = Sp l ine
UpstreamControl = Free
DownstreamControl = Free
Begin Data
( 0 .00100000000 ,74 .247998229 )
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( 0 .00550000000 ,71 .983104002 )
( 0 .00900000000 ,68 .991526641 )
( 0 .013500000000 ,64 .884591488 )
( 0 .0190000000 ,58 .974722354)
End Data
End Segment
End AngleCurve
The first item and last item in the ”Data” section correspond to the geometrical variables β1x
and β2x; the three middle ones are generated by a linear approximation, shown in Eq. (5.2)
for the ith increment:
tan βix = i tan β1x − (i− 1) tan β2x (5.2)
The purpose of this manual interpolation is to override the automation interpolation in Blade-
Grid, which usually generates an axial-plane separation. In that case, the control points for
β2x and β2n would be located on different axial planes.
Shaft diameters and shroud diameters at different cross sections are defined separately.
Here is an example for defining d and D at a selected axial position:
Begin Segment
CurveType = Bez i e r
UpstreamControl = Free
DownstreamControl = Free
Begin Data
( 0 .00100000000 ,0 .005505995 )
( 0 .01900000000 ,0 .005505995 )
End Data
End Segment
5.1.3.2 TurboGrid
TurboGrid session files (extension ”.tse”) are prepared for the rotor and guide vanes, respec-
tively. These session files are generated by recording operations in GUI. Some important
settings include:
• Set ”ATM Topology Optimizer = On” to ensure a better tolerance against changes in
geometry.
• Set the axial positions of beginning and end of the rotor or guide vane section by:
GEO POINT: Low Shroud Point
AR Locat ion Method = Set A
Requested ART = −0.03 [m] , 0 . 0 0 4 [m]
V i s i b i l i t y = On
END
5.1.3.3 CFX
A CFX session file is generated by recording operations in GUI. The simulation domain
includes 500 000 to 600 000 hexahedral mesh cells. TurboGrid governs the final mesh size,
which varies slightly from design to design. As explained in the previous chapter, it includes
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Figure 5.5: Example of a CFD domain considered during the optimization (view in CFX-Pre)
two sections for the inlet guide vane, two sections for the outlet guide vane and one section
for the rotor. At the end, the whole CFD domain looks like Fig. 5.5.
A velocity inlet with a prescribed volume flow rate 0.0417 L/s is considered. This is
half of the target flow rate of 5 L/min [7], since the CFD simulation considers only a half-
pump. ”Opening” boundary condition are chosen to avoid back flow at the beginning of the
simulation. A General Grid Interface (GGI) model is used for coupling rotor and guide vanes.
Figure 5.6 shows the hydraulic efficiency obtained by CFD as a function of timesteps.
For this specific design, efficiency starts showing periodic features already after six rotations.
How many rotations are needed before reaching this stage, depends on the particular design,
in particular on the axial velocity c0 (which is related to cross section area) and also on blade
angle β. In the present study, the total simulation duration is systematically set to a total of
nine rotations (i.e., 540 time steps). Within this duration, all designs have reached periodicity
in practice.
Figure 5.6: Efficiency vs. timestep for a selected design
The simulation of one design takes about 4 hours on a PC with Intel core i5-2500 processor
at 3.3 GHz. The number of timesteps needed before observing a periodic solution for pressure
head and efficiency, is decided primarily by c0. For a fixed flow rate, c0 is directly connected to
the cross section area of the pump. As an alternative to a fixed number of impeller rotations,
as done in the present study, Eq. (5.3) could be used to control the number of timesteps of a
simulation for a specific design, in order to avoid wasting computational capacity in case of
early convergence, and to avoid stopping too early for designs that need a longer simulation
time. However, for this purpose, the constants a1, a2 and a3 should first be determined
empirically.
Ntime step = a1 + a2
(
c0
c0ini
)a3
(5.3)
Finally, another possibility is to use a CEL code in order to check and analyze the evolu-
tion of the pressure head in time, and to stop the simulation when periodic oscillations are
observed.
5.1.3.4 Matlab
Matlab is used for two tasks:
• Coding the equations from pump design theory listed in Section 4.2. The corresponding
code is given in Appendix C.
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• Post-processing the ”.res” result file to get efficiency, pressure head and hemolysis values.
5.2 Results
Using the hardware discussed previously, the total duration of the optimization was almost
exactly five months. At the end, 220 different designs have been evaluated during the op-
timization process following the procedure discussed previously. The first design computed
during the optimization loop had a low hydraulic efficiency of less than 49%. At the end,
the very best design shows an efficiency of 65.3%, corresponding to a relative improvement
by 25%. This value is still relatively poor compared to those obtained for other applications,
for instance large-size centrifugal water pumps. But it must be kept in mind that the con-
sidered application is very specific; the dimensions of the device must be kept small, and
the prescribed values for flow rate and pressure head are not typical of those associated with
a single-stage axial pump. The best set of design parameters obtained by DTB-CFD-O is
presented in Table 5.3. The corresponding geometry is shown in Fig. 5.7.
K−1 K4 β0 d/D ηo Nq ξ
0.0634 0.7715 18.45 0.721 0.9196 88.85 0.03135
Table 5.3: Set of parameter values for the best design
The resulting fields of instantaneous pressure, velocity magnitude and turbulent kinetic
energy for the best design are presented in Figs. 5.8 to 5.10 using volume rendering.
Figure 5.7: Geometry of the best design
Figure 5.8: Volume rendering of pressure in Pa for the best design
Figure 5.9: Volume rendering of velocity magnitude in m/s for the best design
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Figure 5.10: Volume rendering of turbulent kinetic energy in m2/s2 for the best design
A parallel plot combining input variables and objective (hydraulic efficiency) is shown in
Fig. 5.11. In such a plot, commonly used for optimization based on EA, each dashed polyline
represents one different design, including along the horizontal axis all the seven real-valued
design variables simultaneously. The lower and upper bound values of the parameters found
in the optimization are shown individually in the parallel plot for each parameter (seven left
vertical axes). When looking at the ranges covered, it is clear that the 220 designs computed
by CFD correspond to widely differing technical solutions. The optimal configuration is shown
as a thick line.
K-1 K4 Nq ?0 d/D ?o ? ?
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0.999
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0.653
Figure 5.11: Input variables of the optimization and pump efficiency represented using parallel
coordinates. Each dashed line is associated with a different design and connects the values of
the optimization parameters (7 vertical axes on the left) and the objective function (hydraulic
efficiency, last vertical axis on the right).
5.3 Discussion
5.3.1 Range of Input Variables
It is first observed that the optimal values of most design variables, and in particular of ξ
are close to the pre-defined minimal values for these parameters. Even if they do not lie on
the boundary, it might be helpful to reduce further the minimally allowed values for those
parameters in future optimization studies.
5.3.2 Correlation between variables
Figure 5.12 represents the correlations observed during the optimization process for all the
variable pairs. Following observations can be drawn from this figure:
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Figure 5.12: Scatter-plot matrix showing the correlation between the input variables. The
number represents the correlation between two input variables (along the corresponding col-
umn and row, see diagonal for the variable name)
1) The objective (efficiency) is most sensitive to a change in specific speed Nq, and in a
second step to tip clearance ξ. As shown in Fig. 5.13, the efficiency increases significantly
when reducing the tip clearance within the range prescribed for this variable. On the other
hand, the efficiency depends only very little on K−1 and K4.
2) A relatively strong correlation exists between d/D and Nq, with a value of 0.83. How-
ever, this value is not sufficient to assume directly a one-to-one correlation between d/D and
Nq based on design theory. Both parameters must therefore be kept in the optimization.
3) A very strong correlation exists between ξ and Nq, with a value of 0.91. This might
indicate that, in further studies, ξ could be uniquely related to Nq in DTB-CFD-O for an
Archimedes screw pump. However, the corresponding relation could not be derived yet. Up
to that point, ξ should be kept as well as a design variable of the optimization.
5.3.3 Adding hemolysis as an additional objective
The last purpose of this project was to involve hemolysis as a second, concurrent objective
within the optimization. In order to develop high-quality blood pumps, it is in fact absolutely
necessary to simultaneously 1) maximize hydraulic efficiency, as discussed up to now, but
also 2) minimize hemolysis (damage of red blood cells, RBC). It is very well possible that
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Figure 5.13: η vs. ξ and Nq. Bubble grey level represents the efficiency η.
both objectives might evolve in opposite directions. In fact, the developed optimization
procedure would be readily useable for such a concurrent optimization with two (or even
more) objectives. Configurations involving two concurrent objectives have been successfully
considered in numerous other projects of our group, e.g. [118]. The only real problem, which
proved, however, to be considerable, is the availability of a model suitable for CFD and
allowing an accurate prediction of hemolysis in such a complex, unsteady flow, as discussed
extensively in Chapter 2.
The concurrent optimization involving both objectives is computationally extremely chal-
lenging. Computation is still ongoing and results will be attainable in several months, con-
stituting the subject of a dedicated publication. In order to get a preliminary idea of this
more complex optimization procedure, the model proposed in [80] has been used to quan-
tify hemolysis for the optimal pump design. Following [80], hemolysis is quantified through
an indirect quantity, the modified hemolysis HL, which is first computed using a transport
equation reading:
∂HL
∂t
+ v.∇HL =
(3.63× 10−7)(1/0.785)τ (2.416/0.785)(1−HL) (5.4)
For this approach, the results in terms of overall hemolysis are finally collected along pathlines
using a mass flow-rate-average along the domain outlet (outflow boundary condition of the
CFD):
4Hb
Hb
=
∑
outlet cellsHL
0.785m˙cell∑
outlet cells m˙cell
(5.5)
Equations (5.4) and (5.5) can be coded using either CFX’s User’s Fortran or CEL (CFX
Expression Language). For the previously obtained optimal design, the model of [80] has been
implemented and tested. The result of this simulation is shown in Fig. 5.14. As expected,
starting from zero-level (the red blood cells enter the numerical domain without any previous
hemolysis), the level of relative hemolysis 4Hb/Hb (proportion of hemoglobin leakage outside
of the RBC compared to the total initial hemoglobin content) increases rapidly after entering
the rotor. Afterwards, it remains at a relatively constant level, with larger values found in
regions with a high shear rate. Based on this first simulation, the concurrent optimization
involving hemolysis as a second objective is expected to consume approximately 3 times more
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computing time compared to the single-objective optimization. Using the same hardware
and number of processors, this would require around 9 months. In principle, this extremely
long computing time can be associated with a shorter user-waiting time by relying heavily on
parallel computations. Nevertheless, this remains a very challenging numerical problem. The
additional computational cost is due within each CFD evaluation to the additional transport
equations that must be solved, to the larger number of sub-iterations needed for each time
step, and to the smaller time-steps needed for a stable integration. Additionally, the opti-
mization process must also evaluate more designs in order to obtain a sufficient population
of the Pareto front in this higher-dimensional domain.
Figure 5.14: Volume rendering of hemolysis level 4Hb/Hb, as predicted by the model docu-
mented in [80].
Figure 5.15 shows that, when computing nine rotations of the pump, the value obtained for
hemolysis has fully converged and can therefore be used to evaluate the designs. As already
observed in this case for hydraulic efficiency, the pressure head converges to a periodic solution
after five impeller rotations (Fig. 5.16).
Figure 5.15: Plot of mass-averaged value of hemolysis 4Hb/Hb at outlet, as a function of
timestep
Figure 5.16: Plot of pressure head as a function of timestep
5.4 Conclusions
An automatic optimization process allowing the development of improved rotary blood pumps
has been developed and described in this chapter. By combining numerous different tools in a
suitable manner, and accepting long simulation times (three months for the first case presented
here), considerable progress can be achieved. In particular, the hydraulic efficiency of the
pump has been improved by 25% compared to the initial design. Another major finding is
that the proposed integration of design theory into the optimization process is indeed possible.
82
Chapter 5: Optimization of an Archimedes Screw Blood Pump
Therefore, design-theory-based CFD-O can indeed be used to fight against the well-known
“curse of dimensionality” by reducing the number of independent design variables involved in
the optimization. A blind optimization would not have been possible at all for the considered
configuration, involving a three-dimensional unsteady flow in a complex geometry.
By using more computer resources, a superior design could probably be achieved, since
only 220 different designs have already been evaluated. For this purpose, heavily relying on
parallelization is necessary, both for the optimization process (several evaluations running in
parallel) and for the CFD evaluations (each CFD simulation being carried out in parallel).
This aggressive two-level-parallelization is progressively becoming standard within our group
when considering CFD-O.
Further improvements would increase the generality of the optimization procedure. In
particular, allowing a non-linear change of tan β between rotor inlet and outlet appears to be
a promising extension of the considered approach.
Finally, taking into account hemolysis in the simulation is essential for practical purposes
and appears to be possible. However, it requires the availability of a suitable model, with an
acceptable accuracy and a good generality.
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Chapter 6
Tesla Pump as a Possible Blood Pump
As explained in the introduction, the pump proposed by Nikola Tesla is very unusual but
might be advantageous to transport blood, since a low level of hemolysis is expected. In the
scientific literature, incompatible statements and contradictory observations can be found, in
particular concerning the hydraulic efficiency of this system, from almost 100% to fast nothing.
For this reason, several student works considering this issue [10, 123, 124] have taken place in
our group during my Ph.D. This chapter summarizes the most important findings obtained
during supervision of these studies.
6.1 Theoretical Discussion and Literature Review
In a Tesla pump, the fluid is accelerated by the shear imposed onto it by rotating planes. The
average velocity magnitude increases as the fluid passes through the chamber between two
planes. The general velocity direction and streamlines in a well-designed system involving
only two planes is depicted in Fig. 6.1.
Figure 6.1: Typical velocity and pathlines between two plates [125]
Using the standard design proposed by Tesla, the geometry of a Tesla pump can be
parametrized by using only four geometrical variables (see later Fig. 6.8):
1. The gap distance between two planes, h;
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2. The inlet radius of the planes, Ri.
3. The outlet radius of the planes, Ra.
4. The gap distance/clearance between the first and last plane and the shell, hw.
The values of these four parameters have a large influence on the performance of a Tesla
pump. It was found in [126] that the highest efficiency value is achieved when the flow state
between the plates is laminar. To ensure a laminar flow between plates, a prerequisite is that
the gap distance h should not be too large, since the laminar layer (which is close to the wall)
has only a limited thickness. The development of the boundary layer of fluid over a simple
fixed plane is depicted in Fig. 6.2, and the thickness of it can be estimated by Eq. (6.1).
Figure 6.2: Change from laminar to turbulent boundary layer [127]
δ ∝
√
νx
U∞
(6.1)
In a rotating plane system, the evolution of the laminar boundary is more complex. The
relative radial velocity between fluid and planes decreases as radius increases, as shown in
Figs. 6.3 and (later) 6.9. Simultaneously, the relative tangential velocity also decreases as
radius increases, as shown in Fig. 6.10. It was again found in [126] that the thickness of the
laminar boundary layer in a rotating plane system is given by Eq. (6.2) as a proportionality
rule and does not depend on the radius:
δ ∝
√
ν
ω0
(6.2)
Equation 6.2 can be connected to the Ekman number Ek, which characterizes the shape
of the velocity profile in a boundary layer [128]:
Ek =
d
2δ
=
d
2
√
ω0
ν
(6.3)
In Eq. (6.2), ω0 refers to the rotation speed, ν refers to dynamic viscosity of fluid, d refers to
the gap distance (in our notation, d = h).
86
Chapter 6: Tesla Pump as a Possible Blood Pump
Figure 6.3: Radial velocity profile at different radial positions[125]
The choice of h is often constrained by material properties or construction tolerance. From
the point of view of turbomachinery, it must be kept small enough in order to avoid possible
back-flow or flow stagnation in the middle region between the disks, as illustrated in Figs. 6.4
and 6.5.
Figure 6.4: Radial velocity profile for dif-
ferent Ekman numbers [125]
Figure 6.5: Tangential velocity profile for
different Ekman numbers [125]
On the other hand, h cannot be extremely small, since this would increase the weight
of the system and, more importantly, would decrease the squeeze coefficient and lead to
unacceptable frictional losses.
A smaller Ri is advantageous from a constructive point of view. However, a larger Ri may
lead to a smoother change in flow direction between the inlet pipe and the entrance between
the disks. Hence, some intermediate value of Ri is probably the best choice.
A small value of Ra helps reducing the structural size and weight of the pump, but at the
risk of not being able to transfer enough energy to the fluid. On the other hand, a larger Ra
leads to structural difficulties, and might be associated to a transition to turbulence between
the disks, as exemplified in Fig. 6.6.
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Figure 6.6: Evolution of the velocity profile between two rotating planes [129]
A smaller values of hw leads to a larger shear rate in the first and last gap, and larger
torque resistance on the shaft; it might also lead to an increased hemolysis. On the other
hand, a large value of hw usually leads to a large back-flow region, as shown later in Fig. 6.9.
In another publication [130], the hydraulic losses occurring in a Tesla pump are connected
to four main factors:
1. The abrupt change in flow direction at the entrance;
2. The energy dissipation by viscous friction within the fluid between the disks;
3. The turbulent, spiraling vortex structure generated at the outer radial end of the disks;
4. The transition from laminar flow to turbulent flow in the chamber and in the spiral
casing.
Concerning those four points:
• A solution to 1) is considered in this chapter;
• 2) appears to be inevitable, but should be relatively small in a laminar flow, compared to
standard pumps involving a turbulent flow. The reduction of friction losses is discussed
in connection with the first optimization in the next section;
• As discussed above, problem 3) may be reduced or avoided by reducing h and Ra;
• Since the spiral casing is not considered in these first projects, problem 4) is left for
future works and might indeed be an important issue.
As explained previously, four design variables h, Ri, Ra and hw are sufficient to fully
describe the geometry of a standard Tesla pump. CFD-O is used in the rest of this chapter
to find out the best combination of the values of these four variables.
6.2 Design Optimization for a Tesla pump
Building on top of previous experience [123, 124], two advanced optimization steps are dis-
cussed in [10] concerning a Tesla pump. The detailed settings and a thorough description of
the results can be found in [10], and are not repeated here in the interest of space. Only the
important findings are described and discussed, opening the door for further studies.
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Figure 6.7: Simpler geometry considered
for CFD-O of a Tesla pump [10]
Figure 6.8: Complex geometry considered
for CFD-O of a Tesla pump [10]
The first, simple optimization (geometry shown in Fig. 6.7) aims at finding out the highest
transport potential (i.e., hydraulic efficiency) for a fluid enclosed between two rotating planes.
In this optimization, only hydraulic loss is considered (Point 2 above), all the other three
causes for loss are ignored. The maximal efficiency finally obtained is 84.2%, a relatively high
value. It is found for fully laminar flow conditions. In that case, the observed loss corresponds
simply to the energy dissipation introduced by laminar viscous friction within the fluid.
The second, far more advanced optimization (geometry shown in Fig. 6.8) is for a realistic
Tesla pump involving seven plates, a shell case and an inlet with a change in flow direction;
this is indeed a complete Tesla pump. A large transition/decelerating chamber between the
rotor chamber and the outlet is attached to the geometry, in order to minimize the influence
of the outlet boundary in the CFD on the main flow within the pump. Since this is a purely
numerical component, the hydraulic losses computed in this transition chamber are removed
from the total losses. In the optimization, the SST turbulence model has finally been used.
All types of hydraulic losses are considered in the optimization, apart from the loss in the
spiral casing chamber (Point 4), since it is difficult to include the geometry of a spiral chamber
in an automatic optimization involving mesh grid morphing. The maximal efficiency achieved
is now 52.4%. This value is, of course, much lower than the one obtained for the simple (but
purely theoretical) design. But it must be kept in mind that this is only a first attempt
of CFD-O for a Tesla pump; there is certainly a large improvement potential remaining.
Additionally, the value of 52.4% can be compared to the values obtained in Chapter 5 for a
far more complex CFD-O: from 49% up to 65.3%; the range is very similar.
Finally, the high efficiency of the optimal design from the first optimization shows that a
Tesla pump has a large potential for further design improvement, and might be indeed a good
candidate for the design of a pump with a good efficiency. If hemolysis levels are low, such
a solution might indeed be a breakthrough to transport blood. The large difference observed
between the two optimization setups implies that the hydraulic losses associated to Points 1)
and 3) are quite large (about 30%). Therefore, design modifications should be considered to
minimize the influence of these two types of losses.
One solution to minimize the hydraulic loss of type 1) is to use non-flat plates. A possible
design and method are discussed in Section 6.3.
The hydraulic losses of type 1) and 3) are accompanied by high volumetric losses. A
large back-flow region is observed in the first gap (hw-region), as shown in Fig. 6.9. Using an
appropriate sealing at the entrance of the planes, these volumetric losses could be noticeably
reduced, thus increasing again the efficiency.
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Figure 6.9: Obtained radial velocity profile [10]
Figure 6.10: Obtained tangential velocity profile [10]
Looking at Fig. 6.11, it may be observed that the group of solutions with the highest
efficiency (Pareto front) is associated with the minimal inlet radius Ri prescribed in the
optimization. There are two possible reasons: a) using a smaller inner hole at the entrance
helps reducing the swirl in the neck region (Fig. 6.12), thus reducing also the level of back-
flow; b) the prescribed range for Ri has not been chosen properly, and should include even
lower values.
Figure 6.11: Efficiency vs. design variables Ra and Ri in mm [10]
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Figure 6.12: Velocity vectors in the neck region [10]
Another interesting observation from Fig. 6.13 is that efficiency is highly dependent on
h. One explanation is that, since the number of planes and the total flow rate are fixed in
the optimization, the flow rate in each gap is fixed as well. Hence, h completely decides
the type and profile of radial velocity between the disks, which is an essential feature to get
a high efficiency. However, if the number of planes could be varied in the optimization, a
noticeably smaller value for h in combination with a slightly smaller value of Ra should be even
better from a theoretical point of view, since a smaller h facilitates the tangential acceleration
of fluid and leads to a flatter tangential velocity profile. Such a mixed integer/real-valued
optimization is, however, a very difficult task to carry out in automatic mode.
Figure 6.13: Efficiency vs. design variables h (in mm) and Ra/Ri [10]
6.3 Further Improvements
Non-flat plates (Fig. 6.14) are expected to produce a smoother change in flow direction at the
inlet, together with a flatter velocity profile farther from the rotation axis. The major difficulty
for considering this point in a CFD-O lies in the geometrical complexity of this design, which
requires typically many more geometrical input variables compared to a traditional design.
Following the method derived, implemented and tested in Chapters 4 and 5, an approach is
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proposed to reduce the number of design (geometrical) variables to a minimal level, at the
end with only four input variables: d10, b10, d1 and hw in the simplest case. This method
relies again on the ideas underlying DTB-CFD-O of Chapter 4.
Figure 6.14: Possible Tesla pump with non-flat plates
The outer diameter of the plates, d10, and the height of the trailing edge, b10, are the
first two design variables. The diameter d1 of the middle point (Point 1 in Fig. 6.15) of the
entrance edge is taken as the third design variable describing the geometry.
Figure 6.15: Skeleton of the structure of a Tesla-pump with non-flat plates, including a
possible parametrization of the geometry for CFD-O
Then, the height of the entrance edge b1 can be determined by Eq. (6.4), which is based on
the assumption of an identical cross-section area of the flow passage along the radial direction.
b1d1 = b10d10 = b2d2 = b3d3 = ...... (6.4)
Then, d2 is computed as one ninth of the difference between d10 and d1: d2 = d1 +
0.1111(d10 − d1). At that point, b2 is determined similarly to b1 by Eq. (6.4).
Point 1b (the beginning point of the top plate) is located at a fixed position. Then, the
position of Point 1a (the beginning point of the bottom plate) can be calculated by:
x1a = d1 + (d1 − x1b) (6.5)
y1a = y1b −
√
b21 − 4(d1 − x1b)2 (6.6)
The middle line (the red line in Fig. 6.15) between Point 1 and Point 10 is generated
by using a fixed starting slope, gradually reducing this slope to 0. All the edges of the
cross-sections (except the first one) are perpendicular to it.
Finally, the positions of all points (1-10a, 1-10b) on the top plate and the bottom plate
are all known. The middle plates can be discretized by equidistant points on the cross-section
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edges. For simplicity, it is proposed to take a constant clearance hw as the fourth and last
design variable. Then, the whole geometry of the pump is described with four parameters,
but without inlet pipe and spiral casing. Adding these two important components in the
optimization will certainly lead to an optimization with almost 10 design parameters, that
will be left for future projects.
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Chapter 7
Conclusions and Perspectives
7.1 Conclusions
7.1.1 Numerical Hemolysis Prediction Models Need Improvement
Different numerical hemolysis prediction models have been reviewed, partly validated and
compared in this dissertation. Most existing models are only derived from the simple power
law equation, which is based on macroscopic measurements of hemolysis followed by curve
fitting, without any consideration of the real properties of blood. Eulerian formulations of
existing models have been introduced and tested during this PhD. All these models, including
the new approach, show specific advantages and drawbacks, and there is unfortunately no
clear guidelines concerning applicability or limitation of those models. An even worse difficulty
is the lack of well-documented experimental data suitable for a final check or improvement of
those models under realistic conditions!
Based on a first simple validation, one simple Lagrangian power-law model (Model C)
performs best, followed closely by a much more complex Lagrangian stain-tensor-based model
(Model E). Considering that Eulerian models are much more suitable for coupling with CFD
simulation (an Eulerian model with scalar transport equation is directly compatible with
industrial CFD tools), corresponding formulations have been derived, leading to the Eulerian
versions of Model C and E. Unfortunately, the model with the highest potential in principle,
the Eulerian version of Model E, can not be implemented yet into any existing CFD solvers
(including OpenFOAM), due to the structure of the resulting equations. For this reason,
most presented results have been obtained with the Eulerian version of method C, though
this model did not perform well in all tests.
One advantage of model C is that, by modifying the values of a and b in Eqs.(2.33)-(2.34),
the model sensitivity to peak shear stress and average shear stress can be separately adjusted
and balanced. This feature makes model C a good candidate for further optimization(s) based
on parameter fitting, aiming at better prediction of trends but also of absolute values from
relevant experiments, such as those obtained in a blood pump when varying the rotation
speed and flow-rate in a well-instrumented experiment: such data are missing yet, but will
hopefully be released by the FDA in the next months.
Though model C is highly flexible, it is quite simple. In contrary to this, the nature
of blood and the processes underlying hemolysis are extremely complex. A direct physical
modeling of the microscopic nature of hemolysis is not possible in CFD.
The need for further experiments under well-defined, reproducible and well-documented
conditions is in urgent demand. Although this does not necessarily mean that a predictive
model for hemolysis should describe all the microscopic mechanisms, a more complex model
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has obviously a larger chance to be more universally valid and more accurate than the current
ones.
7.1.2 DTB-CFD-O is Feasible
An extended automatic optimization method for a blood pump has been developed and ap-
plied in this Thesis to a a screw-type axial-flow pump. By combining pump design theory
with many numerical tools in a suitable manner, considerable progress can be achieved. The
major finding is that the proposed integration of design theory into the design process is
indeed useful. Therefore, design-theory-based Optimization based on Computational Fluid
Dynamics (DTB-CFD-O) can indeed be used to fight against the well-known ”curse of dimen-
sionality”, by reducing the number of independent parameters involved in the optimization.
A blind optimization was not possible before for the considered configuration, involving a
three-dimensional unsteady flow in a complex geometry, due to the tremendous computa-
tional cost.
Current results are nevertheless still constrained by the performance of the employed
hardware and the availability of software licenses. By using more computer resources, an
even better design could probably be achieved, since only 220 different designs have been
evaluated yet. For this purpose, heavily relying on parallelization is necessary, both for the
optimization process (several evaluations running in parallel) and for the CFD evaluations
(each CFD simulation being carried out in parallel).
Some correlations between the design variables have been found during the optimization.
These findings, though still preliminary, may be helpful to speed-up further by extending
design theory, thus reducing the number of input variables for future optimizations.
Increasing further the complexity of the optimization, i.e., involving more design variables
in order to obtain a more detailed description of the pump, highly depends on the avail-
ability of corresponding computational facilities; there is theoretically no other obstacle to
this process. It is expected that a full 3-dimensional optimization with unsteady flow of a
real, commercial geometry will be possible before end of the current decade. If an open-
source tool like OpenFOAM can be used in a robust manner for CFD, and provided that
high-quality open-source tools become available for geometry parametrization and complex
meshing, DTB-CFD-O will have a broad range of applications.
7.1.3 The Tesla Blood Pump Deserves Further Investigation
The optimization of the simple design involving only two rotating planes shows that this type
of rotor has a potential to reach a sufficient hydraulic efficiency. Considering the lower shear
levels found in the system, a Tesla pump might then be a very good candidate for blood
transport.
Unfortunately, up to now, no comprehensive design theory has been developed for a Tesla
pump. Most existing designs show a much lower efficiency than a standard pump, owning to
the different types of hydraulic losses mentioned in Section 6.1. The proper development of
a design method for advanced Tesla pumps, involving non-flat disks, is of major importance.
This will require much mathematical description and corresponding experimental work.
In parallel to this work, CFD-O remains suitable for optimization, even before getting a
complete design theory. In fact, the results of design theory and of CFD-O will be mutually
beneficial to each other. It is expected that the results of CFD-O for advanced Tesla pumps
allowing for non-conventional designs will be very promising.
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7.2 Perspectives
7.2.1 Numerical Hemolysis Prediction: A Strain-scalar-based Model
Although the Eulerian version of Arora’s tensor-based model might be the best solution for
accurate numerical hemolysis predictions, a strain-scalar-based Eulerian model is more likely
to fit industrial applications in an acceptable computing time, for instance using ANSYS for
CFD.
Such an Eulerian strain-scalar based hemolysis model should include equations to describe
properly the two most important issues:
• the relationship between shear stress and membrane tension (Eq. 7.1), where s refers
to local membrane tension, τ refers to local shear stress;
• and the relationship between membrane tension and hemolysis (Eq. 7.2), where Ht refers
to local hemolysis rate.
ds
dt
= F1(τ, s) (7.1)
dHt
dt
= F2(s,Ht, t) (7.2)
These equations are expected to be derived from a combination of extensive experimental
studies and theoretical work. If possible, the following aspects could be considered when
formulating the equations. When taking into account hemolysis history, Eq. (7.1) will read:
ds
dt
= F ′1(τ, s,Ht) (7.3)
Taking into account membrane hardening h (though it is not clear yet if this aspect is
important for blood pumps), an additional transport equation must be introduced:
dh
dt
= F0(τ, s) (7.4)
Then, the new function F1 will look like:
ds
dt
= F ′′1 (τ, s,Ht, h) (7.5)
The hemolysis equation F2, however, should also possibly be affected by membrane hard-
ening, leading to:
∂Ht
∂t
= F ′′2 (s,Ht, h) (7.6)
After getting an explicit formulation for these equations, an optimization based on pa-
rameter fitting may be carried out. But this requires of course the availability of high-quality
experimental results. . .
7.2.2 More Flexible Coding Platform
Although it is unclear, which hemolysis model will be retained at the end, it is highly probable
that this model will involve complex equations and complex terms within each equation, due to
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the complexity of the process. Unfortunately, all commonly used CFD solvers, such as Fluent,
CFX, or even OpenFOAM, are currently not flexible enough to support such equations.
One possible solution is to include a real-time communication between the CFD solver
and outer mathematical tools, such as Matlab, Maple, or own routines. Another solution
involves an in-depth modification of the CFD-solver, which is only possible for open-source
solvers, such as OpenFOAM.
7.2.3 Meshing
Though Ansysr BladeGen und TurboGrid are powerful and adequate tools for automatic
meshing when optimizing turbomachines, other possibilities also deserve investigation. One
possibility is to carry out a two-stage optimization. The first stage is a ”coarse” optimization,
with a low computational cost, in which a design ”close to the best design” is found, generating
new geometries and new meshes for each individual. In the second stage, the design, and thus
the geometry and the mesh, will not be varied much any more. Therefore, morphing becomes
a convenient alternative. Mesh morphing without re-meshing and without topology change
is then very efficient. Such a task may even be carried out by already existing commercial
tools, such as Sculptorr, or by built-in add-ons in CFD codes.
One advantage of a topology-keeping morph lies in the fact that node and cell numberings
are kept. It is then extremely easy to project the data from an existing result file to the
new mesh. Hence, the new simulation for the new design can be restarted from the previous
solution, saving much computational time.
7.2.4 Design-theory-based Optimizer Algorithm
Current DTB-CFD-O only considers design theory to interconnect design and geometrical
variables, but is not included into the evaluation process. Further development of DTB-
CFD-O may consider the possibility of a ”design-based optimizer”, which would integrate
design theory into the operators of the evolutionary algorithm itself. For instance, the fitness
of a design individual would not only be estimated by its objective values, but simultaneously
also by other factors, derived from design theory.
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Appendix A: Flow Field Contours Required by FDA for Blood Nozzle (see
Section 3.1)
Figures A.1 to A.5 show contours of velocity magnitude.
Figure A.1: Velocity magnitude for Re=500, Reynolds Stress Model, Stress-ω
Figure A.2: Velocity magnitude for Re=2000, Reynolds Stress model, Quadratic-Pressure-
Strain
Figure A.3: Velocity magnitude for Re=3500, Reynolds Stress model, Quadratic-Pressure-
Strain
Figure A.4: Velocity magnitude for Re=5000, Reynolds Stress model, Quadratic-Pressure-
Strain
Figure A.5: Velocity magnitude for Re=6500, Reynolds Stress model, Quadratic-Pressure-
Strain
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Section 3.1)
Figures A.6 to A.10 show contours of turbulence kinetic energy, k.
Figure A.6: Turbulence energy k for Re=500, Reynolds Stress model, Stress-ω
Figure A.7: Turbulence energy k for Re=2000, Reynolds Stress model, Quadratic-Pressure-
Strain
Figure A.8: Turbulence energy k for Re=3500, Reynolds Stress model, Quadratic-Pressure-
Strain
Figure A.9: Turbulence energy k for Re=5000, Reynolds Stress model, Quadratic-Pressure-
Strain
Figure A.10: Turbulence energy k for Re=6500, Reynolds Stress model, Quadratic-Pressure-
Strain
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Appendix B
Flow Field Contours Required by
FDA for Blood Pump (see Section 3.2)
As required by the FDA, selected variable contours are also represented on following cross-
sections:
Blade passage plane zx outlet plane
Upper gap Lower gap
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Section 3.2)
xz inlet plane yz inlet plane
Figure B.1: FDA-defined cross-sections for plotting (see https://fdacfd.nci.nih.gov/)
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Appendix B: Flow Field Contours Required by FDA for Blood Pump (see
Section 3.2)
Figures B.2 to B.7 are pressure contours at blade passage plane.
Figure B.2: Pressure at blade passage plane, 2.5L/min, 2500rpm
Figure B.3: Pressure at blade passage plane, 2.5L/min, 3500rpm
Figure B.4: Pressure at blade passage plane, 4.5L/min, 3500rpm
Figure B.5: Pressure at blade passage plane, 6.0L/min, 2500rpm
Figure B.6: Pressure at blade passage plane, 6.0L/min, 3500rpm
Figure B.7: Pressure at blade passage plane, 7.0L/min, 3500rpm
Figure B.8: Color map for Figures B.2 to B.7, Pa
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Section 3.2)
Figures B.9 to B.14 show velocity contours at blade passage plane.
Figure B.9: Velocity at blade passage plane, 2.5 L/min, 2500 rpm
Figure B.10: Velocity at blade passage plane, 2.5 L/min, 3500 rpm
Figure B.11: Velocity at blade passage plane, 4.5 L/min, 3500 rpm
Figure B.12: Velocity at blade passage plane, 6.0 L/min, 2500 rpm
Figure B.13: Velocity at blade passage plane, 6.0 L/min, 3500 rpm
Figure B.14: Velocity at blade passage plane, 7.0 L/min, 3500 rpm
Figure B.15: Color map for Figures. B.9 to B.14, m/s
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Section 3.2)
Figures B.16 to B.21 show eddy viscosity contours at blade passage plane.
Figure B.16: Eddy viscosity at blade passage plane, 2.5 L/min, 2500 rpm
Figure B.17: Eddy viscosity at blade passage plane, 2.5 L/min, 3500 rpm
Figure B.18: Eddy viscosity at blade passage plane, 4.5 L/min, 3500 rpm
Figure B.19: Eddy viscosity at blade passage plane, 6.0 L/min, 2500 rpm
Figure B.20: Eddy viscosity at blade passage plane, 6.0 L/min, 3500 rpm
Figure B.21: Eddy viscosity at blade passage plane, 7.0 L/min, 3500 rpm
Figure B.22: Color map for Figures B.16 to B.21, in Pa.s
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Section 3.2)
Figures B.23 to B.28 show pressure contours at zx-outlet plane.
Figure B.23: Pressure at zx outlet plane, 2.5 L/min, 2500 rpm
Figure B.24: Pressure at zx outlet plane, 2.5 L/min, 3500 rpm
Figure B.25: Pressure at zx outlet plane, 4.5 L/min, 3500 rpm
Figure B.26: Pressure at zx outlet plane, 6.0 L/min, 2500 rpm
Figure B.27: Pressure at zx outlet plane, 6.0 L/min, 3500 rpm
Figure B.28: Pressure at zx outlet plane, 7.0 L/min, 3500 rpm
Figure B.29: Color map for Figures B.23 to B.28, Pa
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Section 3.2)
Figures B.30 to B.35 show velocity contours at zx outlet plane.
Figure B.30: Velocity at zx outlet plane, 2.5 L/min, 2500 rpm
Figure B.31: Velocity at zx outlet plane, 2.5 L/min, 3500 rpm
Figure B.32: Velocity at zx outlet plane, 4.5 L/min, 3500 rpm
Figure B.33: Velocity at zx outlet plane, 6.0 L/min, 2500 rpm
Figure B.34: Velocity at zx outlet plane, 6.0 L/min, 3500 rpm
Figure B.35: Velocity at zx outlet plane, 7.0 L/min, 3500 rpm
Figure B.36: Color map for Figures B.30 to B.35, m/s
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Section 3.2)
Figures B.37 to B.42 show eddy viscosity contours at zx outlet plane.
Figure B.37: Eddy viscosity at zx outlet plane, 2.5 L/min, 2500 rpm
Figure B.38: Eddy viscosity at zx outlet plane, 2.5 L/min, 3500 rpm
Figure B.39: Eddy viscosity at zx outlet plane, 4.5 L/min, 3500 rpm
Figure B.40: Eddy viscosity at zx outlet plane, 6.0 L/min, 2500 rpm
Figure B.41: Eddy viscosity at zx outlet plane, 6.0 L/min, 3500 rpm
Figure B.42: Eddy viscosity at zx outlet plane, 7.0 L/min, 3500 rpm
Figure B.43: Color map for Figures B.37 to B.42, Pa.s
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Section 3.2)
Figures B.44 to B.55 show selected contours for the flow conditions of 6 L/min and 3500
rpm:
Figure B.44: Velocity at 6
L/min and 3500 rpm, lower
gap
Figure B.45: Pressure at 6
L/min and 3500 rpm, lower
gap
Figure B.46: Eddy viscosity
at 6 L/min and 3500 rpm,
lower gap
Figure B.47: Velocity at 6 L/min and 3500 rpm, upper gap
Figure B.48: Pressure at 6 L/min and 3500 rpm, upper gap
Figure B.49: Eddy viscosity at 6 L/min and 3500 rpm, upper gap
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Figure B.50: Velocity at 6 L/min and 3500 rpm, yz inlet plane
Figure B.51: Pressure at 6 L/min and 3500 rpm, yz inlet plane
Figure B.52: Eddy viscosity at 6 L/min and 3500 rpm, yz inlet plane
Figure B.53: Velocity at 6 L/min and 3500 rpm, zx inlet plane
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Figure B.54: Pressure at 6 L/min and 3500 rpm, zx inlet plane
Figure B.55: Eddy viscosity at 6 L/min and 3500 rpm, zx inlet plane
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Appendix C
Matlab Code for Pump Design Theory
of a Screw-type Axial-flow Pump
clear a l l ;
cA =0; % a x i a l v e l o c i t y
z=2; % a x i a l l e n g t h o f r o t o r
phi1 =0.9 ; % squeeze c o e f f i c i e n t a t b l a d e beg inn ing
beta0=20∗pi /180 ; % average i n l e t b l a d e ang l e
dD=0.8; %s h a f t / s h e l l d iameter r a t i o
D0=0; % e q u i v a l e n t i n l e t diameter
D=0; %s h e l l d iameter
d=0; %s h a f t diameter
u1n=0; %p e r i p h e r a l v e l o c i t y at s h a f t
u1x=0; %p e r i p h e r a l v e l o c i t y at b l a d e top
beta1x =0; %b l a d e ang l e a t b l a d e top
beta1n =0; %b l a d e ang l e a t s h a f t
de l t a =0.001; %t h i c k n e s s o f b l a d e
eta =0.001; % t i p c l e a r a n c e
u2x=0; %p e r i p h e r a l v e l o c i t y at s h a f t
u2n=0;%p e r i p h e r a l v e l o c i t y at s h a f t
phi2 =0.85; % squeeze c o e f f i c i e n t a t b l a d e a x i a l end
c2 =5; % a x i a l v e l o c i t y at b l a d e a x i a l end
alpha2=40∗pi /180 ; % average f l o w ang le at b l a d e a x i a l end
Y=13.3; %p r e s s u r e head
beta2 =0; %average b l a d e ang l e at b l a d e a x i a l end
Q=0.0000833; %f l o w r a t e
Nq=110; %s p e c i f i c speed
Nqy=3∗Nq/1000 ;
n=Nqy∗Yˆ0.75/Qˆ 0 . 5 ; %r o t a t i n g speed
Duration =0; % s i m u l a t i o n dura t ion
t imeStep =0;
beta11x =0; %b l a d e ang l e a t b l a d e top 1/4 a x i a l p o s i t i o n
beta12x =0; %2/4
beta13x =0; %3/4
beta11n =0; %b l a d e ang l e a t s h a f t 1/4 a x i a l p o s i t i o n
beta12n =0; %2/4
beta13n =0; %3/4
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Axial-flow Pump
alpham1x=0; %b l a d e ang l e a t end o f f r o n t gu ide vane
alpham1n=0; %b l a d e ang l e a t end o f f r o n t gu ide vane
% s o l v i n g at r o t o r i n l e t , e q u a t i o n s see chapter 3
for i i =1:1000
cA=(4∗pi ∗( tan ( beta0 ))ˆ2∗ phi1∗Q∗nˆ2/(1−dDˆ 2 ) ) ˆ 0 . 3 3 3 3 ;
D0=(4∗Q/pi/cA ) ˆ 0 . 5 ;
D=D0/(1−dDˆ 2 ) ˆ 0 . 5 ;
d=dD∗D;
u1n=pi∗n∗d ;
u1x=pi∗n∗D;
phi=1−z∗ de l t a / sin ( beta0 )/ pi /( (Dˆ2+d ˆ 2 ) / 2 ) ˆ 0 . 5 ;
i f abs ( phi−phi1 )<0.0001
break ;
end
phi1=phi ;
end
beta1x=atan ( tan ( pi/2−beta0 )∗D/((Dˆ2+d ˆ 2 ) / 2 ) ˆ 0 . 5 ) ;
beta1n=atan ( tan ( pi/2−beta0 )∗d /( (Dˆ2+d ˆ 2 ) / 2 ) ˆ 0 . 5 ) ;
c0=cA∗phi1 ;
uM=((u1nˆ2+u1x ˆ 2 ) / 2 ) ˆ 0 . 5 ; %medium p e r i p h e r a l v e l o c i t y
%s o l v i n g at r o t o r o u t l e t , e q u a t i o n s see chapter 3
for i i =1:1000
c2=Y/ eta /cos ( alpha2 )∗2/uM;
alpha2=asin ( c0/ phi2 /c2 ) ;
phi=1−2∗z∗ de l t a /pi /(d+D)/ sin ( alpha2 ) ;
i f abs ( phi−phi2 )<0.0001
break ;
end
phi2=phi ;
end
%beta2 at middle spanwise p o s i t i o n
beta2=atan ( c0/ phi2 /(uM−c2∗cos ( alpha2 ) ) ) ;
beta0=pi/2−beta0 ; % beta0 i s be ta1
beta2=pi/2−beta2 ;
%c a l c beta2x−2n from middle spanwise p o s i t i o n
beta2n=atan (d / ( ( (Dˆ2+d ˆ2)/2 )ˆ0 . 5 )∗ tan ( beta2 ) ;
beta2x=atan (D/ ( ( (Dˆ2+d ˆ2)/2 )ˆ0 . 5 )∗ tan ( beta2 ) ;
%l i n e a r i n t e r p o l a t i o n f o r 3 a x i a l p o s i t i o n s
beta11x=atan ( tan ( beta1x )+(tan ( beta2x)−tan ( beta1x ) ) ∗ 0 . 2 5 ) ;
beta12x=atan ( tan ( beta1x )+(tan ( beta2x)−tan ( beta1x ) ) ∗ 0 . 5 ) ;
beta13x=atan ( tan ( beta1x )+(tan ( beta2x)−tan ( beta1x ) ) ∗ 0 . 7 5 ) ;
beta11n=atan ( tan ( beta1n )+(tan ( beta2n)−tan ( beta1n ) ) ∗ 0 . 2 5 ) ;
beta12n=atan ( tan ( beta1n )+(tan ( beta2n)−tan ( beta1n ) ) ∗ 0 . 5 ) ;
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beta13n=atan ( tan ( beta1n )+(tan ( beta2n)−tan ( beta1n ) ) ∗ 0 . 7 5 ) ;
alpha4x=−atan ( tan ( alpha2 )∗D/((Dˆ2+d ˆ2)/2)ˆ0 .5∗AO)∗180/ pi ;
alpha4n=−atan ( tan ( alpha2 )∗d /( (Dˆ2+d ˆ2)/2)ˆ0 .5∗AO)∗180/ pi ;
%alpha minus 1
alpham1x=−atan ( tan ( pi/2−beta0 )∗D/((Dˆ2+d ˆ2)/2)ˆ0 .5∗AI)∗180/ pi ;
alpham1n=−atan ( tan ( pi/2−beta0 )∗d /( (Dˆ2+d ˆ2)/2)ˆ0 .5∗AI)∗180/ pi ;
% radian to ang l e
beta2x=beta2x ∗180/ pi ;
beta2n=beta2n ∗180/ pi ;
beta1x=beta1x ∗180/ pi ;
beta1n=beta1n ∗180/ pi ;
beta11x=beta11x ∗180/ pi ;
beta11n=beta11n ∗180/ pi ;
beta12x=beta12x ∗180/ pi ;
beta12n=beta12n ∗180/ pi ;
beta13x=beta13x ∗180/ pi ;
beta13n=beta13n ∗180/ pi ;
D=D/2 ; % change to r a d i u s f o r f u r t h e r c a l c u l a t i o n
d=d /2 ;
t imeStep=1/n /60 ; % s o l v e r time s t e p s i z e in s
Duration=timeStep ∗540 ; % t o t a l s i m u l a t i o n time
n=n∗2∗pi ; % change r o t a t i n g speed to ang l e f o r modeFrontier
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UDF Code for Hemolysis models in
Fluent
#include ” udf . h”
// source f o r the ” dose ”
DEFINE SOURCE( D source , c , t , dS , eqn )
{
r e a l source ;
// t a u x x
C UDMI( c , t , 0 ) = 0.0035 ∗ C U G( c , t ) [ 0 ] ;
// t a u x y
C UDMI( c , t , 1 ) = 0.0035 ∗ C U G( c , t ) [ 1 ] ;
// t a u y x
C UDMI( c , t , 2 ) = 0.0035 ∗ C V G( c , t ) [ 0 ] ;
// t a u y y
C UDMI( c , t , 3 ) = 0.0035 ∗ C V G( c , t ) [ 1 ] ;
// shear s t r e s s s c a l a r , equa t ion see chapter 2
C UDMI( c , t , 4 ) = pow( 0.1667∗ (pow(C UDMI( c , t , 0 ) , 2 . 0 )
+pow(C UDMI( c , t , 3 ) , 2 . 0 ) ) −0 .3333∗C UDMI( c , t , 0 )
∗C UDMI( c , t ,3)+(pow(C UDMI( c , t , 1 ) , 2 . 0 )
+pow(C UDMI( c , t , 2 ) , 2 . 0 ) ) , 0 . 5 ) ;
// source term
source = ABS(pow(C UDMI( c , t , 4 ) , 4 . 0 ) ) ;
dS [ eqn ] = 0 ;
return source ;
}
// source f o r de l taHb /Hb , equat ion see chapter 2
DEFINE SOURCE( HL source , c , t , dS , eqn )
{
r e a l source ;
source = (3 . 31 e−7) ∗ 1/pow(ABS(C UDSI( c , t , 0 ) ) , 0 . 2 3 )
∗ pow(C UDMI( c , t , 4 ) , 4 . 0 ) ;
dS [ eqn ] = 0 ;
return source ;}
129
Appendix D: UDF Code for Hemolysis models in Fluent
130
Appendix E
User’s Fortran Code for Hemolysis
models in CFX
#include ” c fx5ex t . h”
! source f o r the ” dose ”
d l l e x p o r t ( u s e r s o u r c e )
! system v a r i a b l e s , no change
SUBROUTINE USER SOURCE (
& NLOC,NRET,NARG,RET,ARGS,CRESLT,CZ,DZ, IZ , LZ ,RZ)
INTEGER NLOC,NRET,NARG
CHARACTER CRESLT∗ (∗ )
REAL RET(NLOC,NRET) , ARGS(NLOC,NARG)
INTEGER IZ (∗ )
CHARACTER CZ(∗ )∗ ( 1 )
DOUBLE PRECISION DZ(∗ )
LOGICAL LZ(∗ )
REAL RZ(∗ )
INTEGER LENACT
EXTERNAL LENACT
! one v a r i a b l e need v a l u e from the system
#include ” s t a c k p o i n t . h”
s t a c k p o i n t pGRAD V ! p o i n t e r to g r a d i e n t o f v e l o c i t y
! g e t v e l o c i t y grad ient , WW i s the name o f the domain
CALL USER GETVAR ( ’WW. Ve loc i ty . Gradient ’ , CRESLT, pGRAD V,
& CZ,DZ, IZ , LZ ,RZ)
! c a l l the s u b f u n c t i o n
CALL USER SOURCE CAL (RET( 1 , 1 ) , RZ(pGRAD V) , NLOC)
! end o f the run
END
! i n d i v i d u a l l y d e f i n e d sub func t ion , wi th 1 input v a r i a b l e : g rad v
SUBROUTINE USER SOURCE CAL (SOURCE, GRAD V, NLOC)
!
INTEGER NLOC ! mesh s i z e
REAL GRAD V(3 ,NLOC, 3 ) ! ! a 3x3 t e n s o r f o r v e l o c i t y g r a d i e n t
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REAL SOURCE(NLOC) , tau (NLOC) , tau11 (NLOC) , tau12 (NLOC) ,
& tau13 (NLOC) , tau22 (NLOC) , tau23 (NLOC) , tau33 (NLOC)
INTEGER ILOC
! c a l c u l a t e shear s t r e s s
DO ILOC = 1 , NLOC
tau11 (ILOC) = 0.0035 ∗ GRAD V(1 ,ILOC, 1 )
tau12 (ILOC) = 0.00175 ∗ (GRAD V(1 ,ILOC, 2 ) + GRAD V(2 ,ILOC , 1 ) )
tau13 (ILOC) = 0.00175 ∗ (GRAD V(3 ,ILOC, 1 ) + GRAD V(3 ,ILOC , 1 ) )
tau22 (ILOC) = 0.0035 ∗ GRAD V(2 ,ILOC, 2 )
tau23 (ILOC) = 0.00175 ∗ (GRAD V(2 ,ILOC, 3 ) + GRAD V(3 ,ILOC , 2 ) )
tau33 (ILOC) = 0.0035∗ GRAD V(3 ,ILOC, 3 )
tau (ILOC) = (0 .1667∗ ( tau11 (ILOC)∗∗2 + tau22 (ILOC)∗∗2 +
& tau33 (ILOC)∗∗2) +
& 0.3333∗ ( tau11 (ILOC)∗ tau22 (ILOC) + tau11 (ILOC)∗ tau33 (ILOC) +
& tau22 (ILOC)∗ tau33 (ILOC) ) + 0.3333∗
& ( tau12 (ILOC)∗∗2 + tau23 (ILOC)∗∗2 + tau13 (ILOC)∗∗2 ) )∗∗0 . 5
! c a l c u l a t e source f o r the ” dose ”
SOURCE(ILOC) = tau (ILOC)∗∗4 .0
END
#include ” c fx5ex t . h”
d l l e x p o r t ( u s e r s o u r c e 2 )
SUBROUTINE USER SOURCE (
& NLOC,NRET,NARG,RET,ARGS,CRESLT,CZ,DZ, IZ , LZ ,RZ)
INTEGER NLOC,NRET,NARG
CHARACTER CRESLT∗ (∗ )
REAL RET(NLOC,NRET) , ARGS(NLOC,NARG)
INTEGER IZ (∗ )
CHARACTER CZ(∗ )∗ ( 1 )
DOUBLE PRECISION DZ(∗ )
LOGICAL LZ(∗ )
REAL RZ(∗ )
INTEGER LENACT
EXTERNAL LENACT
! 2 v a r i a b l e s need v a l u e from the system
#include ” s t a c k p o i n t . h”
s t a c k p o i n t pGRAD V
s t a c k p o i n t p D
! g e t v a l u e s from system
CALL USER GETVAR ( ’WW. Ve loc i ty . Gradient ’ , CRESLT, pGRAD V,
& CZ,DZ, IZ , LZ ,RZ) ! v e l o c i t y g r a d i e n t
CALL USER GETVAR ( ’WW.HL ’ , CRESLT, p D ,
& CZ,DZ, IZ , LZ ,RZ) ! t he ” dose ” which i s c a l c u l a t e d from the o ther
! source code
! c a l l s u b f u n c t i o n
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CALL USER SOURCE CAL (RET( 1 , 1 ) , RZ(pGRAD V) , RZ(p D ) , NLOC)
END
! s u b f u n c t i o n wi th 2 input v a r i a b l e s
SUBROUTINE USER SOURCE CAL (SOURCE, GRAD V, D, NLOC)
INTEGER NLOC
REAL GRAD V(3 ,NLOC, 3 )
REAL D(NLOC) ! t he s c a l a r f o r ” dose ”
REAL SOURCE(NLOC) , tau (NLOC) , tau11 (NLOC) , tau12 (NLOC) ,
& tau13 (NLOC) , tau22 (NLOC) , tau23 (NLOC) , tau33 (NLOC)
INTEGER ILOC
! c a l c u l a t e shear s t r e s s : tau
DO ILOC = 1 , NLOC
tau11 (ILOC) = 0.0035 ∗ GRAD V(1 ,ILOC, 1 )
tau12 (ILOC) = 0.00175 ∗ (GRAD V(1 ,ILOC, 2 ) + GRAD V(2 ,ILOC , 1 ) )
tau13 (ILOC) = 0.00175 ∗ (GRAD V(3 ,ILOC, 1 ) + GRAD V(3 ,ILOC , 1 ) )
tau22 (ILOC) = 0.0035 ∗ GRAD V(2 ,ILOC, 2 )
tau23 (ILOC) = 0.00175 ∗ (GRAD V(2 ,ILOC, 3 ) + GRAD V(3 ,ILOC , 2 ) )
tau33 (ILOC) = 0.0035∗ GRAD V(3 ,ILOC, 3 )
tau (ILOC) = (0 .1667∗ ( tau11 (ILOC)∗∗2 + tau22 (ILOC)∗∗2 +
& tau33 (ILOC)∗∗2) +
& 0.3333∗ ( tau11 (ILOC)∗ tau22 (ILOC) + tau11 (ILOC)∗ tau33 (ILOC) +
& tau22 (ILOC)∗ tau33 (ILOC) ) + 0.3333∗
& ( tau12 (ILOC)∗∗2 + tau23 (ILOC)∗∗2 + tau13 (ILOC)∗∗2 ) )∗∗0 . 5
! c a l c u l a t e source
SOURCE(ILOC) = 0.000000331∗D(ILOC)∗∗(−0.23) ∗ tau (ILOC)∗∗4 .0
END
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